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Providing primary human stem cells with the optimal environmental factors required to 
promote expansion and differentiation is no trivial task in biomedical research. Many diseases 
and pathologies are caused by deficiencies in oxygen supply or regulation. Here, intestinal 
ischemia/reperfusion injury is presented as an example to highlight the detrimental impact of loss 
of oxygen, i.e. hypoxia, on the intestinal epithelium. This dissertation focuses on oxygen as one 
key environmental factor that must be monitored to mediate cell death and facilitate cell 
expansion. Typical tissue culture platforms, such as polystyrene well plates or flasks, cannot 
supply adequate oxygen to cells nor measure oxygen concentrations at the cell-media or cell-
tissue interface. A microphysiological system (MPS) provides an advantageous platform to 
design and fabricate more physiologically relevant cell culture microenvironments that can be 
continuously monitored in real-time. Oxygen can also be controlled in MPS using the 
appropriate materials, and, furthermore, oxygen can be monitored with many integrated sensors. 
Here, two MPS are designed and built to investigate the role of severe tissue hypoxia on (i) 
tumorigenesis in breast epithelial tissue and (ii) on stem cell function, i.e. proliferation and 
pluripotency, in the intestinal epithelium. Oxygen monitoring is performed in each MPS using 
embedded micro-hydrogel oxygen sensors via phosphorescence detection. For the study of 
hypoxia on intestinal epithelial stem cell function using the developed MPS, significant 
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CHAPTER 1: MODELS OF INTESTINAL PHYSIOLOGY 
 
1.1. Cellular Components of the Human Small Intestine 
In the small intestine, a crypt and villus architecture supports an epithelial monolayer that 
absorbs nutrients and maintains a barrier against luminal contents and bacteria. The epithelial 
monolayer is rapidly renewed by a pool of intestinal stem cells (ISCs) located at the base of the 
crypt (Fig. 1.1). The epithelial lining of the small intestine absorbs and transports nutrients while 
maintaining a protective barrier against environmental pathogens.[1] Intestinal epithelial cells 
respond to stimuli from adjacent cells and their surrounding microenvironment to regulate cell 
turnover, cell death and detachment (anoikis), proliferation, and differentiation.[2] ISCs, located 
at the base of the intestinal crypt between Paneth Cells, are essential to initiate physiologic self-
renewal of all differentiated cells that make up the intestinal epithelium. At the crypt base, 
Paneth Cells are responsible for secreting antimicrobial peptides and enzymes to protect the 
epithelium from microbes and provide critical growth factors to support ISC survival and 
differentiation.[3, 4] Paneth Cells can be identified via expression of Lysozyme and other 
Defensins.[5] Above the crypt base are transit amplifying cells, which undergo up to five rounds 
of cell division during a 48-hour cycle, differentiating to become one of four main intestinal 
epithelial cell lineages (Fig. 1.1).[6] The differentiated intestinal epithelial cell lineages include 
absorptive enterocytes, often marked by Alkaline Phosphatase expression, goblet cells (marked 
by Mucin 2,3)[7], enteroendocrine cells (marked by Chromogranin A)[8], and tuft cells (marked 
by Dcamk1)[9], Paneth cells and M Cells.  
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Migrating from the crypt and entering the villus region of the epithelium, there is a 
unique geometric interplay between the cell population and the environment that gives rise to 
differentiation, form, and function. Microvascular networks exist within villi and provide 
oxygenated blood flow to the epithelial barrier. The amount of microenvironmental oxygen 
available to each intestinal epithelial cell depends largely on the location of the cell along the 
crypt-villus axis. 
The microenvironment of the intestinal epithelium is characterized by a steep oxygen 
gradient. The molecular oxygen concentration levels from the outermost, serosal aspect of the 
small intestine are significantly lower than those of the inner submucosa.[10] While the gut 
lumen is nearly entirely oxygen-depleted or anoxic, the mucosa is highly perfused by oxygen via 
the vast capillary bed surrounding the microarchitecture of the crypts and villi.[11] Despite an 
underlying microvascular network, compared to oxygen-rich tissues of the human body such as 
the arteries, alveoli, and the trachea (physiological oxygen levels from 13% to 18%), the low 
oxygen (approximately 8% O2) environment of intestinal tissue constitutes a state of physiologic 
hypoxia.[12] A common feature of a number of GI-related health conditions occurs when there 
are extensive periods of severe lower oxygen availability (less than 8% O2) in the intestinal 
tissue.[13] Although long term pathophysiologic hypoxia can lead to detrimental intestinal 
damage, little is known about how the duration and magnitude of hypoxia, particularly acute 
ischemia injuries, impact ISC function.  
 
1.2. Physiological Consequences of Ischemia and Hypoxia in the Small Intestine 
 Intestinal ischemia (blockage of blood flow and nutrients) is an aggressive disease state 
often diagnosed after the onset of necrosis in the bowel, offering few treatment options, and, 
consequently, is associated with high morbidity and mortality.[14] Dysregulation of normal ISC-
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driven epithelial renewal causes a loss of the epithelial barrier, inflammation, and, in severe 
cases, death. During intestinal ischemia, if the reduction in dissolved oxygen concentration 
(hypoxia) goes unresolved, then irreversible cellular damage can occur.[15-17]  
 Ischemic injury occurs when blood flow is interrupted for a short (minutes) or long 
(hours) period of time and is often caused by surgery (for abdominal aortic aneurysm, small 
bowel transplantation, strangulated hernias, or neonatal necrotizing enterocolitis), collapse of 
systemic circulation during hemorrhagic or septic shock, or heat stress.[18] There exist both 
occlusive and non-occlusive (surgeries) causes for intestinal ischemia. Occlusive causes, such as 
abdominal aortic aneurysms, acute mesenteric thrombi, and mesenteric emboli, involve a 
blockage in circulation, such as from a blood clot or even an air bubble trapped in vessels (Fig. 
1.2). If the blockage is resolved, a second tissue insult from reperfusion injury can occur when 
return of blood flow initiates a complex cascade of events, including pro-inflammatory cytokine 
release and increase in harmful reactive oxygen species (ROS) that damage cells and degrade 
extracellular matrix components beneath the epithelium.[19]  
 The intestinal microvascular network is the first responder to ischemic damage, as 
ischemia is presented as a blockage in blood flow. The suspended blood flow causes subsequent 
inadequate supply of oxygen to the affected tissue (Fig. 1.2). Decreased oxygen during ischemia 
causes mucosal epithelial cell damage, including sub-epithelial lifting and villi tip sloughing.[20] 
Prolonged ischemia (50+ minute) furthermore prevents the exchange of nutrients and oxygen to 
the epithelium, causing epithelial cell apoptosis and loss of membrane integrity when all villous 
epithelium sloughs off, leaving the crypt is severely damaged.[21]  
Mechanisms leading to irreversible damage of the intestinal epithelium following reperfusion 
are well-documented.[22, 23] During ischemia, hypoxanthine builds up and xanthine oxidase is 
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produced from xanthine dehydrogenase. Once oxygen is reintroduced during reperfusion, 
xanthine oxidase reacts with oxygen to produce dangerous ROS, including superoxide. 
Superoxide further damages the epithelial cell membrane via peroxidation, increasing neutrophil 
activation and inflammation. Oxidative injury continues as more ROS are released by 
neutrophils. At the cellular level, ischemic injury decreases mitochondrial Adenosine 
Triphosphate generation and cell membrane selective permeability.[24] As the duration of 
ischemia increases, epithelial cells that line the intestinal lumen lose their attachment to the 
basement membrane and become necrotic.[15] Furthermore, the duration of intestinal ischemic 
insult is directly proportional to the severity of mucosal injury.[20, 25, 26] In vivo ischemia 
models have revealed that short-term (15 minute) ischemic damage appears to be reversible in 
murine jejunum, with rapid initiation of repair mechanisms in the intestinal epithelium, while 
long-term (50+ minute) is predominantly irreversible.[21] Determining important time dependent 
epithelial repair mechanisms could mitigate ischemic injuries.  
 
1.3. HIF-1 Activation During Ischemia 
From the initial ischemic event to the restoration of blood flow, many signaling pathways 
are activated in the intestine during Ischemia/Reperfusion (I/R) injury that lead to substantial 
infiltration of pro-inflammatory mediators to and from distant organs.[14] To understand how to 
mitigate intestinal damage and injury to distant organs, the events and pathways activated during 
either ischemia or reperfusion must be segregated and studied in depth. To allow for in depth 
studies of ischemia, cells and tissues must be removed from native vasculature and never re-
exposed to environmental oxygen.  
 At the molecular level, ischemia triggers the master transcriptional factor hypoxia-
inducible-factor-1 (HIF-1) to stabilize and translocate to the nucleus, where it reprograms genes 
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to regulate epithelial cell response to low oxygen.[27] While HIF-1 dependent mechanisms have 
primarily been studied in differentiated epithelial cells or colon cancer cell lines and are known 
to impart a number of protective phenotypes, the impact of the ischemia on the self-renewal and 
differentiation capacity (i.e. stemness) of ISCs has not been studied.[28, 29] 
Immunohistochemical analyses of normoxic healthy human intestinal epithelium reveal HIF-1 
expression is absent in the proliferative crypt and importantly demonstrate that the HIF-1 
activation mechanisms are not engaged and have adapted to physiologic hypoxia.[30] However, 
hypoxic conditions imposed during ischemic injury result in an upregulation of HIF-1, 
suggesting a key role for HIF-1 in ISC function.[31] Murine ischemia models of the intestinal 
jejunum have shown that the long-term (50 min) ischemia causes a dramatic reduction in 
epithelial cell viability and membrane integrity.[21] As long-term ischemia causes reduced cell 
viability and influences HIF-1 stabilization along the crypt-villus axis, the duration of ischemic 
injury may influence ISC survival.  
 Ischemia triggers a key transcriptional response governed by hypoxia-inducible factors 
(HIFs) normally repressed by a family of oxygen-sensing HIF hydroxylases under normoxic 
conditions.[32] During ischemia, hydroxylases can no longer hydroxylate HIF-1α subunits due 
to the lack of available molecular oxygen as a co-factor, thereby allowing for HIF-1 stabilization 
and translocation to the nucleus, producing transcriptionally active complexes.[33] Functional 
HIF transcription factors trigger changes in the gene expression of many vital proteins that 
control epithelial response to ischemic conditions, including proteins activated during cell 
proliferation and death.[27] Because intestinal epithelial cells normally experience a low oxygen 
level on their apical surface that would be severely hypoxic in other tissues, precise oxygen 
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sensing is crucial to keep oxygen levels from dropping below threshold levels that impair cell 
viability and function.  
 It is known that ischemia increases the expression of differentiation markers, including 
goblet cell marker Mucin 3 (MUC3), in a HIF-1-dependent manner in mature intestinal epithelial 
cells.[34] HIF-elicited intestinal protection can also occur through anti-inflammatory 
pathways.[35] For example, increased expression of HIF-1 in intestinal epithelial cells from IBD 
patients suggests HIF-1 improves barrier protection and prevents epithelial cell apoptosis.[36] In 
a similar study, conditional knockout of HIF-1 expression in intestinal epithelial cells 
exacerbated barrier injury and resulted in more severe symptoms in a murine colitis model.[35] 
Furthermore, the barrier-protective protein intestinal trefoil factor (Tff3) gene, which is induced 
during hypoxia, has a binding site for HIF-1 in its promoter.[31] Tff3 activation by HIF-1 may be 
important to restore the epithelial barrier post-ischemic injury.   
 As HIF-1 expression correlates with oxygenation, the absence of HIF-1 in the intestinal 
crypt and presence of mature intestinal epithelial cells in the intestinal lumen corresponds to the 
oxygen gradient present during physiologic hypoxia. This localization also supports the notion 
that exposure to ischemia is important to trigger HIF-1 target genes, such as Tff3, that are 
essential for intestinal lumen barrier formation and injury repair in the intestinal mucosa. 
Hypoxic conditions result in both a mobilization of HIF-1 and an upregulation of HIF-1 
expression, suggesting a protective role for HIF-1 in the intestinal epithelium and ISCs.[31] In 
other stem cell types, including breast cancer stem cells and embryonic stem cells, ischemia and 
hypoxia cause increased proliferation and pluripotency in a HIF-1 dependent manner.[37-39] 
The potential for intestinal stem cell protection and expansion in vitro following a short or long 
 7
duration of hypoxia could facilitate enhanced mucosal epithelial regeneration and will be 
investigated further in Chapter 4.   
 
1.4. Animal Models to Study Intestinal Ischemia 
 In the 1990s, studies of I/R injury in animals began by first occluding the Superior 
Mesenteric Artery (SMA) for 10 to 60 minutes with microvascular clamps (to represent an 
ischemic event) and then reperfusion was performed for 2 to 6 hours.[40] Results from these 
initial animal studies in rats revealed I/R injury caused intestinal lipid absorption issues, along 
with necrosis and apoptosis of intestinal epithelial cells.[25, 41] The SMA occlusion model of 
I/R injury in rodents was also used to investigate how luminal nutrients, like arginine and 
glutamine, impacted the production of inflammatory mediators like inducible nitric oxide 
synthase (iNOS) and myeloperoxidase (MPO). One study used intestinal sacs filled with 
glutamine or arginine in conjunction with SMA occlusions to show that arginine, but not 
glutamine, increased iNOS and gut mucosal injury.[42] This finding was insightful, as arginine is 
a precursor of nitric oxide, which reacts with superoxide ions present during reperfusion and 
produces a highly toxic oxidant called peroxynitrite.[43] Although arginine had been previously 
considered a luminal nutrient, this study provided support for a harmful role of arginine in I/R 
injury due to enhanced iNOS production. Generally, the presence of iNOS during I/R injury 
further exacerbates injury to the intestine, as nitric oxide (NO) is a byproduct of iNOS that 
causes cell apoptosis and inflammatory injury. This study suggests reperfusion-based NO 
production can exacerbate ischemic injury to the intestine. 
   Another animal study of NO production sought to unravel the protective effect of the 
female sex hormone estradiol on acute lung inflammation induced during intestinal I/R.[44] 
Female rats were subject to ischemia via SMA occlusion after receiving an ovariectomy and a 
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single injection of 17b-estradiol. The authors found that, as compared to control female rats that 
received I/R without an ovariectomy, ovariectomy rats had enhanced microvascular permeability 
and increased MPO activity in pulmonary tissue, indicative of neutrophil sequestration into the 
lungs. Treatment with estradiol recovered extravasation levels in the lungs of ovariectomy rats. 
In contrast, treatment with a NOS inhibitor (aminoguanidine) increased MPO activity in the lung 
of intestinal I/R-injured rats that underwent ovariectomy. Overall, this study revealed that in the 
absence of ovaries female rats develop substantial dye extravasation (permeability) and MPO 
activity in the lungs following intestinal I/R. These results are in stark contrast to those of 
normal, untreated female rats that were subject to intestinal I/R alone and had no inflammatory 
lung responses. Estradiol exhibits an anti-inflammatory effect on the lung during I/R injury, but 
the mechanism of action causing lung injury after intestinal I/R remains to be determined.  
 As the above study highlights, animal models of I/R injury can reveal important 
relationships between the intestine and distant organs during this mode of injury. Despite these 
important findings, in vivo models of I/R injury are not standardized across studies or species. 
Recently, many animal studies of I/R injury have included 45 minutes of ischemia via SMA 
occlusion followed by 1.5 to 2 hours of reperfusion.[44-46] Although these times for ischemia 
and reperfusion are commonly used to recapitulate I/R injury, there are also recent studies using 
either shorter or longer periods of ischemia and longer periods of reperfusion (more similar to 
the studies performed in the 1990s).[47-49] These differences in durations of occlusion and 
reperfusion make interpreting findings across studies confounding and comparing results 
problematic. Species differences also complicate potential translation of research findings. Small 
animal models of I/R injury are pathophysiologically different than humans, as rodents have a 
high number of oxygen generating enzymes that are absent in human tissues. Rodent I/R injuries 
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are also difficult to create surgically due to microscale features and high mortality rate, rendering 
the results from rodent models less predictive.[50]  
 
1.5. Human Models to Study Intestinal Ischemia 
 While animal models may allow for some controlled experimental parameters and 
methods, they may not accurately reflect human pathophysiology due to morphological 
differences in mucosal epithelial cell populations compared with humans.[50] To study I/R 
injury in humans, intestinal tissues can be collected from patients who have undergone traumatic 
injuries (vehicle collisions, gunshot wounds, soldiers in battle, etc.) or received elective bowel 
resections. The intestinal tissues obtained intraoperatively from patients with acute traumatic 
injuries can be compared to control bowel resection tissues. Human studies of I/R injury have 
revealed many interesting findings regarding intestinal epithelial damage and repair mechanisms. 
   Clinicians have been able to investigate intestinal epithelial cell and lymphocyte 
apoptosis by using intestinal tissue samples obtained from patients with acute traumatic injuries 
and comparing them to patient samples from elective bowel resections.[51] From a cohort of 10 
trauma tissues and 6 normal tissues, the authors found that trauma tissues from the highest injury 
severity scores also had the most severe apoptosis. Using Hematoxylin and Eosin and caspase-3 
and cytokeratin 18 (M30) immunohistochemical staining, M30+ epithelial cells and Caspase-3+ 
lymphocytes with morphological changes in the form of cell shrinkage with condensed nuclei 
(pyknosis) and nuclear fragmentation (karyorrhexis) were considered apoptotic. By following 
two trauma patients from their first to their second operations, the researchers found a reduction 
in apoptosis in intestinal epithelial cells and lymphocytes in the second operation as compared to 
the first. Overall, focal apoptosis in both cell types occurred rapidly (within the first 2 to 3 hours) 
after injury and may support a mechanism for bacterial translocation into the systemic circulation 
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and a predisposition to infection following bowel injury. The authors of this clinical study 
showed for the first time that the apoptotic mechanism of cell death in lymphocytes and 
intestinal epithelial cells is conserved between animal models and human patients that suffered 
from shock and trauma.  
 Another option to study an I/R injury in a human model is to coordinate with patients 
before elective surgeries. For example, intestinal I/R models have been employed in humans 
undergoing Roux-en-Y gastric bypass or pancreaticoduodenectomy. Before removal from a 
patient, a normal segment of jejunum is isolated and subject to 30 to 45 minutes of mesenteric 
vascular occlusion, with varying lengths of reperfusion.[16, 52, 53] The newly I/R-injured 
intestinal segment is then resected, preserved, and processed for downstream analysis. Results 
from studies of experimental human intestinal I/R damage have shown that the human small 
intestine is resistant to short (30 minute) ischemic periods, with the jejunal epithelial lining 
remaining intact, and that reperfusion can cause intestinal damage that is rapidly restored, 
limiting inflammation.[53] These findings contrast similar animal studies that show short 
ischemia, when followed by reperfusion, can still cause an inflammatory response.[54-56] In a 
prolonged (45 minute) ischemic injury followed by reperfusion, the human jejunal intestinal 
barrier showed integrity loss, significant translocation of endotoxin, and an inflammatory 
response that included endothelial activation and release of proinflammatory mediators into the 
circulatory system. Although prolonged I/R injury in humans showed similar inflammatory 
responses as those seen in animals, it is unlikely that a comprehensive inflammatory response 
could be observed before intestinal tissues had to be resected from the patients and preserved.  
 Controlled human studies of ischemic injury are only possible during intestinal 
reconstruction surgeries and do not recapitulate the magnitude (% oxygen available) or duration 
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of ischemic damage typically experienced during severe hypoxia, and rodent models likely do 
not accurately represent pathophysiological I/R injury in humans.[50] Studies utilizing bypass 
patient tissues are limited in terms of their significance because patients suffering from ischemic 
injury experience much more severe ischemic damage than possible during these clinical studies 
performed in the middle of elective surgeries. Additionally, cellular resolution and statistically 
robust controlled perturbations (i.e. biological replicates) are substantially limited with these in 
vivo studies. 
 
1.6. In Vitro Models to Study Hypoxia/Reoxygenation  
 Conventional in vivo ischemic injury studies are often performed along with restitution of 
oxygen (reperfusion) and lack spatial control of the oxygen conditions inside the intestinal tissue. 
To address this concern in vitro, hypoxic chambers are used to culture epithelial cells in low 
oxygen environments for an experimentally defined duration of time. Following hypoxic 
conditioning, cells are transferred to a normoxic incubator for reoxygenation, the in vitro 
equivalent to reperfusion. Recently, Y. Li et al. discovered 6-Gingerol (a main pungent principle 
of ginger) protected the intestinal barrier from I/R-induced damage using both a rat intestinal I/R 
model and Caco-2 cells incubated under hypoxia/reoxygenation (H/R) conditions.[45] For the 
animal intestinal I/R model, rats, pretreated with or without intragastrically administered 6-
Gingerol (6G) for 3 days, were subject to 45 minutes of SMA occlusion ischemia followed by 90 
minutes of reperfusion. For the H/R in vitro culture, Caco-2 cells, pretreated with a range of 6G 
concentrations, were incubated in a microaerophilic system containing 1% oxygen, 5% carbon 
dioxide, and 94% nitrogen gas for 12 hours, and then cells were moved to a normobaric 
incubator to be cultured for 6 hours under normoxic (18.5% oxygen gas) conditions. Authors of 
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this study found that the 6G pretreatment reduced villus injury and maintained goblet cell 
viability in the intestine histological samples. Moreover, the 6G pretreatment reduced expression 
of proinflammatory cytokines (TNF-α, IL-6, IL-1b) and neutrophil infiltration (MPO) as 
quantified using ELISA kits. Cell viability measurements revealed mid to high concentrations of 
6G significantly enhanced cell viability, as compared to untreated H/R-injured Caco-2 cells. 
ROS production was also decreased in the 6G pretreated Caco-2 cells in a concentration-
dependent manner. Both in vivo and in vitro results align and support the conclusion that 6G 
attenuated intestinal I/R injury.  
 I/R injury is associated with increased intestinal barrier permeability as the epithelial 
barrier loses cells to apoptosis or necrosis. To study intestinal barrier permeability in in vitro cell 
culture systems, measurements of Transepithelial electrical resistance (TER) are often performed 
on monolayers of epithelial cells cultured on protein-coated permeable polycarbonate 
membranes inside Transwells. Transwell inserts are used inside a standard 24-well plate but 
remain suspended approximately a millimeter above the bottom of the well.[57] TER is 
measured across the epithelial monolayer using chopstick electrodes placed inside the Transwell 
insert and beside the insert inside the same well. High TER is associated with high resistance and 
corresponding low barrier permeability, whereas low TER signals a more permeable or 
potentially impaired barrier. Using a Transwell seeded with porcine intestinal epithelial cells, 
Yang et al. found that non-essential amino acid (NEAA) deprivation impaired barrier 
function.[58] In the absence of NEAA in the culture medium, impaired barrier function caused a 
significant reduction in TER, along with a reduction in the levels of important tight junction 
proteins, claudin-1 and ZO-1. This study showed a potential NEAA pathway influencing 
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epithelial apoptosis and barrier repair following injury where the addition of a NEAA could 
promote epithelial barrier restoration.  
 In another recent study that used Transwell cell cultures and TER measurements, Caco-2 
cells exhibited reduced TER when a gene called nuclear receptor-related protein 1 (Nurr1) was 
knocked down.[59] Animal studies in mice showed enhanced intestinal epithelial proliferation 
and barrier function when mice were treated with a Nurr1 activator. The mice that received 
treatment had increased Occludin and ZO-1 protein expression, which supports the theory that 
Nurr1 may improve intestinal barrier restoration following I/R injury. Inhibition of the Nurr1 
suppressor (miR-381-3p) in intestinal epithelial cells exposed to H/R conditions helped to 
mitigate paracellular permeability, as evident from decreased FITC-dextran leakage into the 
basal media from the Caco-2 cell monolayer on the Transwell membrane. Moreover, 
measurements of Ki-67 immunofluorescence showed that anti- miR-381-3p elevated epithelial 
proliferation. These findings both in vitro and in vivo boast the therapeutic potential of miR-381-
3p inhibition for mitigating intestinal epithelial damage following I/R injury.  
 Although Transwell studies and H/R conditions induced on Caco-2 cells provide useful 
insights into I/R injury in vitro, these conventional culture models using transformed cell lines 
are limited in their ability to recapitulate physiological relevance and the pathophysiology of 
human ischemia. Tumor-derived Caco-2 cells have been shown to exhibit aberrant responses to 
stimuli, such as dietary compounds, when compared to primary human-derived epithelial 
cells.[60] The discovery of conditions that enable primary intestinal stem cells to be expanded in 
culture enables highly pure populations of ISCs to be studied in H/R conditions.[61, 62] With 
primary human intestinal epithelial cells cultured in a physiologically relevant intestinal 
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microenvironment, ischemic processes can be studied at the cellular level without phylogenetic 
differences.[63]  
A microphysiological system (MPS) is an in vitro cell culture tissue construct designed to 
represent a specific biological organ, tissue, or cell microenvironment. For studying intestinal 
diseases, a MPS would require unique architecture to simulate the intestinal barrier, 
representative human intestinal cells, and nutrients and gases continuously supplied to promote 
cell expansion and physiological cell turnover. MPS of hypoxia offer a novel method to 
investigate intestinal ischemia that allow for strict control of oxygen. With an MPS incorporating 
primary human intestinal epithelial cells cultured in a physiologically relevant intestinal 
microenvironment, ischemic processes, specifically pathophysiologic hypoxia, can be studied at 
the cellular and molecular level without phylogenetic differences. Understanding how hypoxia 
affects the ISC niche has generally been limited by a) the inability to identify, select, and culture 
stem cell populations, and b) the inability to expose these populations to hypoxic conditions of 
varying magnitude and duration without reperfusion. Technologies and methods discussed in 
subsequent chapters will provide a framework to study oxygen-related processes using human 




Figure 1.1. Small intestinal crypt-villus unit. Schematic of human in vivo crypt-villus unit 
showing epithelial monolayer containing intestinal stem cells (ISCs), transit amplifying cells, and 
mature enterocyte lineages. The ISCs are located at the base of the crypt in a steep oxygen (O2) 
gradient that stretches from the underlying vascular network to the nearly anoxic villus tip. 
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Figure 1.2. Ischemic crypt-villus unit schematic. (Left) Human small intestine crypt-villus unit 
with healthy epithelium just as an intestinal blockage is trapped inside the underlying vascular 
network. (Right) Ischemic intestinal tissue with oxygen-starved epithelium as vascular network 




CHAPTER 2: MEASURING AND REGULATING OXYGEN LEVELS IN 
MICROPHYSIOLOGICAL SYSTEMS (MPS)1  
 
2.1. Overview  
  As microfabrication techniques and tissue engineering methods improve, 
microphysiological systems (MPS) are being engineered that recapitulate complex physiological 
and pathophysiological states to supplement and challenge traditional animal models. Although 
MPS provide unique microenvironments that transcend common 2D cell culture, without proper 
regulation of oxygen content, MPS often fail to provide the biomimetic environment necessary to 
activate and investigate fundamental pathways of cellular metabolism and sub-cellular level. 
Oxygen exists in the human body in various concentrations and partial pressures; moreover, it 
fluctuates dramatically depending on fasting, exercise, and sleep patterns. Regulating oxygen 
content inside MPS necessitates a sensitive biological sensor to quantify oxygen content in real-
time. Measuring oxygen in a microdevice is a non-trivial requirement for studies focused on 
understanding how oxygen impacts cellular processes, including angiogenesis and 
tumorigenesis. Quantifying oxygen inside a microdevice can be achieved via an array of 
technologies, with each method having benefits and limitations in terms of sensitivity, limits of 
detection, and invasiveness that must be considered and optimized. This article will review 
oxygen physiology in organ systems and offer comparisons of organ-specific MPS that do and 
do not consider oxygen microenvironments. Materials used in microphysiological models will 
                                                 
1 Chapter previously appeared in Analyst. The original citation is as follows: Kristina R. Rivera, Murat A. Yokus, 
Patrick D. Erb, Vladimir A. Pozdin, Michael A. Daniele. Measuring and regulating oxygen levels in 
microphysiological systems: Design, material, and sensor considerations. Analyst 144(10), 3190-3215. (2019). 
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also be analyzed in terms of their ability to control oxygen. Finally, oxygen sensor technologies 
are critically compared and evaluated for use in MPS. 
 
2.2. Introduction  
 The terminology for describing oxygen content in human tissue, or even cell culture, 
requires a fairly complex description and has been thoroughly described previously.[12] Briefly, 
the partial pressure of oxygen, i.e. oxygen tension, is how much pressure oxygen alone would 
exert if it occupied the volume. In a liquid, such cell culture media, dissolved oxygen is 
proportional to the partial pressure of oxygen in equilibrium with the liquid at the same 
temperature and pressure. However, in blood, hemoglobin binds and transports oxygen 
throughout the body, and the quantity of bound oxygen greatly exceeds the dissolved oxygen 
content. Both in vivo and in vitro, cells, tissues, and organs respond to changes in the oxygen 
tension, i.e. proportional to dissolved gases, and total oxygen availability, i.e. the combination of 
dissolved gases and chemically bound gases, in their local microenvironment. For brevity and 
clarity, we will discuss oxygen content as it relates to the total percentage of oxygen present 
(<21% O2) in a local microenvironment for the extent of this review.  
 In the human body, regions of low oxygen (<5% O2), such as the brain and muscle, exist 
in proximity to regions of much higher oxygen (11% O2), such as the arterial blood and 
kidneys.[12] While atmospheric oxygen levels typically are near 21% O2, the oxygen level in 
inhaled air decreases to approximately 14.5% O2 by the time it reaches the alveoli, i.e. the 
primary gas exchange site of the lungs.[12, 64] To traverse the alveoli, oxygen binds to 
hemoglobin in a higher concentration than dissolved O2, and it is subsequently delivered through 
the body via red blood cells. From the alveoli to capillary beds, oxygen-rich blood moves across 
into tissues and disseminates through the body along a network of arterioles and arteries. During 
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aerobic cellular respiration, oxygen molecules are consumed during the production of the 
necessary energy to perform physiological functions.[65] Many physiological and 
pathophysiological pathways are initiated by changes in these fundamental processes due to 
localized deficiency of oxygen, termed “hypoxia,” including angiogenesis and tumor 
metastasis.[66, 67] During severe or chronic hypoxia, most cells of the human body, apart from 
gut anaerobes, will experience severe stress and become apoptotic and/or necrotic.  
 Although there can be no quantitative oxygen level standardized to describe either 
hypoxic or hyperoxic environments in tissues, as they differ widely across tissues, normoxia can 
be used to describe the physiologic environment of any healthy tissue. The intricate delineations 
of normoxic oxygen levels and localized oxygen gradients across tissues impact cell 
proliferation, angiogenesis, migration, and apoptosis as studied across in vivo and in vitro 
models.[25, 65, 67-73]  
 While the normobaric (1 atm) composition of gases in dry air can be estimated at 
approximately 21% O2 and 79% N2, studies of cellular physiology using in vitro models are most 
often performed inside a cell culture incubator under non-ambient conditions. This level of 
oxygen is much higher than any present in tissue. In a typical cell culture incubator, the 
controlled supplementation of 5% carbon dioxide (CO2) and maintained relative humidity of 
100% results in a normobaric composition of gases at 37°C, as follows: 70.2% nitrogen gas (N2), 
6.2% water vapor (H2Og), 5.0% CO2, and 18.6% O2.[74] To achieve reduced oxygen levels, a 
common practice is to use expensive, bulky hypoxic incubators that only supply one specific 
level of oxygen by either regulating gas composition by using a pre-defined gas mixture or 
introducing more N2 to reduce the partial pressure of O2. The latter systems are called Tri-Gas 
incubators, and neither result in the control of microscale oxygen gradients in cell culture 
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systems during the studies. These all or nothing oxygen environments cannot recapitulate any 
physiological tissue and represent a gap in past model systems. 
 Microsystems providing precise control of environmental parameters such as oxygen can 
help bridge the gap between in vivo tissue conditions and in vitro models. To alleviate the burden 
of animal testing and better inform clinical testing, researchers are using microphysiological 
systems (MPS) that aim to replicate specific micro-anatomies or physiological function by 
integrating engineered human tissue constructs and microfluidic devices. By replicating specific 
physiological function at the micro-scale with human cells and tissues, precise questions 
concerning cell-cell and cell-environment interactions are investigated in a more physiologically-
relevant manner.[75, 76]  
 The exquisite control of both fluid transport and subsequent experimental conditions in 
MPS provides a novel capability to control oxygen levels across the engineered tissue; 
nevertheless, measurement and control of oxygen levels in microfluidic devices and MPS has not 
become a standard practice. MPS are typically gas-permeable microdevices kept inside an 
incubator operating at hyperoxic oxygen levels (19% O2), as endogenous oxygen levels 
experienced by cells within tissues are much less (Table 2.1).[12] If a MPS requires an oxygen 
concentration different from that of an incubator or ambient air, this necessitates a closed off 
environment and constant reduction or addition of oxygen via perfusion of fluid.  
 Engineering MPS that provide a means to control oxygen content while maintaining 
viable cell culture requires consideration of materials science, cellular physiology, and 
mechanical engineering. One scheme to limit oxygen heterogeneity in a microdevice involves 
using only materials that have minimal oxygen diffusivity, and oxygen is only introduced into 
the microdevice through oxygenated media or gas.[77] Another method involves using oxygen 
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permeable materials for the microdevice with isolation inside a hypoxic chamber.[78, 79] 
Specifics of diffusion-controlled methods for regulating oxygen levels in microfluidics have 
been described in prior reviews.[80-82]  
 Herein, we review and assess current methods to measure and regulate oxygen levels in 
MPS. Specifically, we summarize the physiologically relevant oxygen levels for different tissues 
and organ systems, and we address the implications of hypoxic and hyperoxic conditions on 
function and performance of the MPS. With this information in hand, we compare and contrast 
the available methods for measuring and regulating oxygen levels in microfluidic devices, in the 
framework of engineering better MPS. This tutorial review will first discuss microdevices and 
systems used for physiologic studies of oxygen in organs. Next, we explore materials used to 
build microdevices and in silico modeling used to design MPS and predict experimental 
outcomes. We end with a critical assessment of current methods of measuring oxygen in 
microdevices. This review is intended to present a general description of design considerations 
and parameters for measuring and controlling oxygen levels in microphysiological modes; it is 
not intended to serve as a comprehensive review of this rapidly evolving area of research. 
 
2.3. Microdevice models of physiological organ systems and phenomena  
 Microdevice models are rapidly transitioning to function as biological analogues for cell 
studies in vitro. MPS accommodate 3D architecture, mechanical stressors, and other appropriate 
biochemical cues that are present in vivo and necessary to study physiological processes.[83-88] 
Despite advancements in modeling cell mechanics, microdevices often fail to recapitulate the air-
liquid interfaces known to influence cells in vivo. One of the most important air-liquid interfaces 
is between oxygen and tissue, as 100 to 200 micrometers (µm) is the upper limit of oxygen 
diffusion through parenchymal tissue to reach cells before reduced oxygen availability inflicts 
 22
cellular damage.[67] Although 200 µm is the common marker of physiologic oxygen diffusion, 
the true quantity of oxygen available to individual cells depends more on the microenvironment 
provided by the organ that encompasses them and the density and proximity of surrounding 
vasculature.  
 Translating in vitro cellular responses into accurate predictions of in vivo outcomes 
requires mimicking the same physiologic oxygen levels found in the native organ. Recent 
advancements in MPS, both in material fabrication and real-time monitoring, show promise in 
measuring and controlling oxygen diffusion in cell culture. With each organ presenting unique 
oxygen environments, it is important to first define the organ-specific normoxic condition for the 
desired MPS.  The normoxic oxygen conditions and relevant cellular composition for the most 
popular engineered tissue models are illustrated in Figure 2.1. 
  
 2.3.1. Lung 
 Oxygen first enters the body via inhalation. During respiration, oxygen interacts with 
multiple layers of body tissue, from mucosal membranes in nasal passages to alveolar ducts in 
the lung, resulting in gas exchange with the circulatory system. The unique alveolar-capillary 
interface of the lung is composed of a symbiotic sandwich, composed of epithelial and 
endothelial cells separated by an interstitial space at which inspired oxygen-rich air enters the 
body while expired air composed of carbon dioxide exits. Following pathological foreign 
invasion, endothelial cells facilitate extravasation of inflammatory cells to the upper layer of the 
epithelium, where inflammatory cells phagocytose foreign invaders before further damage 
ensues.[89] Diseases that damage the alveolar-capillary interface, such as pulmonary edema, 
have been studied in MPS of lung tissue.[84] Despite the novelty of studying the alveolar-
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capillary interface with a co-culture model system, cell damage in the lung can be caused by 
factors dependent on gas exchange, including reduced or excess oxygen.[90, 91] Considering the 
influence of oxygen on the lung, a MPS that includes an air-liquid interface and the appropriate 
cell types will enable more informative in vitro studies.  
 In 2010, the first MPS was reported as an alveolar-capillary lung mimic that recapitulated 
organ-level function.[92] Huh et al. created this MPS with an alveolar-capillary interface using 
human pulmonary epithelial and human pulmonary microvascular endothelial cells to study the 
impact of breathing motions on lung pathophysiology.[84] The lung MPS showed that the cyclic 
mechanical strain induced to mimic breathing motions could cause increased vascular leakage 
and was associated with progression of pulmonary edema.[84] More recently, the same co-
culture MPS of human lung tissue, with an additional non-small cell lung cancer cell component 
integrated into the upper epithelium, was used to study drug resistance to cancer therapies and 
found that non-small cell lung cancer cells respond to tyrosine kinase inhibitor treatment and 
cyclic mechanical strain (breathing motions) by limiting proliferation and spreading.[93] These 
findings associated with pulmonary diseases and cancer could be further explored in relation to 
oxygen availability in a more advanced lung MPS.  
 A critical component lacking in this lung MPS is controlled oxygen regulation, as oxygen 
deficiency can be caused by pulmonary diseases, and hypoxia is an important development 
during cancer progression. Although this lung MPS was seminal in creating a proof-of-concept 
for using microdevices to study organ-level functions, no iteration of this MPS included oxygen 
control or measurements of oxygen transports between the alveolar and endothelial cell layers. 
 Simultaneously while Dr. Huh and other members of the Wyss Institute worked on 
integrating multiple cell types into a lung MPS, other researcher teams built lung MPS focused 
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on oxygen regulation. To study how oxygen influences lung epithelial cells, Chen et al. seeded 
carcinomic human alveolar basal epithelial (A549) cells in a microdevice with varied oxygen 
gradients.[83] Chemical reaction channels on either side of a central cell culture channel 
provided oxygen scavenging and oxygen generating gas reactions to facilitate the development 
of an oxygen gradient across the cell culture channel, isolated from the chemical reaction 
channels by polydimethylsiloxane (PDMS) walls (Fig. 2.2c). The oxygen scavenging channel 
was created using pyrogallol, a powerful organic reducing agent that absorbs oxygen in an 
alkaline solution, in combination with sodium hydroxide. The oxygen-generating channel was 
filled with hydrogen peroxide, which decomposed into water and oxygen gas with the addition of 
sodium hypochlorite. After seeding and overnight attachment, Chen et al. exposed A549 cells to 
hypoxia (≈ 0.5% O2) for 48 hours and found that a relatively low oxygen tension did not affect 
A549 cell growth. In a second set of experiments, the authors found inducing a hyperoxic 
environment (70% O2) for 6 hours caused A549 cells to peel off the substrate and induced cell 
death. One major drawback of the microdevice created by Chen et al. was the use of potentially 
cytotoxic chemicals. Furthermore, Chen et al. revealed how oxygen influences only one cell type 
found in lung tissue. Oxygen as it relates to more dynamic cell systems should be explored with 
a MPS that incorporates an endothelial component, if not more cell types. Furthermore, oxygen 
permeation through each material in the microdevice could potentially impact cellular response 
to any drug treatment and should be considered when building a lung MPS.  
 
 2.3.2. Kidney 
 The kidneys filter blood to regulate blood pressure, pH and to maintain a balance of 
water, electrolytes, and hormones. The kidneys generate energy for tubular reabsorption and 
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secretion by consuming oxygen to create ATP. The partial pressure of oxygen in the kidney is 
low, ranging from 10-15 mmHg (approximately 2% oxygen) in the inner medulla and papilla to 
40-45 mmHg (6% oxygen) in the renal cortex (Fig. 2.1).[94-97] Due to the higher oxygen levels 
in the renal cortex, cortical cells are the most sensitive kidney cell type to fluctuations in oxygen. 
In contrast, the inner medullary and papillae cells demonstrate a reduced sensitivity to hypoxic 
conditions because they generate ATP from glucose via anaerobic glycolysis.[98] Oxygen 
diffusion through the kidney is tightly regulated to ensure proper pH and molecular composition 
of the blood. A dense network of arteries channel oxygen-rich blood to the kidneys, where blood 
flows at the highest rate per gram of tissue in the entire body.[99] Reactive oxygen species 
(ROS) produced during periods of hypoxia have been shown to inhibit kidney function and cause 
renal damage.[100] Studies of kidney function and ROS have thus far been limited to in vivo 
models, but by developing kidney MPS that include oxygen gradients, the mechanisms of 
oxygen inhibition can be better understood, especially in oxygen sensitive cortical cells. 
 ROS are signalling molecules that correlate directly with the local oxygen environment 
and are released during both hyperoxic and hypoxic events. Kidney cells at the organ level are 
sensitive to increased ROS production during oxidative stress.[101] To study the modulation of 
intracellular ROS levels in Madin-Darby canine kidney (MDCK) cells, Lo et al. created oxygen 
gradients in an open-well culture model by diffusing oxygen through PDMS.[88] The open-well 
culture model was fabricated with a 100 µm-thick PDMS diffusion barrier between a 3 mm 
PDMS bottom with two gas microchannels and a 5 mm PDMS top with a 1 cm diameter 
reservoir space for cells and media. By flowing 0% and 100% oxygen through either 
microchannel, a linear oxygen profile was generated that diffused across the barrier to reach 
MDCK cells in the reservoir space (Fig. 2.2a). MDCK cells exposed to the highest oxygen 
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concentration in a microdevice produced ROS levels 1.5 times more than the initial ROS reading 
at time zero. MDCK cells exposed to the lowest oxygen concentration in a microdevice produced 
ROS levels 1.4 times more than the initial ROS reading at time zero. The 1.5 and 1.4-fold 
increases in ROS production at hyperoxic and hypoxic extremes, respectively, show that MDCK 
cells are influenced by oxygen and, furthermore, that a diffusion-based MPS can be used to 
probe oxygen as a controlled and dose-dependent variable. 
 An important functional unit of the kidney is a capillary network called the glomerulus. 
Here, circulating blood is filtered into urine via filtration across the capillary wall supported by 
differentiated epithelial cells called podocytes.[102] A recent publication by Musah et al. has 
defined culture conditions necessary to direct the differentiation of human induced pluripotent 
stem cells (hiPS) into podocytes.[103] Using the hiPS-cell-derived podocytes and human 
glomerular endothelial cells seeded on opposite sides of a porous flexible PDMS membrane 
inside a microfluidic device, the authors of this study showed for the first time that a glomerulus-
on-a-chip could functionally mimic differential clearance of large and small molecules, including 
albumin and inulin, respectively, and recapitulate drug-induced podocyte injury in vitro. While 
the glomerulus-on-a-chip offers a novel platform to study kidney glomerular function, the 
glomerulus structure is highly influenced by oxygen, as hypoxia-inducible factor (HIF)-1 and 
HIF-2 regulate podocyte development.[104, 105] Incorporating oxygen regulation into such a 
platform of the glomerulus could reveal mechanistic insight into factors that influence kidney 
diseases.   
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 2.3.3. Liver 
 In the liver, oxygen gradients modulate cellular functions over a median physiological 
range from 5 to 6% O2.[12] The drop in oxygen tension from the periportal (11-13%) to 
centrilobular (4-5%) regions of the liver is considered a primary regulator of liver zonation.[106, 
107] Liver zonation, or variant cell function from the portal vein to the central vein, facilitates 
carbohydrate metabolism and detoxification. Hepatocytes exposed to venous and arterial oxygen 
levels have shown different cellular responses, including binding activity and gene 
expression.[106] 
 To study liver oxygen gradients, Allen et al. created a parallel-plate perfusion bioreactor 
system from a polycarbonate block milled with inlet and outlet ports and two microscope slides. 
Following perfusion of media equilibrated with either 10% or 21% O2, subsequent diffusion 
gradients of oxygen were generated in the bioreactor comprised of a monolayer of primary rat 
hepatocytes. Controlled oxygen gradients influenced a heterogeneous distribution of protein 
levels in hepatocytes, including phosphoenolpyruvate carboxykinase (PEPCK, predominately 
localized upstream) and cytochrome P450 2B (CYP2B, predominately localized 
downstream).[87] The protein levels correlate with in vivo distribution, as PEPCK is 
predominately located in the higher oxygen periportal region and CYP2B is found in the lower 
oxygen pericentral region.[108] Despite validation of liver zonal induction and oxygen gradient 
generation (with miniature Clark-type electrodes), the authors of this study found that the 
bioreactor was limited to short-term experimentation (3 to 4 days), as primary hepatocytes in 
their monolayer culture quickly lost their differentiation function.  
 To better mimic the oxygen gradient in the native liver microenvironment, Bavli et al. 
expanded upon the work of Allen et al. to create a liver-on-chip that could maintain 3D 
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aggregates of immortalized human hepatocellular carcinoma cells (HepG2/C3A) for 28 days. In 
the previous parallel-plate perfusion bioreactor system, cells were organized in a single 2D 
monolayer. In contrast, the microdevice created by Bavli et al. included 9 individual microwells 
for the 3D HepG2/C3A aggregates. The 3D HepG2/C3A aggregates cultured as spheroids inside 
microwells introduced complexity to this system, as oxygen was depleted in the center of the 
spheroid. By incorporating tissue-embedded phosphorescent microprobes and a computer-
controlled microfluidic switchboard, oxygen consumption and glucose and lactate levels were 
monitored in real time.[109] This platform also included continuous controlled perfusion of cell 
culture medium. The sensor-integrated platform tracked in real-time the minute shifts from 
oxidative phosphorylation to glycolysis or glutaminolysis, signalling mitochondrial dysfunction 
and chemical toxicity before any effects on cell or tissue viability could be observed.    
 Another example of a real-time MPS that established an oxygen gradient was created by 
Domansky et al.[110] The authors designed a perfused multiwell with isolated bioreactors, each 
containing a reactor well, a reservoir well, and an integrated micropump. The reactor well had a 
collagen-coated scaffold with a diameter of 14.9 mm for cells to self-assemble into an array of 
~0.2 mm 3D tissue structures, while the reservoir well contained continuously circulating culture 
medium. With a co-culture of half murine hepatocytes and half murine liver sinusoidal 
endothelial cells seeded onto the scaffold in the reactor well, cells consuming oxygen created an 
oxygen gradient (Fig. 2.2e). The authors found that a flow rate of 0.25 mL min-1 created a tissue 
outlet oxygen concentration of approximately 50 µM (~5% O2). An oxygen concentration of 
approximately 50 µM provided a reasonable approximation of physiological oxygen gradients, 
as reported human in vivo perivenous (sinusoidal exit) region dissolved free oxygen 
concentrations range from 42 to 49 µM.[111] The oxygen consumption rates of hepatocytes in 
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the bioreactor were comparable to rates for perfused rat livers (2.6 versus 1.8 µmol·hour-1·mg 
protein-1).  
 The microreactor system used in the study by Domansky et al. has been further advanced 
with addition of primary human liver cells and commercialized by CN Bio Innovations 
(Hertfordshire, UK), with multiple researchers using the LiverChip to analyze drug metabolism 
and drug-drug interactions.[112-114] The LiverChip platform includes a pneumatically-driven 
on-board microfluidic pumping system, distributing positive and negative air pressure to 
individual valves and pump chambers, to perfuse each scaffold with culture medium and control 
oxygenation.[115] Each reactor well and reservoir well contains a filter with 5 µm pores and a 
filter support to prevent cells from entering the valves and pumps beneath them. The open well 
format provides for quick cell seeding and media exchange with pipettes. Overall, the LiverChip 
is a promising example of a commercialized MPS that considers oxygen regulation for drug 
studies. The LiverChip platform, containing both primary rat hepatocytes and primary rat 
sinusoidal endothelial cells, could also be used to investigate the impact of oxygen on liver 
zonation. Incorporation of additional cells, including Kupffer cells that line the sinusoids and are 
responsible for phagocytizing bacteria and foreign invaders and stellate cells that are activated 
during liver injury, would enable for more complex studies of liver function. These additional 
cells have recently been incorporated in a liver MPS, but this platform fails to include primary 
human cells or oxygen regulation.[116]  
 
 2.3.4. Vasculature and Skin 
 Integrated throughout all tissues is a vascular network critical for supplying nutrients and 
removing waste, including oxygen and carbon dioxide transport. Oxygen exchange is facilitated 
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largely by blood flow from the macroscale aortic valve of the heart down to the microscale 
capillary beds within tissue. Many vasculature-like structures have been created using 
microdevice technologies. In most examples, microscale vasculature is formed using hydrogels 
seeded with stem cells or mature endothelial cells and growth factors to encourage angiogenesis 
and induce vascularization.[117-120] With a random and spontaneous formation of capillary 
networks, perfusion of media is impossible and the low density of mature capillary networks 
limits diffusion of oxygen. Another option for creating vasculature inside a microdevice involves 
creating a synthetic vessel system composed of a combination of biological and synthetic 
materials.[121-123] The synthetic vessel system provides for perfusion and acts as a nutrient 
supply pathway.  
 Although all living tissues require blood supply via a vascular network, most MPS of 
various organs were first developed without consideration for a vasculature, as the focus was to 
ensure the key cells relevant to a specific organ were recapitulating in vivo functionality. One 
organ in which vasculature was not overlooked initially in MPS fabrication was the skin, as 
oxygen concentration differs significantly across specific layers of the epithelium. Oxygen 
increases significantly from 1% O2 at the outer epidermis layer of human skin to 3% O2 at the 
dermal papillae and 5% O2 oxygen at the sub-papillary plexus.[12] Many MPS have been made 
to include a vascular component (i.e. endothelial cells) in a skin equivalent, but few have realized 
perfusable networks.[124-127]  
 Recently, Mori et al. built a skin-on-chip with a perfusable network of channels coated 
with human umbilical vein endothelial cells (HUVECs).[123] The channels were created inside a 
culture device with 0.52 mm diameter nylon wires strung across connectors of the device. 
Collagen solution containing normal human dermal fibroblasts was polymerized inside the 
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culture device and then removal of the nylon wires left behind hollow channels, where HUVECs 
were seeded to form vascular channels. A dermal skin layer seeded with normal human 
epidermal keratinocytes (NHEKs) was added on top of the collagen hydrogel to complete the 
fabrication of the skin-equivalent with vascular channels. Characterizing the skin MPS, the 
authors found perfused vascular channels remained open while non-perfused channels nearly 
closed. HUVECs and NHEKs were also influenced by nutrient supply, as the perfused skin-
equivalent had 3-fold higher average cell density than the non-perfused skin-equivalent. 
Interestingly, cell density was highest closest to the nutrient supply, a depth range of 0 to 100 µm 
from the perfused skin-equivalent, and cell density was maintained on the order of 108 cells·mL-1 
around the vascular channels. These results are promising support for using perfusion systems to 
fabricate thick tissues with proper nutrient and oxygen supply. Although levels of oxygen were 
not measured in this skin-on-chip, measuring and controlling oxygen inside the perfusion system 
would enable more interesting findings in skin and vascular tissue engineering research.  
 
 2.3.5. Heart 
 The heart is the only organ relegated to dealing with the burden of handling 
deoxygenated blood from the body, pumping it to the lungs for oxygen restoration, and 
delivering oxygenated blood to the rest of the body. Blood flow begins when deoxygenated 
blood enters the vena cava and fills the right atrium, causing the right atrium to contract. 
Contraction leads blood to the right ventricle, causing the ventricle to contract, the tricuspid 
valve to close, and blood to flow through the pulmonary artery to the lungs. The deoxygenated 
blood becomes oxygenated as it flows through the alveoli and out through the pulmonary vein 
(Fig. 2.1). From the pulmonary vein, oxygenated blood enters the left atrium. The left atrium 
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contracts, as the mitral valve closes, and blood fills the left ventricle. After filling the left 
ventricle, the oxygenated blood enters the opened aortic valve and flows through the aorta to the 
rest of the body. The muscles of the heart also require oxygen to function; therefore, coronary 
arteries are necessary to pump oxygen-rich blood throughout the heart itself. The meticulous path 
of oxygenated blood flow throughout the body illuminates why the heart is a vital component to 
consider when investigating oxygen physiology. If there are any problems with the heart, such as 
arrhythmia, palpitations, or angina, the rest of the body can immediately be subject to oxygen 
deficiency. To study oxygen in the heart, cardiac muscle cells or cardiomyocytes have been 
cultured in various oxygen environments in 2D and 3D.[85, 128-131]  
 The impact of periods of low or no blood flow and subsequent low oxygen availability 
(ischemia) on the heart have been studied using primary porcine cardiomyocytes in a low-shear 
MPS of ischemia-reperfusion injury.[85] Using PDMS bonded to a glass slide to create 2 
channels, one for culturing primary porcine cardiomyocytes and one for an oxygen-sensitive dye, 
a microdevice was created. The cell culture channel was coated with Matrigel, loaded with 
cardiomyocytes, and placed inside an incubator for cells to attach before inducing an ischemic 
event. After 2 hours, the microdevice was placed inside a polycarbonate box on a microscope 
stage. The box had an opening on the bottom for cells to be imaged and inlet and outlet ports on 
the top for nitrogen flow to displace oxygen and induce ischemia within 30 minutes. Reperfusion 
was induced via rapid restoration of oxygen to the microdevice. The authors of this study found 
that during a 3-hour period cardiomyocytes exhibited 0% apoptosis while in “normoxic” 
conditions. By contrast, the number of cardiomyocytes that underwent apoptosis increased from 
3% to 22% O2 from hour 2 to hour 3 in the ischemic condition. Further evidence of ischemic 
injury came from morphological assessment of cardiomyocytes. After 1 hour of ischemia, 
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cardiomyocytes retracted from the Matrigel-coated surface and displayed spheroid morphologies, 
indicative of cell stress. Overall, this microdevice with controlled oxygen levels proved useful 
for revealing cellular responses to controlled ischemic events that would not have been possible 
in typical cell culture systems. With the perfusable polycarbonate box, oxygen content on the 
microdevice could be rapidly and precisely controlled, to simulate ischemic events of varying 
durations, from acute to long-term, to be further investigated using cardiomyocytes harvested 
from a single animal. The microdevice could be translated to clinical outcomes of 
ischemia/reperfusion injury by incorporating cardiomyocytes derived from patient-specific 
human induced pluripotent stem cells (hiPSCs).  
 Another MPS created to recapitulate myocardial function was designed to include a co-
culture of hiPSC derived cardiomyocytes and hiPSC-derived endothelial cells.[132] 
Photolithography and microfabrication techniques were used to form a PDMS microdevice with 
2 outer channels for endothelial cells and a central channel for cardiomyocytes encapsulated in a 
photocrosslinkable hydrogel of gelatin methacrylamide (GelMA). The outer channels served as 
1.1 mm wide microvasculature channels separated from the central channel by PDMS posts and 
supplied nutrients and oxygen to the central channel through media flow. The entire device was 
fabricated with PDMS and possessed a shallow depth of 160 µm, so diffusion through the top 
and side walls could deliver oxygen to the cell channels. Using this myocardium-on-chip, Ellis et 
al. revealed that cardiomyocytes and endothelial cells derived from hiPSCs from a single 
individual could be functionalized inside a microfluidic device for 7 days without losing 
phenotypic lineage commitments. Endothelial cells formed tube-like networks that infiltrated 
into the cardiac muscle channel, closely mimicking the microvasculature of human myocardium. 
Future studies that include longer culture and additional growth factors could reveal functional 
 34
networks that transport cytokines from endothelial channels to cardiomyocytes. The 
myocardium-on-chip could also be enhanced to measure and regulate oxygen diffusion, enabling 
more in-depth studies of ischemia on cardiac and endothelial cells before and after drug 
treatment.  
  Both cardiac MPS described above aim to recapitulate cardiac functions through control 
of fluid flow and cellular response. To achieve complete cardiac function on the microscale, 
human cardiomyocytes and endothelial cells must be organized in relevant microarchitecture, 
form capillary-like networks for fluid exchange, exhibit synchronized beating frequency, and 
proper stimulation response. Studies of oxygen exchange in a cardiac MPS are only possible 
after such characterization is achieved in a reproducible, long-term manner. With realized 
capillary flow and proper diffusion of gas, oxygen can become a single experimental parameter 
that can be easily manipulated in a cardiac MPS to reveal new relationships and responses on 
cell-specific functions in the heart.  
 
 2.3.6. Brain 
 With the highest metabolic activity per unit weight of any organ, the brain consumes 20-
25% of the oxygen in the entire body.[133, 134] Decreased oxygen concentration in brain tissue 
can occur with increased depth, but normal brain tissue functions with an oxygen concentration 
of approximately 4.6% O2.[12] Although the brain demands high oxygen, its inability to store 
metabolic products makes it critically dependent on oxygen delivery. Any slight decrease in 
oxygen can lead to severe brain damage in minutes. Cell-specific responses to post-ischemic 
brain damage include degradation of the extracellular matrix and astrocyte and endothelial 
detachment from basal lamina, causing increased brain microvascular permeability and glial and 
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endothelial apoptosis.[135, 136] A variety of brain MPS have been created to investigate cell-
specific responses, but controlled delivery of oxygen in these models is still in its infancy.  
 One important example of controlled delivery of oxygen in a microdevice was created to 
study hypoxia in 350 µm thick murine hippocampal brain slices.[137] Mauleon et al. altered a 
standard open bath perfusion chamber by adding a gas inlet and outlet and added this chamber to 
the top of a 100 µm thick PDMS membrane and 200 µm thick PDMS microfluidic channel atop 
a glass slide. The permeable PDMS membrane allowed oxygen diffusion from the gas channel to 
brain slice. Overall, by introducing fluid flow above and below the brain slice, the microdevice 
achieved more stable and uniform oxygen levels throughout the brain slice than had been 
previously reported with a perfusion chamber alone. The authors could induce physiologically 
relevant hypoxic insults at controllable rates and at defined locations on the brain slice. This 
technology was used to study calcium indicator dyes in brain slices from multiple species, 
including naked mole rats and mice, and multiple age groups, including postnatal (12 to 30 days 
old) and adult mice.[138, 139] 
 A more advanced brain MPS developed by Johnson et al. involved 3D printing complex 
geometry into microfluidic channels and incorporating multiple cells types, including primary rat 
embryonic sensory and hippocampal neurons.[140] The platform was manufactured using micro-
extrusion 3D printing strategies with cell suspensions fed into extruder tips to create 350 µm 
wide microchannels and 3 adjacent 6 mm chambers directly on protein-coated petri dishes. The 3 
adjacent chambers created a compartmentalized neural system with primary rat neurons and 
axons in the first chamber, self-assembled Schwann cells (S16, CRL-2941, ATCC) in the second 
chamber, and porcine kidney epithelial cells in the third chamber. The highly functional neural 
system provided a route for axon termini from the first chamber to interact with both cell types in 
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the adjacent chambers to create aligned axonal networks. Recreating the glial cell-axon interface 
inside a biomimetic system could be further expanded upon by introducing relevant fluid flow 
and oxygen exchange in 3D microchannel networks, as considered in the previous Mauleon et al. 
brain slice platform. Further examination of neural activity in an in vitro model of the brain 
requires more control of relevant brain physiology, including oxygen distribution.     
 
 2.3.7. Tumor 
 Oxygen also plays a significant role in tumor development and metastasis. As a tumor 
grows, the distance from the tumor center to the surrounding vasculature increases, leading to the 
generation of a hypoxic core. Tumor cells farther away from native blood vessels receive less 
oxygen and have limited mass transfer. The tumor stroma develops an altered extracellular 
matrix with more fibroblasts that synthesize growth factors, chemokines, and adhesion 
molecules.[141] Tumor cells respond to hypoxia by secreting chemokines that induce 
neoangiogenesis, or new vascular formation. As the tumor becomes denser and cells form close 
contacts, therapeutic drugs meant to deliver lethal concentrations of a cytotoxic agent are limited 
to outer boundaries and heterogonous distribution, thereby targeting only a fraction of tumor 
cells. Thus, a hypoxic environment can lead to drug resistance and tumor progression.[66, 142] 
Understanding how hypoxia-induced changes create tumor masses that are more resistant toward 
chemotherapy and radiotherapy could significantly improve cancer therapies.  
Microdevices with controlled oxygen mechanisms provide better experimental conditions for 
studies of hypoxia-induced changes in cancer cells and the tumor microenvironment.[66, 143-
146] One method for creating a hypoxic environment is to place a microdevice in a small metal 
hypoxic chamber and displace oxygen via nitrogen flow in the chamber.[66] Khanal et al. 
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showed that even with constant flow of oxygenated medium, a PDMS microdevice inside a 
hypoxic chamber could be deoxygenated to approximately 1% oxygen within five minutes. The 
PDMS microdevice then served as an oxygen sink, quickly deoxygenating media perfused 
through the microdevice. By displacing oxygen rapidly to establish a hypoxic environment, 
shorter pre-conditioning of cells was necessary to evaluate drug response. Preconditioning 
human prostate cancer cells to hypoxia lead to significantly different drug responses, including 
resistance to the cancer drug staurosporine and decreased apoptosis. By quickly preconditioning 
cells to hypoxic environments using microdevices, more research into drug resistance 
mechanisms could lead to improved anti-cancer compounds that are more effective against 
hypoxic tumor cells.     
 Recently, methods for generating intratumoral hypoxic microenvironments have focused 
on regulating oxygen diffusion through hydrogels and adjusting cellular oxygen consumption by 
altering cell-seeding density.[146, 147] In one example, an oxygen gradient was made in a 
fibrous collagen hydrogel by changing the thickness of the hydrogel. The fibrous collagen 
hydrogel created had an oxygen gradient increasing from approximately 1% oxygen at the 
bottom to 21% oxygen at the top.[146] Collagen was chosen as the hydrogel matrix because it 
has a fibrous structure that can be adjusted and it has a relatively low oxygen diffusion 
coefficient.[148] By adjusting the pre-incubation period of collagen gel solution (at 4C), but 
keeping the collagen concentration constant, collagen fibers aggregated without cross-linking to 
form either high fiber density (2-hour pre-incubation) or low fiber density (30 minute pre-
incubation) collagen hydrogels.  After fabricating low and high fiber density gels of heights 3 
mm tall (gradient from 1 to 15% O2) and 1.5 mm tall (gradient from 10 to 15% O2), murine 
undifferentiated pleomorphic sarcoma cells encapsulated in high fiber density hypoxic gels were 
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reported to migrated faster and degraded the matrix more rapidly than the low fiber density 
hypoxic gels (Fig. 2.2d). The increased speed of sarcoma cell motility suggests that fiber density, 
hydrogel size, and stress relaxation of hydrogels cause different cellular responses under hypoxic 
gradients. These findings are relevant to tumor progression in vivo as the tumor 
microenvironment changes from a lower to a higher density as tumorigenesis progresses. Using 
oxygen concentration to define the density of a tumor could help determine potential treatment 
options as increased fiber density may require higher doses of chemotherapy delivered to 
specific regions of the tumor.  
 
 2.3.8. Intestine 
 Hypoxic and near anoxic environments are also found in normal physiologic regions. 
One example of a normal or physiologic hypoxic microenvironment in vivo is the intestinal 
lumen, where intestinal epithelial cells and anaerobic microbes co-exist within a steep oxygen 
gradient. The steep oxygen gradient is formed through layers of tissue, from the oxygenated, 
highly vascularized lamina propria and submucosa (8% O2) to the tip of the villi (1.5% O2).[11] 
At the tip of the lumen, facultative and anaerobic microbes flourish in a near anoxic environment 
(<1% O2).[149] Interestingly, the low oxygen environment necessary to sustain a diverse and 
enormous population of facultative and anaerobic bacteria, approximately 1014 bacteria strong, 
fluctuates dramatically following digestion and metabolic demand. Within seconds of epithelial 
contact with nutrients, intestinal blood flow and oxygen extraction locally increase and then, 
following absorptive hyperemia (accumulation of blood in the underlying vessels), oxygen 
tension within the villus decreases from approximately 2% to <1% O2 as the microbial zone 
expands to break down nutrients.[150] In the rest of the gastrointestinal tract, hypoxia is 
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associated with poor function, as patients with active inflammatory diseases are often plagued by 
loss of epithelial barrier function and development of lesions.[151] Any damage to the epithelial 
barrier increases the possibility of bacteria escaping the lumen and infiltrating the body. This 
devastating phenotype of a complicated inflammatory pathway requires inflammatory disease 
studies that include controlled oxygen environments. Typically, in vitro cultures of intestinal 
epithelial cells only include constant oxygen concentrations, in contrast to the cyclic and 
gradated intestinal oxygen levels. 
 To study intestinal oxygen, MPS have been designed where precise manipulation of flow 
and diffusion support co-culture of anaerobic bacteria and mammalian cells.[152-155] One 
version of a co-culture intestinal MPS was created by Kim et al. using a PDMS microdevice with 
top and bottom cell culture microchannels separated by a porous PDMS membrane.[153] On the 
left and right sides of the cell culture microchannels, hollow vacuum chambers facilitated 
peristalsis-like cyclic mechanical strain to promote epithelial cell differentiation and villus 
formation. The microdevice included human epithelial colorectal cells (Caco-2 cell line) that 
spontaneously formed intestinal villi on the top microchannel after approximately 100 hours of 
medium flow and cyclic mechanical stretching. On the bottom microchannel, human capillary 
endothelial cells were cultured to form a monolayer on the opposite side of the porous PDMS 
membrane. Probiotic gut microbes Lactobacillus rhamnosus GG (LGG) were added to the top 
cell culture of Caco-2 cells and grew in direct contact with the epithelium for more than two 
weeks. Kim et al. found that microbial cells predominately colonized the intervillus spaces, 
despite uniform seeding, and that confined intervillus spaces within the densely packed 
microchannel potentially caused facultative microbes to rapidly consume oxygen, thereby 
producing a local anoxic microenvironment to support anaerobic microbial growth. Increased 
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microbial cell colonization in the intervillus spaces could be confirmed by measurements of 
oxygen in the gut MPS. Further investigation into the oxygen consumption facilitated within the 
cell culture microchannels would support the use of oxygen controllable systems to study host-
microbe interactions in the gut.   
 Another example of a colon MPS with a co-culture of Caco-2 cells and LGG was 
fabricated using a polycarbonate (PC) outer enclosure with sandwich silicone rubber gaskets and 
semi-permeable PC membranes.[154] The device included three microchambers, the bottom for 
medium perfusion, the middle for the Caco-2 cell chamber, and the top chamber for LGG 
microbial cells. Separating each chamber were either micro- or nanoporous membranes to permit 
exchange of biomolecular and oxygen gradients. The microporous membrane (pore diameter, 1 
µm) separated the perfusion chamber from the epithelial cell chamber to allow for perfusion-
dominant exchange, while the nanoporous membrane (pore diameter, 50 nm) separated the 
epithelial cell chamber from the microbial chamber to prevent microorganism infiltration. Both 
normoxic and anoxic culture media were perfused to the respective microchamber, with the 
concentration of oxygen in the anoxic culture media maintained at 0.1% by bubbling with 
nitrogen gas. Shah et al. used this microdevice system to show that when co-cultured with LGG, 
Caco-2 cells display transcriptional responses in agreement with host-microbe in vivo 
interactions.  
 Despite the novelty of co-culture systems, the intestinal MPS described above are limited 
by the tumorigenic cell line used to generate Caco-2 cells because Caco-2 cells differ from 
normal human enterocytes in regards to contact inhibition, as they possess tighter cellular 
junctions than normal epithelial cells.[156] A co-culture model of human-microbial crosstalk 
with oxygen control could be further enhanced with more representative cell types found in the 
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human small intestine or colon, such as primary intestinal epithelial cells and multiple anaerobic 
and aerobic bacteria that occupy the native human lumen.  
 
2.4. Design considerations for engineering physiologically-relevant oxygen gradients in 
MPS  
 
 2.4.1. Materials 
 To engineer a MPS with an oxygen gradient or hypoxic region, a material impermeable 
to oxygen must be used and any oxygen introduced into the MPS must be removed quickly. 
Cellular respiration, deoxygenation and reoxygenation of media, and removal of waste will alter 
oxygen levels, and the material must allow for rapid adjustment and reestablishment of the 
desired concentration of oxygen. To measure and control oxygen, the first parameter to optimize 
is the potential oxygen exchange through each material. Some key materials used for cell culture 
and microdevice fabrication include polydimethylsiloxane (PDMS), polystyrene (PS), 
polycarbonate (PC), poly(chloro-p-xylyene) (Parylene-C) and polymethyl methacrylate 
(PMMA). PDMS and PMMA are chosen for easy and repeatable fabrication that can provide 
microscale architecture needed for cell attachment and proliferation. Due to limited oxygen 
diffusivity, PC and Parylene-C provide microenvironments with controlled gas exchange and 
limited oxygen contamination from the surrounding environment. Collecting data from a MPS 
should be considered when choosing a material, as studies focused only on endpoint readouts 
cannot readily benefit from the real-time monitoring offered by optically transparent materials. 
Deciding on a material to fabricate a MPS involves consideration of critical characteristics, 
including oxygen diffusivity (Table 2.2) and workability, as explored for each material below. 
  Polydimethylsiloxane (PDMS). Many MPS are constructed from the elastomer, PDMS, 
in part due to ease of fabrication and optical transparency, but also due to its high gas 
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permeability, which is often desired to transport oxygen from the incubator into the cell culture 
device.[157] PDMS allows for microscale features to be designed and molded for prototyping 
via soft lithography.[158] With control of part thickness, semi-permeable membranes of PDMS 
can facilitate transport of gases through walls or layers. Despite its ubiquity in microfabrication, 
PDMS may not be the best material for microdevice applications focused on controlling oxygen 
because oxygen possesses a high diffusivity (3.4 x 10-5 cm2∙s-1) and solubility in PDMS 
compared to other common materials and thick PDMS is required for mechanical strength (Table 
2).[159] PDMS can also negatively impact cell studies because it can absorb small hydrophobic 
molecules, such as drugs, and leaches un-crosslinked oligomers into solution.[158, 160, 161] The 
absorption of hydrophobic molecules is especially an issue for MPS that intend to test drugs or 
rely on perfusion of media; therefore, the use of PDMS may contribute confounding variables in 
such studies. PDMS is also expensive and could be replaced with polymers more resistant to 
small molecule absorption, such as polyurethane or polycarbonate.[162] PDMS can be 
chemically modified using oxygen plasma treatment to enhance hydrophilicity and allow for 
better cell attachment and viability.[163] PDMS microdevices can also be coated with ECM-
components or integrated with hydrogels, but these additions may negatively impact the optical 
transparency of the microdevice surface, sacrificing visibility needed for monitoring cell 
morphology via real-time microscopy.  
 Polystyrene (PS) is the most popular cell culture material used to manufacture cell 
culture flasks and plates. Its optical clarity, ease of molding, and stability during sterilization via 
irradiation make it a gold-standard material for mass production of cell culture platforms. PS has 
a relatively low oxygen diffusion coefficient (2.3 x 10-7 cm2∙s-1) compared to other plastics and 
polymers, therefore, it can be used for microdevices which aim to control oxygen permeation 
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(Table 2.2).[164] PS can create 3D oxygen gradients, as it is a semi-impermeable barrier on the 
sides and bottom of any culture dish and allows for oxygen to only traverse the space between, 
which can be filled with hydrogel for a cell system.[146] One disadvantage of PS for cell culture 
is its hydrophobic surface, which limits cell adhesion. Most PS plates are treated using either 
gas-plasma under vacuum or corona discharge under atmospheric conditions to be more 
hydrophilic.[165, 166] If an MPS is to be fabricated with PS walls or layers and requires cell 
attachment, then the surface will require chemical modification. PS is also more difficult and 
expensive to prototype on the microscale, as it requires expertise in micromilling and thermal 
bonding, as compared to the soft-lithography techniques used for PDMS prototypes.[167]  
 Polycarbonate (PC) can be added to microdevices to control oxygen.[85, 87, 154] PC 
has a very low oxygen diffusion coefficient (8.0 x 10-8 cm2·s-1) compared to other microdevice 
materials and PC films have been used to surround PDMS devices and prevent oxygen diffusion 
from an incubator into a microdevice.[144, 168] PC is also easy to machine and can be sterilized 
via autoclave. In one study, a PDMS device was created with a PC film layered above 
microchannels composed of a central gel region with media channels and gas channels flanking 
each side (Figure 2).[144] Normoxia was created using a humidified gas mixture of 21% O2, 5% 
CO2, and 74% N2, each supplied to the microdevice channels at a flow rate of 18 ml min
-1, 
corresponding to fluid flow dominated by advection. A 10 wt.% sodium sulfite (Na2SO3) 
solution humidified a 0% O2 gas mixture to remove dissolved oxygen and generate uniform 
hypoxia in the microdevice. Next, one gas channel was switched from 0% to 21% O2 to generate 
an oxygen gradient. The authors of this study found that with the PC film approximately 2% O2 
could be achieved within a microdevice, whereas without the PC film the lowest oxygen tension 
achieved was 6.5% O2. Once validated, the microdevice was used in studies comparing how 
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normoxic and hypoxic environments affect human breast cancer cell migration. Using 3D 
confocal imaging in real-time, the authors reported that hypoxic conditions promoted directional 
cancer cell migration and increased migration speed as compared to normoxic conditions. 
 Poly(chloro-p-xylyene) (Parylene-C) has been used to coat PDMS microdevices and 
prevent oxygen contamination from ambient air. Using a film as thin as 2.5 µm, a Parylene-C 
coating has been shown to inhibit oxygen diffusion through a PDMS membrane.[123, 157, 169, 
170] In experiments designed to compare the diffusion of oxygen through Parylene-C, PDMS 
microchannels were fabricated and bonded to PDMS membranes with and without Parylene 
coatings.[169] Using fluorescent oxygen sensors placed directly below the membranes, 
researchers found that an infusion of 0% oxygen gas (5% carbon dioxide and balanced nitrogen) 
through the PDMS gas channel caused an uncoated PDMS membrane to equilibrate to 0% O2 
within a minute. In contrast, a Parylene-coated PDMS membrane sustained an oxygen 
concentration of approximately 21% O2, remaining at the same concentration of oxygen as 
present in the surrounding environment despite the flow of anoxic gas on the opposite side of the 
coated membrane.[169] Similarly, when challenged with an infusion of pure O2, the uncoated 
PDMS membrane reached 100% O2 within a minute, whereas the Parylene-coated PDMS 
membrane remained at approximately 21% O2. These results demonstrated that Parylene-C is a 
useful coating to add on to any microdevice material to prevent oxygen contamination from 
ambient air when coated on the outer walls of the microdevice or between different layers when 
coated on partitioned membranes.  
 One major disadvantage to coating any surface with Parylene-C is its hydrophobicity, 
which can lead to extremely low cell adhesion. O2 plasma treatment can be used to alter a 
Parylene-coated surface to make it more amenable to cell culture as the treatment alters the 
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surface from hydrophobic to hydrophilic.[171] O2 plasma treatment has been shown to increase 
the adhesion of collagen and cells on Parylene by permanent addition of hydrophilic groups, 
such as hydroxyl and carboxyl groups that increase adsorption of adhering molecules of the 
culturing medium.[172, 173] Comparing a plasma-treated Parylene-C surface to a non-treated 
Parylene-C surface, Hoshino et al. found that plasma-treatment increased neural cell 
adhesiveness more than twenty times.[172] These findings significantly support the use of O2 
plasma treatment to increase cell attachment, because neuronal cells typically have worse cell 
adhesiveness than any previously tested cells. Another option when using Parylene-C is to only 
coat the walls and outside of a microdevice, thereby allowing for cells to adhere to an uncoated 
surface or membrane inside the device and still limiting outside environmental oxygen 
contamination.[169] Coating a microdevice with Parylene-C can be performed using a 
commercial chemical deposition system to complete vacuum vapor deposition polymerization.  
 Polymethyl methacrylate (PMMA) has a very low oxygen permeability (2.7 x 10-8 
cm2·s-1) compared to other common microdevice materials.[174] PMMA, also known as acrylic, 
is biocompatible and amenable to micromachining, therefore it has been used to create replicate 
microdevices.[91, 109, 175-178] PMMA is often used as a support layer on the top and/or 
bottom of microdevices to prevent environmental oxygen contamination. PMMA is 
mechanically and thermally robust enough to support multiple microfabrication techniques 
including, laser cutting/engraving, milling, hot embossing, and injection molding, while 
maintaining high-resolution microscale geometries.[179-182] PMMA is transparent to visible 
and near infrared (NIR) light, allowing for in situ imaging and fluorescence-based 
characterization.[183] PMMA can be fabricated into porous microfluidic films to transform the 
material from possessing a very low permeability to one that possess a high permeability 
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comparable to PDMS.[184] Gas diffusion is possible across the PMMA porous film, which can 
be used to oxygenate media on the opposing side of the film without disturbing cell aggregates or 
monolayers beneath the film. With PMMA porous films, multiple layers in a microdevice can be 
easily stacked, allowing for different functions and morphology across a single microdevice. For 
MPS, a PMMA porous film could facilitate oxygen diffusion through specific layers and offers 
an alternative material to bypass the potential leaching of oligomers into solution observed in 
PDMS. 
 
 2.4.2. Methods of controlling oxygen content and distribution in MPS 
 Hydrogels form 3D extracellular matrix (ECM)-like environments for cells to align 
within, on top of, and alongside which are much more like native tissue in the body than standard 
flat tissue culture plates. Hydrogels can also be modifiable, as cells secrete their own ECM 
proteins and remake a hydrogel matrix. Cellular hydrogels can be made of many biological 
materials such as agarose, collagen, gelatin, and Matrigel and supplemented with additional 
ECM-like components such as RGD-binding motifs.[144, 147, 148, 185, 186] One example of 
an oxygen gradient in a microdevice created with a hydrogel was made with agarose gel and 
PDMS.[186] The microdevice was made with two perfused microchannels, the bottom channel 
filled with 0% O2 gas (in balanced nitrogen and 5% CO2) and the top channel filled with either 
5% or 21% O2 gas. With continuous perfusion of oxygen, a steady-state oxygen gradient was 
formed in an agarose hydrogel sandwiched between the two microchannels. A platinum-based 
fluorescent oxygen sensor was used to confirm the presence of an oxygen gradient across the 
agarose gel and will be described in more detail below. Generating an oxygen gradient across a 
hydrogel can be easily realized inside MPS designed with inlet and outlet ports for gas flow. One 
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consideration when deoxygenated via gas diffusion is that the defined oxygen levels at each step 
across the oxygen boundaries cannot be measured without multiple oxygen sensors measuring in 
parallel along the length of the hydrogel.   
 Transwells can be used for hypoxic studies with an additional insert. A transwell, or 
Boyden chamber, is a porous membrane-based platform polarized for migration and invasion cell 
studies. A transwell is composed of a chamber insert with a Polyethylene terephthalate (PET) 
porous membrane placed inside a PS tissue culture well plate well. Typically, two different cell 
types are cultured inside the transwell on opposing sides of the porous membrane, facilitating 
cellular interaction. Using microdevice fabrication techniques, a hypoxic chamber has been made 
inside a transwell with a Parylene-coated PDMS microfluidic network for gas infusion, as shown 
in Figure 2.2f.[169] By enclosing the entire well within the Parylene-coated insert, a hypoxic 
environment in the device was achieved, equilibrating to 1% O2 in just 20 minutes.[169]  
 Although transwell inserts offer a simple method to studying cell-cell interactions, 
generating a controlled oxygen environment in a transwell by adding more components is more 
difficult than creating a controlled oxygen environment with a microdevice alone. Transwells are 
limited to studies of only two cell types, whereas microdevices have been designed to include as 
many as four cell types thus far.[116] Microdevices offer higher sensitivity and control over 
diffusion of soluble factors than transwell derivatives because microdevices can be fabricated 
with channels and compartments to provide greater spatial organization.[57] Some initial co-
culture studies of oxygen can be performed using modified transwell inserts, but the number of 
cells and medium required will remain limiting factors in Transwells that are typically in 
volumes of milliliters, whereas microdevices offer an alternative approach to investigate oxygen 
in cell culture systems while minimizing resources.   
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 Microdevices can rely on rapid diffusion of small molecules to generate an oxygen 
gradient.[87, 109, 146, 147, 154] Diffusion through liquid medium can be estimated inside a 
microdevice, assuming steady-state transport in a uniform flow field. With lateral diffusion in a 
given direction, oxygen concentration at any location is dependent on the channel height and 
length, as well as oxygen diffusivity and the Peclet number. The Peclet number is the ratio of 
advection to diffusion, calculated using the average flow velocity in a channel, the width of the 
channel, and coefficient of diffusion.[87] A Peclet number of 100 characterizes transport of fluid 
flow dominated by advection. As flow velocity decreases, the Peclet number decreases and 
diffusive transport dominates convective transport. Dominately diffusive transport at lower flow 
rates allows for oxygen gradients to form along the length of a microdevice, as shown by Allen 
et al. in 2003.[87] By perfusing media across the length of a 28 mm x 55 mm x 100 µm channel 
at a rate of 0.35 mL·min-1 for 24 hours, Allen et al. created a MPS of the liver with appropriate 
zonation of oxygen, from 21% O2 at the inlet to <1.5% O2 at the oulet. Developing an oxygen 
gradient across a channel with simple Cartesian geometry provides a uniform flow field, but 
deleterious fluid shear and cell seeding conditions can lead to non-uniformity in the flow field 
and must be considered in any model predictions.  
 Oxygen gradients in microdevices have been generated with O2-N2 mixtures.[66, 85, 176, 
187-189] Using an off-chip multichannel gas mixer, Alder et al. fabricated oxygen concentration 
gradients with linear, exponential, and non-monotonic profiles ranging from 0 to 21% O2 in a 
single device. By optimizing the thickness of PDMS between the flow and gas channels (120 
µm), a discrete series of oxygen concentrations in the gas channels translated to smooth gradients 
of oxygen in the flow channels.[187] Oxygen gradients created using O2-N2 mixtures are limited 
by the number of gas channels, the period of the gas channel array, and the thickness of PDMS 
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between the gas and flow channels. Polinkovsky et al. fabricated microdevices that included on-
chip gas mixing networks to generate a series of nine different gas mixtures using only two gas 
inlets, each fed with pure N2 and O2.[176] With serpentine channels and three stages of mixing, 
one microdevice exhibited a linear dependence of oxygen concentration on the channel number. 
The oxygen concentration increased from 0% to 100% O2 across the array of microchannels in 
the device. Another microdevice created by Alder, Polinkovsky and colleagues with serpentine 
gas-mixing networks but with gas inlets of pure N2 and 20.9% O2, produced an exponential 
dependence of oxygen concentration on channel number, shifting from 0% O2 in channel one to 
20.9% O2 in channel nine (Fig. 2.2b). A feasibility study looking at how an exponential change 
in oxygen affected Escherichia coli (E. coli) growth found that cells grew faster at a higher 
oxygen concentration but colony growth rates displayed the largest increase at near 0% O2.[188] 
Although gas mixtures can achieve well-defined oxygen gradients, the disadvantages include 
intricate system design and setup and potential issues drying out the chamber when gas flow is 
used. 
 Liquid oxygen scavengers can remove oxygen chemically to achieve a desired oxygen 
concentration and bypass some potentially complicated microdevice designs. Chemicals that 
removed oxygen from solutions, or oxygen scavenging agents, have been used in PDMS 
microdevices to consume oxygen in culture and create oxygen gradients.[83, 177, 190, 191] One 
potential drawback to using an oxygen scavenging agent is its potential cytotoxicity at high 
chemical concentrations, which can lead to unwarranted cell stress and apoptosis.[192] 
Separating the oxygen scavenging liquid from cultured cells is paramount to limit chemical 
toxicity, and with microdevice fabrication techniques, separate channels can be manufactured to 
prevent unwarranted chemical interactions. In the lung model created by Chen et al., pyrogallol, 
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a powerful organic reducing agent, was combined with sodium hydroxide to create an oxygen 
scavenging reaction, while hydrogen peroxide and sodium hypochlorite were combined in 
another chemical channel to generate oxygen.[83] The chemical channels created an oxygen 
gradient across a microdevice without interfering with the cell culture channel in between them, 
because each chemical channel was separated by 50 µm thick PDMS walls (Fig. 2.2c). The 
thickness of the walls was significant as it allowed for oxygen to diffuse readily but limited toxic 
chemical by-products from harming cells.  
 Using oxygen scavenging liquids with a gas permeable membrane to control oxygen 
gradients was first proposed by Skolimowski et al.[177] The novelty of Skolimowski et al. 
comes from a microfluidic device design that separates channels containing oxygen-scavenging 
liquid from chambers with media. The complete device includes two PMMA bottom layers for 
inlets and outlets and the oxygen scavenging liquid is composed of 10 mM sodium citrate. Next, 
there is a 60 µm thick PDMS oxygen permeable membrane. Lastly, there is a 150 µm thick cell 
culture chamber and a glass slide covered with oxygen sensing dye. The device was used to 
culture bacteria Pseudomonas aeruginosa (P. aeruginosa), which is a pathogenic, recurrent 
cause of lung infections in patients with cystic fibrosis. During metabolic challenges associated 
with varying oxygen availability within the mucus layers of the CF respiratory system, P. 
aeruginosa sustains colonization in the human airways by switching from aerobic to anaerobic 
respiration. Studies of P. aeruginosa in different dissolved oxygen environments required a 
device with controlled oxygen concentrations. The authors of this study reported that P. 
aeruginosa was negatively influenced by reduced oxygen, as a decrease in oxygen availability 
caused a reduction in the number of attached cells to the surface. 
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 2.4.3. Computational Modeling 
 When designing MPS, in silico modelling is an invaluable tool for simulating physical 
parameters. Computational modelling not only saves resources, but also it can inform expected 
results or potential limitations of a MPS design. In silico models provide a theoretical data set to 
compare to in vitro results, a necessary engineering process that can simultaneously characterize 
and validate a model. Important categories to distinguish in an in silico model include steady-
state versus dynamic, stochastic versus deterministic, continuous versus discrete and local versus 
distributed. Finite element analysis (FEA) is a form of discrete simulation described by local and 
deterministic calculations of ordinary or partial differential equations that represent the physical 
phenomenon at steady-state or dynamically. Other methods include lumped element modelling 
and Monte Carlo simulation, which can both evaluate and refine the underlying theory of 
models. The main physical phenomena simulated in in silico modelling include fluid dynamics, 
mass transfer, and solid mechanics, and, to a lesser extent, electronics, acoustics, and magnetics.  
 FEA is perhaps the most popular method for simulating fluid dynamics and mass transfer. 
The typical workflow of running a simulation involves describing the physics, building the 
model, establishing the boundary conditions, discretizing the model into elements, applying the 
relevant equations to the elements and boundaries, calculating the numerical solutions to the 
equations and, finally, visualizing the simulated model solutions. With known material properties 
and reasonable assumptions, thorough mathematical models have been used to predict 
experimental outcomes for various MPS.[110, 147, 177, 187, 193, 194]  
 Inside MPS, dynamic fluid flow is finely tuned and controlled in ways not possible on the 
macroscale due to inertial forces. Fluid dynamics of MPS are described by the Navier-Stokes 
equations and the fluid continuity equation, which maintain local conservation of momentum and 
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mass, respectively. Cell media is considered incompressible, Newtonian, and fully developed, 
with no-slip boundary conditions. This simplifies the Navier-Stokes equations and continuity 
equations, which can be further simplified if the model is simulated at steady-state and the fluid 
is in the laminar flow regime. In microchannels, fluid flows are generally considered laminar, 
because viscous forces far exceed inertial forces resulting in laminar flow.[75, 195]  
 Steady-state versus time-dependent is a parameter that can be changed based on the 
model and the experiment. At steady state, an oxygen transport model uses fluid dynamics 
equations to calculate flow profiles and mass transfer equations to calculate the oxygen 
concentration.[110] Navier-Stokes and fluid continuity are equations of fluid dynamics, while 
convection-diffusion, Brownian motion, Fick’s Laws, and the mass continuity equation, are 
equations of mass transfer. Fluid dynamics equations are used to calculate the velocities and 
momentum of liquid and gaseous fluids, while mass transfer equations are used to calculate 
chemical concentrations and diffusion in those fluids. In order to accurately model oxygen levels 
in microfluidic devices both fluid dynamics and mass transport should be coupled. Typically, the 
solution to the fluid dynamics simulation is calculated and used as a variable in the mass transfer 
equations to solve for the concentration profile of dissolved oxygen due to convection and 
diffusion. On the microscale, there is no turbulent flow to enhance mixing, but laminar flow can 
be significant when dealing with gradients, therefore the convection-diffusion equation is used to 
define the concentration of oxygen species throughout a microchannel. The change in 
concentration over time can be solved for by calculating the flux of oxygen due to diffusion and 
convection then adjusting for any flux sources or sinks. Flux is the amount of a chemical species, 
oxygen, moving through an area over time. Cellular consumption rate, a value dependent on both 
cell type and cell density, is an example of an oxygen sink. Concentration profiles are generated 
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across the geometric space. With known values for parameters including density, viscosity, and 
diffusivity of oxygen in media, gas, and microdevice materials, the optimal oxygen tension for a 
respective cell culture can be simulated before experimental validation. Varying degrees of shear 
stress in a channel can be predicted with a simulation, but, experimentally, shear stress should be 
minimized to ensure long-term cell survival in any MPS.  
 Experimental cellular respiration values are important to consider for models that are 
meant to study cell mechanics in vitro compared to in vivo.[110, 147] Many different gases are 
generated as by-products of cellular respiration and metabolism; therefore, anaerobic 
microdevices must be able to evacuate gaseous products to sustain low oxygen levels. Oxygen 
consumption values for bacteria and mammalian cells are often reported in units of millimoles 
(mmol) per hour per number of cells and must be converted to oxygen flux for use in most 
computational models. Using Henry’s Law and a known cellular respiration, the oxygen flux 
necessary to sustain a tightly packed monolayer of cells can be calculated. Henry’s Law states 
that the concentration of a dissolved gas is equal to the partial pressure times the solubility 
coefficient of that gas.[196] At a constant temperature, the oxygen flux of cells in a microdevice 
can be calculated by multiplying a known concentration of oxygen by Henry’s constant. The 
oxygen flux can represent a flux discontinuity at the individual cell boundary or entire monolayer 
surface. The cell density can then be altered to achieve a limited change in oxygen concentration 
across a material.[176] Analytical solutions to computational models of cellular respiration 
typically overestimate oxygen consumption in low oxygen environments because constant 
oxygen uptake is assumed, although many cell types report oxygen uptake decline following 
isolation.[193, 197, 198] An explicit approximation of Michaelis-Menten oxygen consumption 
kinetics offers numerical solutions that more closely correlate with measured values.  
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An in silico model of a physiological phenomenon, such as oxygen exchange in cells, can 
have its shortcomings, including assumptions such as constant influx of nutrients or constant 
cellular uptake. Such shortcomings can be bypassed with in-depth cellular experiments beforehand 
and knowledge of the differences between a given cell type in vivo versus in vitro culture. To better 
predict and control oxygen in a MPS, in silico models should account for fluctuations in oxygen 
levels due to cellular respiration and proliferation and be experimentally validated. Vertical oxygen 
gradients generated by highly active cells, such as hepatocytes that deplete oxygen at the media-
cell surface interface faster than it is replenished by media oxygen diffusion, must be considered 
when comparing computations to experimental measurements.[199] Computational modelling of 
physiologic systems using the appropriate equations and assumptions can offer insight into 
complicated processes experienced by cells at the microscale level. 
2D numerical simulations of oxygen profiles in microdevices have been created to simplify 
geometry and allow for quick computations.[187] Some negligible differences in peak oxygen 
concentration have been observed when comparing experimental results to 2D numerical 
simulations of non-monotonic oxygen concentrations in a microdevice with 9 gas channels 
containing various oxygen-nitrogen gas mixtures.[187] 3D numerical simulations of oxygen 
transport offer more defined oxygen profiles at the expense of computation time and simulation 
complexity, as an extra dimension necessitates more input parameters, detailed geometry, and 
boundary conditions to generate an accurate simulation that can be experimentally validated. One 
example of a 3D computational model of oxygen profiles in a liver MPS was created by Domansky 
et al.[110] The liver model, described above, included a reactor well and a reservoir well, fitted 
together inside a larger well where cell culture medium circulates between an open channel. 
Oxygen concentration varied with position and oxygen was replenished via the air-liquid interface 
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on top. The control volume region within the larger well extended from the air-liquid interface 
down to the scaffold in the reactor well and across the filter in the reservoir well. Fluid moved 
from the reservoir well to the reactor well with cells. It was assumed that fluid was completely 
mixed from the underlying pump and fluid entering the lower scaffold where cells were seeded 
had a uniform concentration. Fluid exiting the scaffold was assumed constant as no significant 
differences were observed experimentally at different regions of the scaffold due to uniform cell 
distributions. As fluid moved upward from the scaffold, oxygen concentration profiles were altered 
by the boundary conditions at the walls and convection and diffusion from the gas-liquid interface. 
Fluid moved back across an open channel into the reservoir well, creating a non-uniform oxygen 
concentration profile in the reservoir well. The control volume region within the larger well 
extended from the air-liquid interface down to the scaffold in the reactor well and across the filter 
in the reservoir well. Oxygen probes placed inside the reactor and reservoir wells confirmed the 
concentration of oxygen with an estimated error of less than 5%.  
 
2.5. Measuring oxygen in microdevices  
 Although simulations of gas and fluid exchange offer insight into design parameters, real-
time oxygen measurements are necessary to adjust and maintain desired oxygen levels in a MPS, 
as oxygen fluctuates continuously during cellular respiration and metabolism.[11] Measuring 
oxygen in MPS can be challenging due to the microscale features, complex flow profiles, need 
for sterility, and need for minimal oxygen consumption such that the oxygen concentration in the 
microenvironment does not change significantly.  
 Fortunately, there is a considerable body of literature on oxygen sensing. Much attention 
has been paid to gas-phase oxygen sensing[200, 201]; nevertheless, there are multiple reports 
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options for dissolved oxygen sensing in MPS. Oxygen can be measured in MPS by integrating 
either electrochemical or optical sensors, which are the most commonly reported technologies 
for dissolved oxygen measurement.[202-212] For further detail on the specific operation and 
performance of recent oxygen sensors, we suggest reading the focused review on microscale 
oxygen sensors which has been published by Oomen et al.[82] Herein, we will briefly define the 
most common oxygen sensors, which have been adapted to in vitro models—(1) amperometric 
oxygen sensors and (2) fluorescence or phosphorescence quenching oxygen sensors.  
 
 2.5.1. Electrochemical oxygen measurement 
 Electrochemical oxygen sensors can be categorized by their principle of operation: 
amperometric or potentiometric. Amperometric sensors are the most reported electrochemical 
technology for quantification of gaseous and dissolved oxygen.[213, 214] While potentiometric 
measurement of gaseous oxygen, potentiometric measurement of dissolved oxygen is emerging 
as a potential alternative.[215, 216] 
 For this review, we will focus on the more common amperometric measurement 
techniques, but we will briefly discuss the principles and emerging benefits of potentiometric 
measurement of dissolved oxygen. Equilibrium potential measurements enable oxygen 
measurement via the Nernst Equation (Equation 1), where E (Volts) is the potential difference 
of the electrochemical cell, E0, is the potential of the reduction or oxidation reaction or the 
standard potential, R is the gas constant (mol-1·K-1), F is Faraday’s constant (C·mol-1), T is 
temperature (K), n is the number of electrons active in the reaction, and [O2] is the dissolved 
oxygen concentration (mol·L-1). The sensor output varies logarithmically with oxygen 
concentration, and if the solid electrolyte is an ionic conductor, the sensitivity of the equilibrium 
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potentiometric sensors is given by RT/nF and depends only on temperature, as the number of 
active electrons is fixed for the specific reaction at the electrode. 




log O    (1) 
 Potentiometric measurement have long been employed for the measurement of oxygen in 
the gas phase.[207, 217, 218] There have been few demonstrations of potentiometric dissolved 
oxygen sensors, using working electrodes that range from heavy metal alloys and ceramics to 
polymer films.[219-222] Potentiometric sensors for dissolved oxygen at physiologically-relevant 
oxygen concentrations have been most recently demonstrated by Zimmermann et al., but they do 
not demonstrate any operation in a cell culture system.[216] It should be noted, oxygen 
concentrations were measured from 0.1-228 µM, but their measurements significantly deviated 
from the classical Nernstian logarithmic transfer function (Eq. 1); therefore, potentiometry 
measurements in liquid phase systems may have to consider alternative models during operation.  
Ultimately, this demonstration may pave the way for future application of potentiometric sensors 
in MPS. 
 A vast majority of reported and prospective electrochemical oxygen sensors integrated 
into MPS operate via amperometry. Amperometric measurement of correlates the concentration 
of dissolved oxygen to the electrical current produced by an electrochemical reaction. A 
concentration gradient of oxygen, caused by its depletion at the electrode surface during the 
electrochemical reaction, leads to mass transport by diffusion, and the flux of oxygen is directly 
proportional to the reduction current according to Faraday’s Law (Equation 2), where ireduction is 
the electrical current, F is Faraday’s constant (C·mol-1), n is the number of electrons active in the 
reaction, A is the area of the electrode (m2), and JO2 is the flux of oxygen (mol·m
-2·s-1). 
Accordingly, by measuring the reduction current, the flux of oxygen can be related to the moles 
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of oxygen per unit volume, i.e. oxygen concentration, via Fick’s Law. This conversion requires 
that the diffusion constant of oxygen in the selected medium is known and assumes the 
concentration of oxygen at the electrode surface is zero. 
 = − F"#$%   (2) 
 In general, for amperometric systems the sensor performance (e.g., magnitude of current, 
sensitivity, response time) depends on the electrode material (e.g., gold or platinum)[223], 
surface area of the electrode (i.e., improved sensitivity and response time result with larger 
electrode areas)[224, 225], temperature[225, 226], solubility of the oxygen in electrolyte[226], 
and oxygen diffusion rate through the electrolyte and any incorporated gas-permeable 
membrane.[225, 226] Due to these parameters, it is most common for electrochemical oxygen 
sensors to be operated via comparison to a calibration standard, rather than a Coulometric 
manner. 
 The most established of the amperometric oxygen sensors was developed by Clark et 
al.[227] The Clark-type (CT) electrode consists of a silver-silver chloride anode, a platinum 
cathode, an electrolyte, and a gas-permeable membrane (e.g., cellophane or Teflon®).  
 The gas-permeable membrane covers all electrodes in the system, as illustrated in yellow 
in Figure 2.3a. Oxygen diffuses through the selective, gas-permeable membrane to the internal 
electrolyte covering the electrodes. The addition of a selective, gas-permeable membrane 
separates the medium under test from the electrolyte solution at the surface of the electrodes 
(typically potassium chloride). In addition, the gas-permeable membrane creates a diffusion 
profile where the response of the sensor is controlled by the oxygen diffusion instead of reaction 
kinetics on the electrode surface, i.e. the steady-state current is proportional to the concentration 
of dissolved oxygen.  
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 During operation, oxygen is reduced to water at the cathode, and metallic silver is 
oxidized to silver chloride at the anode. Current is generated by reduction of oxygen at the 
cathode surface according to the reaction presented in Equation 3.[228] The current generated at 
the necessary overpotential for the electrochemical cell is proportional to the concentration of 
dissolved oxygen in the system. CT electrodes in microfluidic systems have been shown to 
operate in arrange of -0.6 V to -0.8 V.[227, 229] The applied potential is set such that all oxygen 
molecules are consumed at the cathode and the generated current is directly proportional to the 
oxygen diffusion from medium, across the membrane, and to the cathode.[230]  
 
O + 2HO + 4e
) → 4OH) (3) 
 
 It should be noted that the consumption of oxygen in CT electrodes is not trivial, and 
stable signals can be difficult to generate in small, microscale volumes. To overcome this 
challenge, there have been efforts for miniaturization of CT electrodes[231-235], but there are 
limited examples of CT electrodes being miniaturized and integrated into microfluidic 
devices.[236] Early attempts exhibited operational stability problems due to dissolution of the 
reference electrode material when operating in two-electrode configuration (i.e. no counter 
electrode). This deleterious effect could be limited by using three-electrode configurations, 
which drive most of the current through a counter electrode and little current flows through the 
reference electrode.[237] Park et al. created a miniaturized Clark electrode with a three electrode 
configuration for measuring cellular oxygen consumption, and it was reported that membrane 
type and working electrode area were the two dominant factors in determining both the stability 
and sensitivity of the oxygen sensor.[238]  
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 As an alternative to CT-electrodes, direct amperometric oxygen sensors have been 
reported, including two electrode (working and reference/counter)[224, 228, 239] or three 
electrode (working, reference, and counter)[226, 240] configurations. Figure 2.3b illustrates an 
example MPS containing bare, thin-film platinum electrodes used as oxygen sensors. In this 
example, Weltin et al. incorporated amperometric oxygen sensors with small-molecule 
biosensors to achieve dynamic monitoring of human glioblastoma multiform T98G cells (Fig. 
2.3b).[178] In direct amperometric oxygen sensors, oxygen is reduced at the working electrode 
without a selective membrane. The system is designed for diffusion-limited operation, such that 
the oxygen concentration is linearly proportional to the current. These direct amperometric 
oxygen sensors are typically operated as chronoamperometric measurements, in which a 
potential step is applied to the working electrode with respect to the reference electrode and the 
resulting current response is measured. The generated current density is linearly proportional to 
the concentration of dissolved oxygen.  
 As demonstrated in many examples, amperometric detection is advantageous for fast and 
sensitive detection of oxygen in the microchannels of MPS and many other bioreactors.[228, 
241-244] Challenges to facile adoption and integration of oxygen sensing electrodes into MPS 
include: electrode fouling due to biological-electrode interactions, resultant signal drift, local 
oxygen consumption and depletion of internal electrolyte, material instability and dissolution, 
susceptibility to electrical interference, and signal fluctuation under flow.[157, 189]  
 While many of these challenges can be overcome by utilizing alternatives to CT 
electrodes or employing alternative electrochemical modalities, like potentiometry, there are also 
material and engineering design considerations that can improve the operation of integrated 
oxygen sensors.  
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 Selective, gas-permeable and electrolyte-permeable membranes may also be considered 
for application as protective barriers in non-CT electrochemical oxygen sensors. Selective 
membranes or coatings of the sensor electrodes can be employed to reduce fouling and 
biological-electrode interactions. Bare metal electrodes are vulnerable to contamination from cell 
adhesion, protein adsorption and interaction with other electroactive species.[245] Many oxygen 
selective membranes are made from oxygen permeable polymers such as silicone[224, 246], 
polyethylene[247], polypropylene[225], and PDMS.[225, 229] However, the slower diffusional 
characteristic of such materials, as previously described (Table 2.2), may limit the dynamic 
sensing of oxygen in a rapidly evolving system. It should also be noted, that these gas-permeable 
coatings do not permit electrolyte transmission, and therefore are only suitable in solid-state gas 
oxygen sensors.[248-250] Select membrane materials, such as NafionTM, polyelectrolytes, and 
hydrogels, may better serve as electrode protectants, while enabling rapid diffusion of oxygen to 
and from the electrode surface and also behave as electrolyte and ionic conductors in aqueous 
media.[251-254] 
 The method of sensor fabrication and integration may also play a critical design role for 
instrumented MPS. Planar amperometric oxygen sensing electrodes on glass[224, 239] and 
flexible Kapton® [255] have been integrated in-line with microfluidic channels and are the most 
common. Bare metal electrodes can be fabricated via myriad vapor deposition processes. 
Rodrigues et al. designed planar amperometric oxygen and glucose sensors at the inlet and outlet 
of a PDMS chamber for cell culture analysis of hepatocytes; this approach provided real-time 
monitoring of the composition and consumption of nutrients in the cell culture medium before 
and after its contact with cells.[256] Weltin et al. also utilize a distributed sensing design in 
which the system included two oxygen sensors in the inlet, one electrode in the cell culture area, 
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and two electrodes in the outlet channel to investigate the oxygen concentration inside and 
outside of the cell culture and provide some spatial resolution of oxygen concentration. More 
complex microelectrode architectures have also been explored for oxygen sensing “on-chip.” Lee 
et al. created amperometric gold oxygen sensing microneedles for evaluation of dissolved 
oxygen microprofiles. The fabricated microneedles were used to penetrate into the microfluidic 
channel for vertical measurement of dissolved oxygen levels in the microchannel, and as a pre-
conditioning step, the electrodes were polarized before calibration.[228]  
 Lastly, preconditioning of electrodes is carried out when a dry sensor is first introduced 
to the solution for measurement. In bare metal electrodes, near-zero oxygen levels at the 
electrode surface can be achieved in less than one second; whereas, the introduction of high-
surface area electrodes, hydrogel coatings, solid polyelectrolytes, or other membranes, may 
require increased preconditioning to achieve a stable baseline and accurate measurement of 
oxygen. Numerous strategies have been employed to reduce preconditioning times for planar 
amperometric oxygen sensors[257], and various materials have been used as a gas permeable 
membrane to control the time to and stability of the internal electrolyte for fabricating planar 
type oxygen sensors.[258-261]  
 
 2.5.2. Fluorescence/phosphorescence-based oxygen measurements 
 Luminescence is the cold-body radiation of light. Photoluminescence, which is 
luminescence due to the absorption of photons, is a property exploited for the quantification of 
oxygen concentration in the local microenvironment of the selected light-emitting substances, i.e. 
luminophores. Specifically, fluorescence and phosphorescence quenching are the predominant 
forms of luminescence-based optical sensors that can be integrated into both in vitro tissue 
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cultures and microfluidic devices for oxygen quantification. Fluorescence and phosphorescence 
are forms of photoluminescence that result from singlet-singlet electronic relaxation with 
nanosecond lifetimes and triplet-singlet electronic relaxation with microsecond or greater 
lifetimes, respectively.  
 Popular fluorescence and phosphorescence-based oxygen sensors operate by quenching 
of the excited states of luminophores by molecular oxygen.[262] Fluorescent and phosphorescent 
radiative emissions are generated when the excited molecule returns to the ground state from its 
singlet and triplet electronic states, respectively. If oxygen is present in the environment, it acts 
as an energy acceptor and non-radiatively quenches the excited singlet or triplet states of the 
molecule prior to relaxation and emission of photons. This energy transfer, i.e. quenching, leads 
to a decrease of the intensity and lifetime of the fluorescence and phosphorescence of the 
luminophore. The degree of quenching is determined by the probability of an encounter between 
an oxygen molecule and an indicator dye in its excited state.[263] Therefore, the change in 
fluorescence and phosphoresce intensity or lifetime is proportional to the molecular oxygen 
concentration. The quenching of the indicator dye can be modelled according to Stern-Volmer 






= 1 + ./+ O   (4) 
where + and , are excited-state lifetime and luminescence intensity in the absence of O2, O 
is the oxygen concentration, + and , are the lifetime and intensity, respectively, at a given oxygen 
pressure, and ./ is the quenching rate constant. According to the Stern-Volmer equation, the 
quenching of luminescence intensity by oxygen is non-linear. In practice, the quenching of 
luminescence intensity is non-linear due to inhomogeneity of the system’s optical properties. 
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Compared to amperometric sensors, oxygen sensing by luminescence quenching is well suited 
for small fluid volumes and offers fast and stable detection of oxygen with minimal signal 
drift.[189] Optical sensing via luminescence quenching enables oxygen sensing without 
disturbing the microfluidic setup and provides spatiotemporal imaging of cell cultures during 
long-term studies.[265] 
 Luminophores for quantification of oxygen in microfluidic devices are affected by 
various factors such as efficiency of the quenching process, lifetime of the indicator dye, stability 
of the luminophore (i.e., photobleaching and leaching), absorption and emission of spectra of the 
indicator dye, availability of optical components (i.e., excitation and detection devices), and 
background interference (i.e., autofluorescence from plasma and cells).[210]  
 There are two main groups of oxygen-sensitive indicators: ruthenium-based complexes 
and metalloporphyrin complexes (Fig. 2.4, Table 2.3). Tris(4,7-diphenyl-1,10-phenanthroline) 
ruthenium(II) dichloride ([Ru(dpp)3]Cl2) [85, 266-270] and ruthenium tris(2,2′-dipyridyl) 
dichloride ([Ru(bpy)3]Cl2) [83, 157, 187, 265, 271, 272] are commonly used ruthenium-based 
compounds for microfluidic devices. [Ru(dpp)3]Cl2 has longer excited state lifetimes (5.34 µs vs. 
0.6 µs) and higher quantum yield of luminescence (ΦL: 0.3 vs. 0.0042) than [Ru(bpy)3]Cl2.[273] 
Ruthenium-based dyes are photo-stable and have short excited state lifetimes (<10 µs) as 
compared to the excited state lifetimes of metalloporphyrin dyes.[273, 274] The ability of 
oxygen to quench a luminophore increases if the luminescent probe has long lived excited states 
(i.e., natural lifetime of the excited state, +, in the absence of oxygen), which in turn results in 
more sensitive oxygen sensors. Platinum (II)-5,10,15,20-tetrakis-(2,3,4,5,6-pentafluorphenyl)-
porphyrin (PtTFPP) [275-278], palladium(II) or platinum(II) meso-tetra(4-fluorophenyl) 
tetrabenzoporphyrin (PdTPTBPF and PtTPTBPF) [279], palladium-meso-tetra (4-
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carboxyphenyl) porphyrin (Pd-TCPP) [280], platinum octaethylporphyrin (PtOEP) [191], 
platinum octaethylporphine-ketone (Pt-OEPK) [189, 281], and Pt(II) meso-
di(pentafuorophenyl)diphenyl porphyrin [282] are some of the commonly used metal porphyrin 
based oxygen sensors in microfluidic devices. Therefore, the oxygen sensors made by metal 
porphyrins are more sensitive to oxygen than ruthenium-based sensors popularized in earlier 
studies.  
 Indicator dyes are usually immobilized in polymeric or sol-gel matrices to protect the 
dyes from degradation and to reduce dye leaching. Several polymers are commonly used for 
immobilization of dyes in microfluidic devices. Indicator dyes such as PtTFPP and Pt-OEPK 
were embedded in polystyrene.[189, 275, 281] PtOEP, PdTCPP, PtTFPP and [Ru(dpp)3]Cl2 were 
incorporated into PDMS. [191, 268, 277, 280] Other matrices such as silica gels [266, 283], 
poly(sodium styrenesulfonate) (PSS) [271], and polyfluorenes [282] were also utilized as 
immobilization medium.  
 Properties of the luminescent dyes (i.e., sensitivity, response time and Stern-Volmer 
calibration graph) are strongly dependent on the type of polymer used as it controls the oxygen 
diffusion through the polymer matrix.[284] Permeation of oxygen through a polymeric matrix is 
dependent on diffusion constant and solubility of oxygen within that matrix (0 = D2, where P: 
permeation rate, D: diffusion constant (cm2 s-1), S: solubility of oxygen (cm3 (STP) cm-3 (cmHg)-
1)). According to Amao et al., PDMS has higher permeation rate than organic glassy polymers 
such as polystyrene (PS), poly(methyl methacrylate), and poly(vinly chloride) (PVC). 
Fluoropolymers exhibit high permeability to oxygen due to the high electronegativity of 
fluorine.[285] Andrew et al. studied the sensitivity, response and recovery times of Pt-OEP and 
Pd-OEP immobilized in cellulose acetate butyrate (CAB) and PMMA.[273] Pt-OEP and Pd-OEP 
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embedded in CAB polymer had higher oxygen sensitivities and smaller response and recovery 
times than similar luminophores embedded in PMMA polymer, which was attributed to higher 
permeability of oxygen in CAB. It was reported that incorporation of plasticizers, such as tributyl 
phosphate, increased the oxygen sensitivity of the sensors due to localization of the 
luminophores in plasticizer rich areas within the polymer. Moreover, substitution of Pt-OEP with 
Pd-OEP in CAB or PMMA film produced much more sensitive films because of a long lifetime 
of Pd-OEP than Pt-OEP (0.99 vs 0.0091 ms). Hartmann et al. investigated sensitivity of Pt-
OEPK and Pd-OEPK in PVC and PS films and reported that Pd-OEPK had the highest oxygen 
sensitivity among other combinations of the Pt and Pd metal complexes in PVC and PS matrices.  
 There have been various methods for integration of luminescent oxygen sensors into 
microfluidic devices. Regardless of the integration technique, several criteria should be met for 
successful oxygen sensor integration. First, the oxygen sensitive dyes should not detach from the 
surface of the microchannel. Second, the indicator dye must withstand repeated cleaning steps 
(i.e., solvent stability), and should not present any toxicological effects to cell cultures.[210] 
Lastly, the distribution of the indicator dye in the matrix and within the microfluidic channel 
should be homogenous as it changes the light intensity and spatial resolution of the intensity-
based readout techniques.[286] Measuring oxygen inside microfluidic devices has been done 
using a commercial handheld oxygen probe (e.g., Neofox, Ocean OpticsTM), which includes 
oxygen sensitive dyes at the tip of the probe.[137, 287-290] This method of measurement lacks 
the integration of oxygen sensors with microfluidics.  
 An alternative method for measuring oxygen inside a microchannel involves perfusing 
oxygen sensitive dye with media, where the fluorescent luminophore (e.g., [Ru(bpy)3]Cl2) is 
injected into channels for oxygen monitoring.[83, 265, 272] This method may require 
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replenishment of the medium and does not provide an integrated sensing approach. An integrated 
oxygen sensing approach was reported by Ochs et al., where a microfluidic chip was fabricated 
by spin coating PDMS polymer on a commercially available oxygen sensor foil. The PDMS 
surface was then treated with an oxygen plasma for bonding it to a complementary pre-molded 
PDMS piece for oxygen level measurement during cell culturing.[291] Sato et al. mixed an 
oxygen sensitive phosphorescent Pd-TCPP dye with PDMS polymer to create a thin oxygen 
sensing membrane by spin coating on a glass slide. Afterwards, the membrane was attached to 
the sealed O2 and N2 PDMS microchannels for detection of oxygen gradients in a microfluidic 
device.[280, 281] Wang et al. and Thomas et al. used a similar spin coating technique to spin 
coat phosphorescent PtOEP and PtTFPP embedded PDMS polymers on glass slides, 
respectively.[191, 277] Subsequently, the pre-molded PDMS pieces were combined with the spin 
coated O2 sensing layers via plasma bonding to measure oxygen gradients in the microchannels. 
This way of luminescent dye integration into polymeric matrices yields more mechanically 
durable sensing layers as compared to physical adhesion.  Lasave et al. and Chang-Yen et al. 
studied physical adsorption of the luminophore on glass substrates.[83, 282] Lasave et al. filled 
the microfluidic channel with oxygen sensitive conjugated polymer nanoparticles. Due to the 
positively charged quaternary ammonium groups, the oxygen sensitive sensor was adhered to the 
negatively charged glass surface. Similarly, Chang-Yen et al. used a layer-by-layer deposition 
technique for physical adsorption of the indicator dye on a glass substrate. The glass slides were 
dipped into a mixture of interpolyelectrolyte complex ([Ru(bpy)3]Cl2 with PS polymer) to form a 
negatively charged surface. The slides were subsequently dipped into a poly(diallyl 
dimethylammonium) chloride (PDDA) solution to form a positively charged surface. Repeated 
dipping formed alternating layers of a desired thickness. Other integration techniques such as 
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airbrush spraying of indicator dyes [279], wet etching of glass substrate and subsequent 
luminophore pipetting [189], knife-coating of luminophore solution onto glass slides [278], and 
recess-filling with an indicator dye, where the recesses were created via reactive ion etching of a 
silicon wafer or micro molding of a PDMS polymer have been reported.[267, 268] 
 Quenching of a luminophore dye results in a decrease in luminescence intensity and 
excited-state lifetime. Therefore, two main readout techniques (e.g., intensity and lifetime) have 
been developed for measurement of oxygen concentration. The first readout technique, intensity-
based oxygen sensing, is based on detection of luminescence intensity, which can be easily 
implemented compared to the lifetime-based readout techniques. In this technique, the 
luminophore is excited with an excitation light source and the emitted light intensity is measured 
with a detector. Intensity-based oxygen sensing has been implemented for quantification of 
oxygen in microfluidic devices.[83, 85, 187, 266, 267, 271] However, intensity-based oxygen 
measurement is dependent on concentration of luminophore, photobleaching, optoelectronic 
properties of excitation source and detector.[292] Therefore, ratiometric sensing has been 
proposed to overcome the disadvantages of the intensity-based measurement. In this technique, 
an oxygen-sensitive dye and an oxygen-insensitive dye were incorporated into the sensing film. 
The emission spectra of the dyes differ from each other and only the oxygen-sensitive dye is 
quenched by oxygen. The quantification of oxygen is made by taking the ratio of the 
luminescence intensity of the oxygen-sensitive dye to that of the oxygen-insensitive dye (Fig. 
2.3d). This method reduces the effects of factors that are common to both dyes, such as sample 
inhomogeneity and variations in excitation light and detector sensitivity.[212] John et al. used 
ratiometric sensing based on fluorescent [Ru(dpp)3]Cl2 and safranin dyes for measurement of 
oxygen concentration in microtiter plates. The ratio of the luminescence intensities of both dyes 
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in the presence and absence of oxygen was related to the oxygen concentration by using the 
Stern-Volmer equation.[283] In another study, Ungerbock et al. used red emitting 
phosphorescent PtTFPP and green emitting Macrolex Fluorescent Yellow (MFY) dyes for 
measurement of the respiratory activity of HeLa carcinoma cells and human dermal fibroblasts 
via ratiometric sensing. MFY dye acts as an antenna dye for collection of blue light and transfers 
part of its energy to the Q-bands of the oxygen sensitive PtTFPP indicator dye, thus, eliminating 
the need for two different excitation sources.[278]  
 The second type of readout technique, lifetime-based oxygen sensing, measures the 
lifetime of the luminophore. The lifetime is defined as the average amount of time a fluorophore 
remains in the excited state following excitation.[293] Frequency [189, 279, 282] and time-
domain [280, 292] lifetime measurements have been studied to measure oxygen concentration in 
microfluidics. Lasave et al. used phase fluorometer for measurement of enzyme activity of 
glucose oxidase.[282] The frequency domain technique applied a modulating excitation light to 
the luminophore with an LED and measured the emission of the light with a photodiode. The 
phase lag between the excitation light and the emitted light was measured using a reference LED 
for phase correction. The lifetime of the luminophore was calculated from the luminescent phase 






where f is the modulation frequency and ∅ is the phase shift. The frequency-domain lifetime 
measurement is advantageous over the time-domain method for measurement of lifetimes of 
dyes with close emission wavelengths. In contrast to the frequency-domain lifetime 
measurement, the time-domain technique is based on “pulse and gate” method (i.e., rapid 
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lifetime detection). The measurement starts with switching on the modulated excitation source 
(i.e., square wave) for a short period of time. Then, the light source is turned off and the detector 
is turned on to allow measurement of the luminescent light at two different times (t1 and t2). The 








where A1 and A2 are the photon counts at two different times. Sato et al. designed a microdevice 
for measurement of oxygen consumption rate of hepatocytes. The device used a pulsed laser at 
532 nm and a photomultiplier for irradiation of the sensor and detection of the emitted 
phosphorescence, respectively.[280] Similarly, Sud et al. designed a microfluidic bioreactor for 
continuous O2 monitoring of mouse myoblasts using fluorescence lifetime imaging microscopy 
(FLIM). The FLIM system included an excitation source (337 nm to 960 nm) and a gated CCD 
camera for image recording.[265] Overall, lifetime-based measurement is advantageous over 
intensity-based measurements because it is independent of concentration of luminophore, 
photobleaching, drifts in source intensity and detector sensitivity.[209]  
 
2.6. Conclusion  
 Measuring and regulating oxygen levels in microdevices is paramount to develop the next 
generation of in vitro tools for studying human physiology and pathophysiology. Often 
microdevices used to study cell biology, tissue or organ function, or drug response studies are 
criticized for their simplicity. By using primary human cells and accurately recapitulating the in 
vivo environment inside a microdevice, basic scientific questions can be answered, and the 
design of more complex experiments can be better informed. Before designing a MPS, a desired 
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oxygen gradient or constant concentration must be defined using previous knowledge attained 
from in vivo measurements of oxygen in a human organ or hypothesized oxygen concentrations 
extrapolated from reported animal models. Materials should be chosen to generate cells-specific 
microenvironments and in silico models can help determine appropriate seeding densities and 
expected oxygen concentrations at material interfaces. Overall, the most important factors 
determining the success of a MPS are the ability to measure oxygen in real-time and adjust 
oxygen concentration easily. Microdevice architecture should inform the best oxygen sensor 
integration.  
 With more knowledge of the intricate and critical role of oxygen in physiologic and 
pathophysiologic phenomenon, microdevices can be fabricated that are more representative of 
true human organ and cell-level responses to damage or repair and lead to better predictions of 
drugs and cell therapies. It is important to consider how organ systems respond to oxygen 
fluctuations based on function. MPS should incorporate fluctuating oxygen, but this will only be 








Table 2.1. Physiologic oxygen concentrations in selected normal tissues[12] 
 
  
Organ pO2 (mmHg) % O2 
Alveoli 110 14.5 
Lung 43 5.6 
Arterial blood 100 13.2 
Kidney 72 9.5 
Liver 41 5.4 
Skin (superficial region) 9 1.3 
Skin (sub-papillary plexus) 38 4.6 
Brain 35 4.4 
Intestinal tissue 58 7.6 
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Table 2.2. Oxygen diffusivity of common plastics 
  
Material O2 diffusivity (cm
2·s-1) Ref. 
Polydimethylsiloxane (PDMS) 3.4 ± 1 x 10-5 [159] 
Polyetheretherketone (PEEK) 1.38 x 10-6 [295] 
Polytetrafluoroethylene (PTFE) 2.83 x 10-7 [296] 
Polypropylene (PP) 2.33 ± 0.4 x 10-7 [297] 
Polystyrene (PS) 2.3 ± 0.2 x 10-7 [164] 
Polyurethane 1.16 x 10-7 [298] 
Polycarbonate (PC) 8.0 x 10-8 [168] 
Polyethylene terephthalate (PET) 2.89 x 10-8 [299] 
Polymethyl methacrylate (PMMA) 2.7 ± 0.2 x 10-8 [174] 
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Figure 2.1. Schematic representations of oxygen content inside organs. The human body is 
composed of numerous oxygen gradients and organ-specific microenvironments that require 
microphysiological systems to study oxygen exchange in a tunable and controllable manner. The 
brain contains neurons, astrocytes, and pericytes situated above and within the basal lamina. 
Oxygen crosses the endothelium to reach brain cells via the capillary lumen. A tumor creates new 
vasculature as it grows (neoangiogenesis), while the core of the tumor continues to become more 
hypoxic. The lung receives oxygen in air, which then binds to hemoglobin molecules after crossing 
through the epithelium and interstitial space. For the liver, oxygen rich blood travels from the 
portal vein toward the central vein, providing nutrients to sinusoidal endothelial cells, stellate cells 
in the perisinusoidal space, and hepatocytes. The kidney contains oxygen gradients within each 
renal medulla and from the inner papilla to the renal cortex. The intestine has a steep oxygen 
gradient from the microvasculature underneath the crypt-villus axis to the bacteria populated 
lumen. The skin is an oxygen barrier with the epidermis at very low oxygen. The heart contains 
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numerous levels of oxygen as oxygen-poor blood flows into the vena cava and oxygen-rich blood 




Figure 2.2. Methods for controlling oxygen in microphysiological systems (MPS) to study 
cellular responses. (a) Gas diffusion used to generate an oxygen gradient across a layer of 
Madin-Darby Canine Kidney (MDCK) cells. Reproduced from Ref.[88] with permission from 
The Royal Society of Chemistry. (b) Gas filled channels create an oxygen gradient from 0% to 
20% oxygen. Reproduced from Ref. [188] with permission from The Royal Society of 
Chemistry. (c) Oxygen scavengers in leftmost chemical reaction channel remove oxygen, while 
oxygen generators in the rightmost channel create a gradient of oxygen between the chemical 
reaction channels, inside the cell culture channel. Reproduced from Ref. [83] with permission 
from The Royal Society of Chemistry. (d) Oxygen diffused through collagen hydrogels of 
various height and fiber density to create oxygen gradients. Reproduced from Ref. [146] with 
permission from The Royal Society of Chemistry. (e) Cells consume oxygen inside the liver 
MPS to create oxygen-limited environment. Reproduced from Ref. [110] with permission from 
The Royal Society of Chemistry. (f) Transwell insert contains Parylene coating to prevent 
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environmental oxygen from contaminating inner hypoxic device. Reproduced from Ref.  [169] 




Figure 2.3. Measuring oxygen in microdevices. (a) Schematic of non-Clark type amperometric 
oxygen sensing. An optional membrane or coating can be applied over the electrodes to limit 
fouling or cell-electrode interactions. An oxygen-selective membrane can also be integrated to 
achieve a Clark-type system, i.e. using only an anode and cathode. (b) An example of 
amperometric oxygen sensing. (Top) Schematic of the fabricated microfluidic device. (Bottom, 
left) Fabricated microfluidic device with integrated electrochemical O2 sensors. (Bottom, right) 
Amperometric continuous oxygen measurement. Reproduced from Ref. [178] with permission 
from The Royal Society of Chemistry. (c) Schematic of optical oxygen sensing. (d) An example 
of optical oxygen sensing. (Top, left) Schematic of the fabricated microfluidic device. (Top, right) 
Fabricated microfluidic device with integrated optical O2 sensors. (Bottom) Fluorescent images of 
the microbeads doped with two dyes, oxygen sensitive ruthenium dye and oxygen-irresponsive 
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Nile blue, to 21% and 7% oxygen concentrations. Reproduced from Ref. [302] with permission 




Figure 2.4. Common oxygen sensing via luminescent optical dyes. (a-d) Chemical structures of 
Ru(II) complexes and metalloporphyrins. M stands for Pt(II) or Pd(II) metal ions. Reproduced 





CHAPTER 3: INTEGRATED PHOSPHORESCENCE-BASED PHOTONIC BIOSENSOR 
(IPOB) FOR MONITORING OXYGEN LEVELS IN 3D CELL CULTURE SYSTEMS2 
 
3.1. Overview 
 Physiological processes, such as respiration, circulation, digestion, and many pathologies 
alter oxygen concentration in the blood and tissue. When designing culture systems to 
recapitulate the in vivo oxygen environment, it is important to integrate systems for monitoring 
and controlling oxygen concentration. Herein, we report the design and engineering of a system 
to remotely monitor and control oxygen concentration inside a device for 3D cell culture. We 
integrate a photonic oxygen biosensor into the 3D tissue scaffold and regulate oxygen 
concentration via the control of purging gas flow. The integrated phosphorescence-based oxygen 
biosensor employs the quenching of palladium-benzoporphyrin by molecular oxygen to 
transduce the local oxygen concentration in the 3D tissue scaffold. The system is validated by 
testing the effects of normoxic and hypoxic culture conditions on healthy and tumorigenic breast 
epithelial cells, MCF-10A cells and BT474 cells, respectively. Under hypoxic conditions, both 
cell types exhibited upregulation of downstream target genes for the hypoxia marker gene, 
hypoxia-inducible factor 1α (HIF1A). Lastly, by monitoring the real-time fluctuation of oxygen 
concentration, we illustrated the formation of hypoxic culture conditions due to limited diffusion 
of oxygen through 3D tissue scaffolds.  
                                                 
2 Chapter previously appeared in Biosensors and Bioelectronics. The original citation is as follows: Kristina R. 
Rivera, Patrick D. Erb, Ashlyn T. Young, Natalie A. Wisniewski, Scott T. Magness, Michael A. Daniele. Integrated 
phosphorescence-based photonic biosensor (iPOB) for monitoring oxygen levels in 3D cell culture systems. 
Biosensors and Bioelectronics, 123: 131-140, 2019. 
 83
3.2. Introduction 
 The measurement and control of oxygen concentration in cell culture has been a topic of 
intense discussion for more than 60 years.[305] Oxygen levels are dynamic in the human body, 
varying from less than 2% in the rectal lumen to 15% in the pulmonary alveoli.[12, 306] The 
terms normoxia, hypoxia and anoxia are relevant to discussions of cell environments, but they 
are often broadly defined across different research fields in terms of ranges and units, leading to 
misunderstandings concerning physiologic oxygen levels and oxygen levels outside the human 
body. Common descriptions of oxygen include partial pressure of oxygen (pO2) or oxygen 
tension, with units of kilopascal (kPa)[307, 308], millimeters of mercury (mmHg)[269, 309, 
310], dissolved oxygen concentration (µmol·L-1)[110, 311] and percent oxygen concentration 
(%)[312, 313]. Such terminology does not capture the physiological description of oxygen 
tension or oxygen concentration in the human body; thus, it is difficult to accurately replicate 
physiological oxygen levels in experimental conditions. Nonetheless, there are standard methods 
to convert between the relevant oxygen measurements. For example, using Henry’s Law to 
convert from a dissolved oxygen concentration of 100 µM to a percent oxygen concentration of 
≈ 7.5%, the temperature (here, 21°C) and pressure (atmospheric, 101.3 kPa) must be defined. 
Accordingly, at physiological temperature (37°C) and atmospheric pressure, the conversion to 
percent oxygen can be roughly estimated by dividing the dissolved oxygen by a factor of 10. 
This estimate can be used to estimate physiological oxygen conditions in vitro. 
 The physiological oxygen conditions affecting healthy physiology and pathologies vary 
widely across the tissues of the human body. During respiration, humans breathe air containing 
percent oxygen concentration of 20.9%, i.e. the partial pressure of oxygen in the environment 
(PeO2) is ≈ 21 kPa. The percent oxygen concentration is immediately reduced to ≈ 15% in the 
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pulmonary alveoli, where hemoglobin binds oxygen and transports it throughout the body inside 
blood.[12] Although oxygen is uniformly transported to the edge of the circulatory system 
through arterioles and capillaries, some parts of the body consume oxygen at higher rates. For 
example, the brain, with the highest metabolic activity per unit weight of any organ, consumes 
20-25% of all the oxygen in the entire body [133, 134], while gut and muscle tissue demand 
variant oxygen levels depending on rest or contraction status.[314, 315] Consequently, a range of 
physiological oxygen levels exists throughout the body, including percent oxygen concentration 
of ≈ 10% in the kidneys, 7% in the intestines and less than 5% in the sub-papillary plexus region 
of the skin and brain tissues.[12] Apart from the entrance of the respiratory tract, tissue in the 
human body does not contain more than a percent oxygen concentration of ≈ 15%, and this 
should be considered to be the maximum oxygen concentration for in vitro normoxic tissue 
culture.  
 However, the standard tissue culture incubator is held at hyperoxic conditions. The 
standard tissue culture incubator, which most in vitro systems utilize, maintains a temperature of 
37°C, recapitulating human body temperature at 100% relative humidity to ensure medium does 
not evaporate and cell metabolism is not compromised by changes in osmolarity. The gaseous 
mixture contained within the tissue culture incubator is composed of nitrogen gas (N2), gaseous 
water (H2Og) and carbon dioxide (CO2). When 20.9% oxygen gas (O2) is added to the incubator 
containing 70.2% N2, 6.2% H2Og and 5.0% CO2, the resulting O2 is 18.6% at sea level.[74] The 
oxygen concentration inside a normobaric incubator (18.6%) is hyperoxic in physiological terms, 
because no body tissue exists at a higher oxygen environment than the 15%.[316-318]  
 Ultimately, environmental oxygen differences between tissue culture and in vivo 
physiology can hinder translating research findings from benchtop to bedside. Studying cells in 
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inaccurate environments makes predicting appropriate drug dosages for in vivo models difficult, 
leading to drug failure during clinical trials.[319] For example, complex in vitro systems are 
often developed to investigate pathologies and novel therapies, especially tumorigenesis and 
metastases [320-322]; however, these systems do not accurately recapitulate the oxygen 
environment of in vivo tumors.[323] This is a particularly notable shortcoming because oxygen 
concentration has been implicated in tumor metastasis [67, 324, 325]. In vivo tumors create a low 
oxygen environment, i.e. average percent oxygen concentration of ≈ 1.5%, which becomes more 
hypoxic from outer edge to inner core region, where vasculature is leaky or absent.[142, 326]   
 To translate in vitro results and better predict the outcome of in vivo testing, the 
physiological oxygen environment surrounding a cell or tissue of interest must be accurately 
recapitulated. For example, hypoxia is implicated in a myriad of developmental and pathological 
functions.[37, 73, 149, 327] Hypoxia can be any physiologic environment in which a cell or 
tissue is responding to a reduced oxygen availability, regardless of the quantitative value 
assigned to the concentration of oxygen present. Creating a desired oxygen concentration and 
controlling it in a cell culture system is currently limited by the cost and feasibility of available 
techniques. Large hypoxic incubators can generate stable low oxygen environments, but they 
require high operating costs.[328, 329] Alternatively, a smaller hypoxic chamber with microtiter 
plates can be deoxygenated and placed inside a normobaric tissue culture incubator.[330] 
Microdevices that recapitulate the hypoxic environment of a tumor have been created using a 
variety of methods and materials, such as oxygen scavenging chemicals, gas supply channels and 
oxygen impermeable materials, as reviewed by Byrne et al.[331] These small hypoxic chambers 
are expensive to maintain, as they require significant gas exchange, and cannot be opened or 
manipulated easily to change media or collect samples during an experiment. With microdevice 
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technology, even smaller hypoxic chambers, on the scale of a single well in a microtiter plate, 
can be created in parallel to allow for multiple oxygen environments to be tested 
simultaneously.[187] Furthermore, with connections and ports, sampling of fluids can be 
performed to measure cellular responses while maintaining a hypoxic environment.[109]  
 In the aforementioned systems, an integrated monitoring systems and control loop is 
necessary to maintain the hypoxic environment as cells respond to oxygen deficient 
environments or injury by increasing cellular respiration. Real-time oxygen biosensors can be 
integrated into a cell culture system to create the first step in the control loop required to sustain 
a desired oxygen environment. Next, oxygen must be depleted or quickly expelled from the cell 
culture device, while maintaining appropriate nutrients and other molecules for cell culture. 
Hydrogels can be used to maintain a nutrient rich environment for cells, while N2 can be used to 
expel free O2 from the air above the hydrogel and medium.[66] By closely tracking and adjusting 
the level of oxygen in a microfluidic culture system, gas flow and medium can be simultaneously 
introduced and exchanged with minimal reagent usage or waste accumulation.  
 Herein, we present a method and system for real-time, remote monitoring and control of 
oxygen concentration in 3D cell cultures. The 3D culture and oxygen monitoring system is 
composed of (1) a microfluidic cell culture-gas exchange chamber and (2) an integrated 
phosphorescence-based oxygen biosensor (iPOB). The system was validated in a study to control 
hypoxic conditions and evaluate the effect of oxygen concentration on benign and tumorigenic 




3.3. Materials and methods 
Fabrication of 3D culture and oxygen monitoring system 
 The 3D culture and oxygen monitoring system was fabricated using polymethyl 
methacrylate (PMMA) and photopolymer resin (Formlabs, Inc.). PMMA was chosen to fabricate 
the microfluidic cell culture chamber and gas exchange channels because it possesses a very low 
oxygen diffusion coefficient (2.7 × 10-8 cm2·s-1), as compared to polydimethylsiloxane and 
polycarbonate. [174, 331] PMMA was also selected because it can be easily laser cut or 
machined without significant variation between replicates. The photopolymer resin was 3D 
printed to form a bottom frame to support the 3D culture device and simultaneously house the 
optical reader for the iPOB (Fig. 3.1a). A Computer-Aided Design file for 3D printing is 
provided in the Online Supplementary Material. 
 The microfluidic cell culture chamber and gas exchange channels were fabricated from 
5.8 mm and 3 mm polymethyl methacrylate (PMMA) sheets (44352, 44292; US Plastics). The 
microfluidic culture chamber was composed of a circular chamber with a diameter of 11 mm and 
rectangular gas channels of 8.3 mm by 1.0 mm by 3.0 mm for length, width and height of, 
respectively. Three PMMA layers were laser cut and annealed with acetone. The bottom and top 
pieces of PMMA were laser cut from a 3.0 mm-thick PMMA sheet, while the middle piece, 
where the circular cell culture chamber was located, was laser cut from a 5.8 mm-thick PMMA 
sheet. Briefly, to remove dust and burr material with minimal cracking, each PMMA surface was 
quickly wiped with 100% IPA solution and air dried. Acetone was added to each PMMA piece 
and pieces were stacked and bonded together between two sheets of stainless steel using a 
compression clamp. Annealing was performed inside a convection oven set at 80°C for 2 hours, 
then the device was cooled for 1 hour at 60°C. A rubber gasket was laser cut and placed on top 
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of the PMMA layer to seal the cell culture chamber and gas channels, prior to bolting together. 
The device was tested for leaks using water and cracks were sealed by application of 
dichloromethane to the seams (Fig. 3.1b).  
 
Integrated phosphorescence-based oxygen biosensor (iPOB) 
 Oxygen concentration in the system was continuously measured with an iPOB by NIR 
phosphorescence lifetime fluorimetry (Fig. 3.1c). Briefly, the iPOB is composed of porous 
poly(2-hydroxyethyl methacrylate) (pHEMA) gel functionalized with palladium-benzoporphyrin 
derivatives (Pd-BPD) that respond to local oxygen concentrations via phosphorescence 
quenching, resulting in an oxygen dependent variation in phosphorescent lifetime (Fig. 
3.1d).[332] The iPOB has been manufactured in a variety of sizes, but for all experiments 
presented here a disk-shaped iPOB with dimensions of 5 mm diameter and 0.5 mm thickness was 
used. The optical front-end of the NIR phosphorescence lifetime fluoroscope was inserted into 
the support frame below the 3D culture chamber. The iPOB and NIR phosphorescence lifetime 
fluoroscopes were provided by Profusa, Inc. 
 
Breast epithelial cell culture  
 Immortalized benign human breast epithelial cells (MCF-10A, CRL-10317; ATCC) [333] 
and non-metastatic tumorigenic human breast epithelial cells (BT474, HTB-20; ATCC) [334] 
were cultured. 3D tissue constructs were composed of cells seeded inside 8.2 mg·mL-1 of High 
Concentration (HC) Matrigel Basement Membrane Matrix (354248; Corning). Detailed culture 
conditions and protocols for conversion from 2D adherent monolayers to 3D embedded cultures 
are provided in the Supplemental Material (Appendix A).  
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Computational model of gas flow in device 
 COMSOL Multiphysics® (Burlington, MA) was used to simulate the oxygen 
concentration inside the cell culture-gas exchange chamber. The oxygen transport was simulated 
for chambers operating under constant flow of N2 at various flow rates to determine the amount 
of time necessary to create a hypoxic environment, which we have defined as <2% O2 (Table 
3.1). The geometry of the device was modeled in 3D to represent the cell culture-gas exchange 
chamber, comprised of medium, with a depth of 5.8 mm and surface area of 0.95 cm2. Inlet and 
outlet gas channels, comprised of air, were modeled as ports feeding into the cell culture. A 
video of the simulation is provided in the Online Supplemental Material. 
 
Characterization of iPOB and 3D culture system 
 For experiments requiring gas flow, metal barb adapters screwed into the top of the 3D 
culture device were connected to tubing and an N2 tank. Gas flow was regulated using a pin 
valve and monitored with a mass flow meter with digital output (GFMS-010061; Aalborg GFM). 
The device included an input adapter for N2 inflow and an output adapter for O2 outflow (Fig. 
3.1a). To characterize the iPOB and compare to the results of the computational models, initial 
experiments were performed inside a standard tissue culture incubator at 37°C. The iPOB was 
suspended in 1X PBS in the cell culture chamber. Oxygen concentration data was collected 
without N2 flow for 15 minutes. Following a stabilization period, N2 flow was introduced into 
the culture chamber at a constant rate (3, 5, or 7 mL·min-1) for 2 hours. The device was also 
tested with alternating N2 flow at a high rate (8 mL·min
-1) over a period of 6 hours to measure 
the time required to deoxygenate and reoxygenate the cell culture chamber. Lastly, the iPOB was 
 90
either embedded inside Matrigel® or placed in medium on top of Matrigel® inside the cell culture 
chamber and oxygen concentration was measured for 20 hours.  
 
Real-time monitoring and control of oxygen concentration in 3D culture 
 To determine cellular response to sustained hypoxia, breast epithelial cells were grown to 
confluency 75 cm2 culture flasks then trypsinized, counted and re-suspended in Matrigel® inside 
the cell culture chamber. MCF-10A cells were seeded at a concentration of 0.85 x 106 cells·ml-1 
inside Matrigel® with the iPOB in the cell culture chamber. Following a Matrigel® 
polymerization period of 30 minutes at 37°C, the rubber gasket and lid were sealed onto the 
device. The optical reader was attached to the bottom of the device and lifetime, temperature and 
oxygen measurements were recorded for the duration of each experiment. The device was placed 
inside an incubator maintaining a temperature of 37°C, 5% CO2 and 100% humidity and N2 was 
introduced into the device at a rate of 6.0 mL·min-1. The N2 flow rate of 6.0 mL·min
-1 was 
chosen to expel oxygen without evaporating liquid medium overlaid on the hydrogel.  Within 2 
hours, the iPOB reported the amount of oxygen inside the cell culture chamber had reached a 
hypoxic environment. The hypoxic condition was maintained for 24 hours with continuous N2 
flow. BT474 cell experiments were performed following the same procedure as explained above 
for MCF-10A cells, except BT474 cells were seeded in Matrigel® at a concentration of 0.6 x 106 
cells·ml-1, as previously reported. [335] 
 
Immunohistochemistry and gene expression  
 After 24 hours under hypoxic conditions, cells were characterized for hypoxia induced 
responses by immunohistochemical (IHC) and quantitative real-time polymerase chain reaction 
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analyses (qRT-PCR). Samples were stained for cellular apoptosis marker active cleaved 
Caspase-3 Alexa Fluor 488 conjugate (rabbit, 1:50 dilution in protein block, Cat. No. 96035S; 
Cell Signaling) for 2 hours and nuclei counterstain bisbenzamide (1:1000 dilution in 1X PBS, 
Cat. No. 1155; Millipore Sigma) for 5 minutes at room temperature. BT474 cell samples were 
also stained for Laminin alpha V, beta II Tubulin and bisbenzamide. All samples were imaged 
using a laser scanning confocal microscope (Zeiss LSM 710) and image analysis was performed 
using ImageJ [336] to quantify Caspase-3 positive cells (dead cells) and DAPI positive cells 
(total cell number). From this analysis, we compared % cell death across BT474 and MCF-10A 
cells culture in either normoxic or hypoxic environments after 24 hours. To assess the expression 
of genes that are responsive to hypoxia, a portion of breast epithelial cells encapsulated in 
Matrigel® was collected for qRT-PCR analysis. For each sample and experiment, triplicates were 
made and normalized to 16S mRNA levels. Fold change was expressed relative to normoxic 
controls using ∆∆CT analysis.[337] All statistics for IHC quantification and gene expression 
were generated using a Student’s t-test. In all statistical analysis, p < 0.05 was considered 
significant. Detailed materials and methods for the immunohistochemical and gene expression 
analysis are provided in the Supplemental Material (Appendix A). 
 
3.4. Results and discussion 
 A system was designed and engineered for real-time monitoring and control of oxygen 
concentration in 3D cell culture (Fig. 3.1). For findings presented in this paper, an oxygen 
concentration will be considered hypoxic if it is less than 2% oxygen or ≈ 20 µM, and a 
normoxic oxygen concentration will be 18.6% oxygen or ≈ 186 µM (Table 3.1).  
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 By using continuous gas exchange of N2 and O2 in the medium above the 3D tissue 
scaffold, oxygen concentration was precisely controlled to generate a range of normoxic and 
hypoxic conditions. N2 displaces O2 quickly inside the 3D culture-gas exchange chamber, similar 
to a tri-gas incubator. Tri-gas incubators create hypoxia by controlling CO2 and O2 using N2 to 
purge ambient air during incubation.[338-340] On a much a smaller scale, the 3D culture-gas 
exchange chamber replaced O2 with N2 in the medium above the 3D tissue scaffold to create a 
hypoxic environment for culturing cells. An intermediate oxygen concentration, such as 5% 
oxygen, could be maintained for 24-hour culture with continuous N2 flow rate lower than 3 
mL·min-1. 
 Inside the 3D tissue scaffold, an iPOB was embedded and via NIR phosphorescence 
lifetime fluorimetry the oxygen concentration inside the culture was monitored (Fig. 3.1c, d). 
The operation of the iPOB is based on the principle of phosphorescence quenching of 
metalloporphyrins by molecular oxygen.[341, 342] The phosphorescent chromophore 
(porphyrin) of the probe molecule can be converted to the triplet state by light absorption, 
followed by return to the ground state either with light emission (phosphorescence and/or 
delayed fluorescence) or by energy transfer to molecular oxygen.[343] pHEMA is a 
biocompatible hydrogel and the porosity of the hydrogel facilitates liquid and gas exchange, 
along with penetration of the resident cell population. A portable phosphorescence lifetime 
fluoroscope was utilized to record the signal from the iPOB (Profusa, Inc.). Use of 
phosphorescence has been demonstrated as a viable method for measuring oxygen distribution in 
tissue in animals and humans.[341, 342, 344-346] The phosphorescence lifetime of the 
metalloporphyrins is inversely related to oxygenation and can be measured within 2 µs, 
providing an oxygen detection range from 2 to 70 µM.[332] For in vitro oxygen measurements 
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requiring phosphorescence lifetime detection in seconds, the detection range can be extended to 
150 µM.  
 
Computational model of gas flow and comparison to the experimental performance of the iPOB 
in the 3D culture and oxygen monitoring system 
 The computational model developed to recapitulate the geometry and fluid dynamics of 
the device predicted the amount of time a given N2 flow rate would take to deoxygenate the 
entire 3D culture-gas exchange chamber. Representative results of the simulation are shown in 
Fig. 3.2a. The results of the simulations at various N2 flow rates show that a N2 flow rate of 7.0 
mL·min-1 creates a hypoxic environment inside the cell culture chamber of PO2 = 1 kPa or ≈ 1% 
O2 within 45 minutes (Fig. 3.2b).  
 To experimentally validate the computational models, the iPOB was suspended in PBS 
solution and N2 flow was introduced into the 3D culture-gas exchange chamber. The 
phosphorescence intensity output of the iPOB was processed to calculate the phosphorescence 
lifetime decay (τ), as previously reported.[341] Phosphorescent lifetime decay of Pd-BPD 
correlates directly to the oxygen concentration of its surrounding environment.[347, 348]  
 Repeated cycling of N2 flow for 6 hours at a flow rate of 8.0 mL·min
-1 showed that the 
oxygen concentration equilibrated to normoxic conditions within one hour after N2 inflow 
ceased, as shown in Fig. 3.2c. Based on the Einstein-Smoluchowski equation for diffusion of 
gases in solution (t = 0.5·r2·D-1)[349-353], where r equals the height of 500 µL of PBS inside the 
device (5.26 mm) and D is the diffusion coefficient of O2 (2.46 x 10
-9 m2·s-1[354]), the expected 
time required for O2 to diffuse through PBS was calculated as ≈ 90 minutes. Because the oxygen 
concentration returned to normoxia in less than 1.5 hours once N2 inflow ceased, the calculated 
 94
O2 equilibration period through PBS agreed with the experimental cycling of N2 for lifetime 
decay and oxygen concentration. Although an N2 flow rate of 8.0 mL·min
-1 was experimentally 
tested inside the device containing the iPOB suspended in PBS, when this high gas flow rate was 
used with the device containing a hydrogel and medium, we noticed the high N2 flow rate caused 
evaporation of the liquid medium overlaid on the hydrogel. Previously reported values for gas 
flow rates used in hypoxic cell culture devices include a range from 5 mL·min-1 to as high as 20 
mL·min-1.[143, 144, 187, 188] Further optimization of N2 flow with the hydrogel revealed that a 
flow rate of 6 mL·min-1 expelled oxygen rapidly while maintaining medium on top of the 
hydrogel (data not shown).  
 Experimentally tested flow rates of 3, 5 and 7 mL·min-1 reveal similar trends of 
deoxygenation as predicted by the computational simulations. At 3 mL·min-1, the lowest N2 flow 
rate tested, an oxygen concentration less than 27 µM (≈ 2.7% O2) was achieved in less than 2 
hours (Fig. 3.2d). Compared to the computation simulation at an N2 flow rate of 3 mL·min
-1, 
which found an oxygen concentration less than 27 µM in 36 minutes, it took more time than 
predicted to achieved this oxygen concentration experimentally. At an N2 flow rate of 5 mL·min
-
1, an oxygen concentration less than 20 µM (≈ 2% O2) was achieved in less than 40 minutes (Fig. 
3.2d). The simulation found at this flow rate that an oxygen concentration less than 20 µM was 
achieved in 30 minutes, which agrees well with experimentally measured time. Finally, at 7 
mL·min-1 N2 flow rate, within 23 minutes an oxygen concentration less than 10 µM (≈ 1% O2) 
was achieved (Fig. 3.2d) experimentally, which was approximately 25 minutes faster than the 
simulation predicted. Humidity and temperature change inside the incubator could account for 
slight differences between simulation and experimental results. The 3D culture-gas exchange 
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chamber and iPOB sustained repeated experimental testing at 37°C with no signs of damage or 
degradation.  
 In addition to testing the iPOB embedded inside the tissue scaffold, we tested the 
response of the iPOB in the medium above the tissue scaffold. We found that there was on 
average a 20 µM (≈ 2% O2) decrease in oxygen concentration between the medium and inside 
the Matrigel® (Fig. 3.3d). When the iPOB was embedded inside Matrigel® the oxygen 
concentration was on average 119 µM (≈ 12% O2). When the iPOB was placed in medium on 
top of the Matrigel® the oxygen concentration was on average 139 µM (≈ 14% O2). A similar 
trend was recorded when the iPOB was inserted in “cell-free” tissue scaffolds and exposed to N2 
flow rate of 7.0 mL·min-1 (Fig. 3.3e). A higher oxygen level was measured on top of the tissue 
scaffold as compared to inside the tissue scaffold, until both conditions dropped below the 
hypoxic level (20 µM).  These results illustrate the spatial resolution of the iPOB and the 
capability to identify the effects of the tissue scaffold on the oxygen transport; moreover, this 
demonstrates a method to monitor oxygen concentrations in thicker (> 2 mm) 3D tissue cultures.  
 
Monitoring of oxygen concentration in 3D culture of healthy and tumorigenic breast epithelial 
cells 
 The variation of native oxygen environments and tumorigenic status of the two breast 
epithelial cell lines derived from the same native tissue make them optimal candidates to monitor 
and compare cellular responses to hypoxia for validation of the reported 3D cell culture and 
oxygen monitoring system. Benign human breast epithelial cells, MCF-10A cells, and 
tumorigenic human breast epithelial cells, BT474 cells, have been shown to respond to the same 
duration and magnitude of hypoxia with unique mRNA and protein expression levels.[355-357] 
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MCF-10A cells were derived from benign human breast tissue, where the concentration of 
oxygen has been reported to be greater than 9%; BT474 cells were derived from solid, invasive 
ductal breast carcinomas, where the concentration of oxygen has been reported to be as low as 
0.3% oxygen.[358] The native oxygen environments from which the MCF-10A and BT474 cells 
are derived represent normoxia and hypoxia in breast tissue, respectively.  
 To compare MCF-10A and BT474 cellular response in the system after 24 hours of 
hypoxia, we fixed hydrogels containing cells and performed immunohistochemical (IHC) 
analysis for cleaved Caspase-3. Both MCF-10A and BT474 cells responded to hypoxic 
conditions by exhibiting significant cellular apoptosis, quantified as the ratio of apoptotic marker 
cleaved Caspase-3 positive cells to nuclei marker bisbenzamide positive cells (Fig. 3.3a,b). Most 
importantly, MCF-10A cells exhibited a significantly higher percentage of cell death than BT474 
cells. The increased cell death of MCF-10A cells in response to hypoxia, as compared to the 
tumorigenic BT474 cells, was not unexpected as MCF-10A cells typically occupy a higher 
oxygen environment and may experience hypoxic stress more quickly than tumorigenic breast 
epithelial cells. IHC analysis of cellular apoptosis showed that the hypoxic environment induced 
inside the system instigated the expected apoptotic responses in both MCF-10A and BT474 cells 
with an exacerbated response in the benign MCF-10A cells. 
 To investigate 3D cell morphology following hypoxic culture, we examined the cellular 
basement membrane and microtubules of BT474 cells by staining for Laminin, alpha V and beta 
II Tubulin, respectively. In BT474 cells cultured for 24 hours under hypoxic conditions, there 
was a noticeable absence of Laminin, alpha V, representing a lack of intact basement membrane, 
as compared to BT474 cells cultured under normoxic conditions for 24 hours (Fig. 3.3c). BT474 
cells also exhibited lower levels of beta II Tubulin, as compared to BT474 cells cultured under 
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normoxic conditions. Confocal images collected from samples of normoxic and hypoxic cultured 
BT474 cells collectively suggest that the hypoxic environment imposed inside the device 
imparted morphological changes on the BT474 cells. Although the cell morphology of BT474 
cells cultured under hypoxic conditions was qualitatively different than that of normoxic BT474 
cells, a quantitative comparison was not made due to increased non-specific staining of the 
scaffold and hypoxia-induced cellular debris.  
 When culturing MCF-10A cells under both normoxic and hypoxic conditions, oxygen 
concentrations were measured below standard culture conditions, i.e. less than the conventional 
hypoxia (2% ≈ 20 µM) or normoxia (18.6% O2 or ≈ 186 µM) conditions. Representative data 
from one culture period (20 hrs.) is displayed in Figure 3.3f. Under hypoxic conditions, an 
average oxygen concentration of 12 µM (≈ 1.2% O2) was measured. Under normoxic conditions, 
an average oxygen concentration of 127 µM (≈ 13% O2) was measured. When culturing BT474 
cells in our system, even lower oxygen concentrations were measured in both the hypoxic and 
normoxic conditions (Fig. 3.3g). During the normoxic experiments, an average oxygen 
concentration of 95 µM (≈ 9.5% O2) was measured, while during the hypoxic experiments the 
oxygen concentration was 6.4 µM (≈ 0.6% O2). These results confirm the 18.6% O2 contained 
within the normobaric incubator is significantly limited by diffusion through the thickness of the 
cell-laden tissue scaffold and medium (4.21 mm), which is corroborated by oxygen concentration 
measurements made in the “cell free” experiments. The type of cell, either non-tumorigenic 
(MCF10A cells) or tumorigenic (BT474 cells), had an impact on the amount of oxygen measured 
under each condition.   
 To determine whether known genetic responders to hypoxia were upregulated following 
hypoxic conditioning in our device, we evaluated the expression of selected downstream target 
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genes of HIF1 (Hypoxia inducible factor-1) using mRNA collected from BT474 and MCF-10A 
cells. The HIF protein is a transcription factor composed of two subunits: the oxygen-dependent 
α subunit and the ubiquitously expressed ß subunit.[359] During hypoxia, the HIF-1α subunit is 
rescued from oxygen-dependent degradation in the proteasome and activates a complement of 
downstream target genes.[32, 360] The stabilized HIF-1 transcriptional activator binds genetic 
enhancer sequences in the promoter of HIF-1 target genes.[361] A subset of these target genes 
include the following: vascular endothelial growth factor (VEGF)[362], solute carrier family 2 
member 1 (SLC2A1)[363] and BCL2 (B-cell lymphoma 2) interacting protein 3 (BNIP3)[364], 
which are important for angiogenesis, glucose metabolism and apoptosis, respectively.  
  Since the oxygen-dependent HIF1A is primarily regulated at the post-transcriptional level 
by nuclear localization and protein stabilization [365, 366], we did not expect substantial 
changes in HIF1A mRNA following 24-hour hypoxia. While HIF1A slightly increased in both 
BT474 and MCF-10A cells, there was a significant and substantial increase in HIF1 target genes 
VEGFA, SLC2A1 and BNIP3. Interestingly, the tumorigenic BT474 cells had the most 
significant upregulation of BNIP3 when compared to normoxic controls (Fig. 3.4a, purple bars, 
p < 0.05, Student’s t-test). These results contrast greatly with non-tumorigenic MCF-10A cells, 
which displayed little change in BNIP3 expression. Although BNIP3 upregulation has been 
previously reported following similar durations of hypoxic conditioning [367], cells encapsulated 
in a hydrogel 3D tissue construct differ from previous culture methods in which MCF-10A cells 
were adherent to tissue culture plates. The 3D tissue scaffold could provide a barrier to protect 
MCF-10A cells from apoptotic injury, leading to less mRNA expression of BNIP3. Another 
study comparing durations of hypoxia reported BNIP3 expression peaks after 72 hours, 
suggesting BNIP3 expression is a later hypoxic response than downstream targets VEGFA and 
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SLC2A1.[364] Overall, the difference in BNIP3 expression between MCF-10A cells and BT474 
cells suggests tumorigenic BT474 cells are more susceptible to hypoxia-induced apoptosis, as 
evident from 12-fold increase in BNIP3 expression. MCF-10A cells cultured under hypoxic 
conditions showed a significant 5.0-fold increase in VEGFA and 7.0-fold increase in SLC2A1 
expression, as compared to normoxic controls (Fig. 3.4b, purple bars, p < 0.05, Student’s t-test). 
These results support that non-tumorigenic MCF-10A cells initially respond to hypoxia by 
primarily upregulating the angiogenic (VEGFA) and glycolytic (SLC2A1) pathways. The 
upregulation of VEGFA mRNA present in both BT474 and MCF-10A cells agrees with previous 
findings, which showed an increase in endogenous secreted VEGF protein levels via ELISA and 
VEGF mRNA levels via RT-PCR for the same cell types under similar 24-hour hypoxic (defined 
as 0.5% O2) conditions.[355] 
 While there were consistent increases in VEGFA and SLC2A1 gene expression between 
the two cell types, in BT474 cells HIF1A expression showed a slight but significant increase, 
with little change in MCF-10A cells. Because activation of HIF-1 depends in part on post-
transcriptional stabilization of HIF-1α [368], its near-absence in mRNA cell samples after 24 
hours of hypoxic conditioning is unsurprising [369], and the upregulation of downstream 
reporter genes VEGFA, SLC2A1 and BNIP3 further supports this interpretation. Overall, the 24-
hour restrictive oxygen conditioning revealed key hypoxia-dependent genes were upregulated 
within the hypoxia device. These changes were consistent with low oxygen levels that were 
measured by the iPOB embedded within the Matrigel® containing either BT474 or MCF-10A 




 Microdevices built for in vitro cell culture with iPOBs provide a route to study cells and 
tissues in more physiologically-relevant oxygen environments. By quickly and accurately 
monitoring local oxygen concentration in 3D tissue cultures, the oxygen concentration can be 
manipulated to recapitulate healthy and pathological environments. The reported 3D culture and 
oxygen monitoring system demonstrated a simple design to remotely monitor oxygen 
concentration during tissue culture. We recorded fluctuations in the local tissue environment due 
to external controls (N2 inflow). We demonstrate in situ controllable and reversible oxygen 
conditions over a relatively short period of time and large oxygen concentration range. As more 
knowledge concerning the micro-environments surrounding cells is discovered, in vitro cell, 
tissue and organ models must sustain relevant oxygen levels to generate more “translatable” 
results.  
 During the reported validation testing, MCF-10A and BT474 breast epithelial cells 
revealed distinct differences in response to the same magnitude and duration of hypoxia. IHC 
analysis showed a significant increase in apoptotic marker cleaved Caspase-3 for both cell types. 
Genetic analysis differentiated the response of the cell types to hypoxic culture conditions by 
revealing sizable and significant upregulation of only apoptotic marker BNIP3 for tumorigenic 
BT474 cells and significant upregulation of both VEGFA and SLC2A1 for MCF-10A cells. The 
additional upregulation of hypoxia-associated genes VEGFA and SLC2A1 in MCF-10A cells 
demonstrates that non-tumorigenic breast epithelial cells are more effected by hypoxia, as 
compared to BT474 cells. Intrinsic markers of hypoxia and their downstream targets, provide a 
mechanistic basis for interpreting cellular response to different oxygen levels. The distinct 
hypoxic pathways responsible for benign and tumorigenic breast epithelial cell differences could 
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be further investigated using the device and iPOB. With fine control over the oxygen 
microenvironment, questions concerning the mechanisms influencing cell fate through hypoxic 
pathways can be answered. When combined with in-line analytical techniques, such as media 
sampling and imaging, the iPOBs provide a powerful method to remotely measure the interstitial 
oxygen environment, monitor cell culture performance and study complex phenomena in 3D 
tissue models.  
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Table 3.1. Definitions of Relevant Oxygen Environments at 37°C  
 
  
Environment O2 (%) pO2 (kPa) cO2 (µM) 
“Normoxia” 21.0 19.9 210 
    
Normoxia (incubator) 18.6 17.7 186 
    
Low Oxygen 5.0 4.75 50.2 
    
Hypoxia 2.0 1.90 20.1 
    
Near Anoxia 0.5 0.48 5.02 
 
Anoxia 0.0 0.0 0.0 
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Figure 3.1. 3D Culture and oxygen monitoring system. (a) A schematic of device compartments. 
A photopolymer resin bottom frame supports PMMA cell culture chamber and gas exchange 
channel.  Rubber gasket seals gas flow into and out of the culture chamber and gas exchange 
channel. Barbed connectors screwed into the top lid provide gas flow into and out of the device. 
The optical connects to a phosophorescence-lifetime fluorimeter and interrogates the culture 
chamber, where the 5 mm diameter, 0.5 mm thick integrated phosphorescence-based oxygen 
biosensor (iPOB) is located. (b) Photographs of device. Left: Image of device with iPOB (black 
arrow) embedded in hydrogel. Middle and Bottom Right: Images of the assembled device with red 
and blue dyes to differentiate the gas channels and cell culture chamber, respectively. Top Right: 
Device enclosed inside frame with optical reader underneath (c) Schematic of oxygen sensing via 
hydrogel iPOB inside hydrogel containing cells. The iPOB is composed of poly(2-hydroxyethyl 
methacrylate) gels functionalized with palladium-benzoporphyrin derivatives (Pd-BPD). The 
photoluminescence excitation and detection wavelengths are 630 nm and 800 nm, respectively. (d) 
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Modified Jablonski diagram demonstrating the scheme of oxygen concentration detection from 
porphyrin luminescence. Luminescence from the triplet state in porphyrin is quenched by energy 







Figure 3.2. Computational Model of oxygen concentration in 3D culture and monitoring with 
Integrated Phosphorescence-based Oxygen Biosensor (iPOB). (a) Results from COMSOL 
Multiphysics® computational model of the 3D culture-gas exchange chamber showing N2 flow at 
5.0 mL·min-1 used to purge O2 from the left inlet to the right outlet over a 50-minute interval, with 
four color maps displaying oxygen tension after 0, 10, 30 and 50 minutes. The color maps display 
the oxygen tension from 0 to 21 kPa. (b) COMSOL Multiphysics® simulation results of N2 flow 
at various flow rates show the amount of oxygen inside the bottom of the cell culture chamber 
decreases more rapidly with increased N2 flow rates. (c) Experimental results of purging and re-
oxygenating the culture chamber by turning on and off N2 at a flow rate of 8.0 mL·min
-1 over 6 
hrs and allowing for passive diffusion of oxygen from the atmosphere into the cell culture chamber. 
(d) Experimental results illustrating the operation of the iPOB in PBS measuring changes in 
phosphorescence lifetime at different N2 flow rates. (e) Conversion of phosphorescent lifetime to 
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oxygen concentration for iPOB in PBS at different N2 flow rates. Note the hypoxic environment 







Figure 3.3. Monitoring and controlling oxygen concentration in 3D cell culture. (a) Left: Breast 
epithelial cells grown in T-75 flasks for 6 days. Middle: Breast epithelial cells embedded in 
Matrigel® and cultured in a normoxic environment for 24 hours. Fluorescent images: Caspase-3 
(green), DAPI (blue). Right: Breast epithelial cells embedded in Matrigel® and cultured in a 
hypoxic environment for 24 hours. Fluorescent images: Caspase-3 (green), DAPI (blue). (b) 
Quantification of cell death from confocal images using ratio of Caspase-3 positive cells to DAPI 
positive cells. n = 3; *p<0.05, **p<0.01. (c) Fluorescent micrographs of BT474 cells showing 
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basement membrane (Laminin alpha V, red), microtubules (Beta II tubulin, green) and nuclei 
(Bisbenzimide, blue) after 24 hours of normoxic or hypoxic culture inside the device. (d) 
Integrated Phosphorescence-based Oxygen Biosensor (iPOB) measurements of oxygen 
concentration in “cell-free” tissue scaffolds over 20 hours. There is less oxygen inside the tissue 
scaffold (shown in purple) than on top of the tissue scaffold (shown in blue). (e) iPOB 
measurements of oxygen concentration in “cell-free” tissue scaffolds exposed to an N2 flow rate 
of 7.0 mL·min-1 over 20 hours. (f) iPOB measurements from inside the tissue scaffold for MCF-
10A cells cultured under hypoxic and normoxic conditions (shown in purple and black, 
respectively) for 20 hours. Under hypoxic conditions, average oxygen concentration of 12 µM (≈ 
1.2% O2) was measured. Under normoxic conditions, an average oxygen concentration of 127 µM 
(≈ 13% O2) was measured. (g) iPOB measurements from inside the tissue scaffold for BT474 cells 
cultured under hypoxic and normoxic conditions (shown in purple and black, respectively) for 20 
hours. Under hypoxic conditions, average oxygen concentration of 6.4 µM (≈ 0.6% O2) was 
measured. Under normoxic conditions, an average oxygen concentration of 95 µM (≈ 9.5% O2) 
was measured. Horizontal dashed lines are the normoxic oxygen concentration (186 µM) and 






Figure 3.4. Response of breast epithelial cells to hypoxic culture conditions. (a) Gene expression 
analysis of BT474 cells after 24 hours of hypoxic or normoxic conditioning (purple and black bars, 
respectively). Hypoxia-associated genes including HIF1A, VEGFA, SLC2A1 and BNIP3 mRNA 
measured by qRT-PCR relative to the average expression in normoxic (21% oxygen) controls. n 
= 4; *p<0.05. (b) Gene expression analysis of MCF-10A cells after 24 hours of hypoxic or 
normoxic conditioning (purple and black bars, respectively). Hypoxia-associated genes including 
HIF1A, VEGFA, SLC2A1 and BNIP3 mRNA measured by qRT-PCR relative to the average 
expression in normoxic (21% oxygen) controls. n = 4; *p<0.05.  
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CHAPTER 4: SEVERE HYPOXIA PREPARES HUMAN INTESTINAL STEM CELLS 




 Oxygenated blood flow throughout the small intestine is vital to homeostatic regulation of 
epithelial cell function. Ischemia/Reperfusion injury is marked by a blockage of blood flow and 
the initiation of an inadequate oxygen, or hypoxic, microenvironment. Many intestinal diseases, 
including chronic inflammation and ulcerative colitis, are also coupled with tissue hypoxia. A 
novel microphysiological system (MPS) has been developed to deliver various durations and 
magnitudes of oxygen to primary human intestinal epithelial stem cells (ISCs). The MPS allows 
for precise remote monitoring and control of oxygen concentrations in real-time at the cell surface 
interface. Using the MPS, dynamic changes in gene expression in populations of human small 
intestinal ISCs, along with single cell transcriptomics, reveal key hypoxia-dependent responses. 
ISCs isolated and reintroduced to an oxygen environment show increased organoid survival with 
increasing duration of hypoxia. A set of hypoxia-dependent cytokine receptors, including 
interleukin 6 (IL6), interleukin 10 (IL10), and interleukin 22 (IL22), are found to be upregulated 
in human ISCs following hypoxia.   
 
                                                 
3 Full list of contributing authors: Kristina R. Rivera, Michael J. Czerwinski, Vladimir A. Pozdin, Ming Yao, 
Michael A. Daniele, and Scott T. Magness. 
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4.2. Introduction 
 Cellular respiration in complex multi-layered tissues relies on a constant supply of oxygen 
to maintain healthy physiologic states. The majority of cells in a tissue are perfused by a vast 
network of vessels that terminate in capillary beds where oxygen is released to adjacent cells in a 
local microenvironment.[12] Cells that comprise a tissue can experience marked differences in 
physiologic oxygen concentrations, such as in the intestinal microarchitectural framework of the 
crypt-villus axis where crypt-based cells experience higher oxygen levels compared with the cells 
at the tips of the villi.[11] Here a steep gradient is set-up within oxygen microenvironments that 
are ~10-fold different within just  ~100 cell distances.[370] While these differences are tolerated 
as normal, sudden or dramatic changes in the magnitude and duration of oxygen loss, known as 
hypoxia, triggers a rapid transcriptional response mediated by hypoxia-inducible factors (HIFs) in 
an attempt to spare cellular functions. HIF response appears to be a universal property of cells 
across various tissues and is likely an adaptation that enables cells facing injury or disease to 
modify functions to preserve cell viability when oxygen levels fall below physiologic ranges with 
disrupted blood flow.[149, 371] 
Clinical presentation of larger mesenteric vasculature occlusion brought on by bowel 
strangulation, aneurysm, organ harvest for small bowel transplantation, and neonatal necrotizing 
enterocolitis can produce an ischemic event, or loss of oxygenated blood flow to the intestine.[18] 
Less appreciable are conditions like chronic inflammation or ulcerated bowel that cause 
vasoconstriction and disrupt the capillary beds, leading to localized hypoxic events.[21, 50] While 
ischemic hypoxia is harmful, counterintuitively, reperfusion with oxygenated blood can promote 
further tissue injury as reintroduction of oxygen produces highly toxic reactive oxygen species 
(ROS). Ischemia-reperfusion (IR) injury has been nicely characterized in porcine and human 
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translational models.[50, 372] Collectively, the findings indicate that short term (30 minute) 
ischemia followed by reperfusion is well tolerated and recoverable, however, longer ischemic 
times (>45 minutes) followed by reperfusion produces profound loss of barrier function, increased 
translocation of endotoxin, and substantial inflammatory response characterized by release of 
inflammatory cytokine mediators and immune cell infiltration.[16] These studies indicated that the 
human differentiated intestinal epithelium is exquisitely sensitive to hypoxia and that the 
subsequent immune response is a feature of epithelial repair dynamics.  
What remains unclear is how the duration and magnitude of hypoxia specifically impact 
the human intestinal stem cell (ISC) population, which must be spared for epithelial replacement 
and healing. Porcine models of prolonged IR-injury (1-4 hours) demonstrate a reduction of active 
ISC (aISC) markers, Lgr5 and Sox9, and enrichment of the reserve ISC (rISC) marker, Hopx, 
suggesting Hopx+ cells are more tolerant to I/R-injury and might contribute to epithelial 
recovery.[373] The human translational model suggests only long-term IR-injury of 2 hours 
produces appreciable apoptosis in the crypt zone, however, it is unclear what cell types are 
sensitive to IR-induced cell death. In culture, monolayers of primary mouse epithelium reenact a 
hypoxia-associated ‘injury-regeneration’ cycle where oxygen tension appears to be a functional 
switch between injury and epithelial regeneration in the colonic epithelium.[374] Also in mice, 
ischemic preconditioning of intestinal tissue has been shown to improve tissue repair[375] and 
reduce cell death during ischemia by activating ISCs.[376] Interestingly, in humans the colonic 
epithelium is less susceptible to IR-induced injury demonstrated by increased apoptosis in the 
small intestinal crypts and villi, immune cell infiltration, and expression of injury-related 
cytokines.[377] These studies suggest variable and perhaps divergent hypoxia-dependent 
responses of ISCs in different species and across different regions of the small intestine and colon. 
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They also reveal gaps in knowledge related to important mechanisms human ISCs engage in during 
short and long-term hypoxic events. 
Investigating the impact of hypoxia on human ISCs has been historically challenging due 
to the limited physiologically relevant models, ethical considerations of human research, and lack 
of high-resolution in vitro platforms that are required to recreate hypoxic environments where 
oxygen levels can be exquisitely tailored and monitored in real time. In this study we developed a 
microphysiological system (MPS) to deliver various durations and magnitudes of hypoxia to 
primary human ISCs. The MPS allows for precise remote monitoring and control of oxygen 
concentrations in real-time at the cell surface interface. We use the MPS to explore the dynamic 
changes in gene expression in populations of human small intestinal ISCs and at cell-resolution 
using single cell transcriptomics to reveal key hypoxia-dependent responses. Our analysis 
concentrates on a set of hypoxia-dependent cytokine receptors that are regulated in human ISCs, 
and we extend these findings to test immune-related cytokine mechanisms that impact ISC survival 
and function after experimental reoxygenation. Aside from a new high-resolution picture of 
dynamic transcriptomic changes and functional consequence that occur in ISCs from the onset of 
a hypoxic event until reperfusion, our study underscores important immune related influences that 
directly impact ISCs post-IR-injury. Our study has important implications for better understanding 







4.3. Results  
A new microphysiological system (MPS) enables precise regulation and real-time monitoring of 
oxygen levels at the cell-media interface  
Existing platforms were incapable of supporting ISC expansion and providing direct 
measurements of oxygen levels in real-time at the cell-media interface, therefore, we developed a 
novel microphysiological system (MPS) the size of a standard microscope slide where oxygen 
levels could be tailored to precise levels in five independent wells, each containing a hydrogel 
scaffold that facilitates ISC expansion (Fig. 4.1A, B). The MPS was designed as a closed system 
in which ambient air was sparged over each well via continuous delivery of mixed gases. A 
biocompatible integrated phosphorescent oxygen sensor (iPOB) was placed on the hydrogel 
scaffold surface to provide real-time oxygen measurements specifically at the media-cell interface 
(Fig. 4.1B). Oxygen levels were quantified by the iPOB using Near Infrared (NIR) 
phosphorescence lifetime fluorimetry, as local oxygen quenches phosphorescence, resulting in 
detectable change in lifetime using a commercially available optical system (Fig. 4.1A, C).[332] 
The iPOBs are highly sensitive and validate that different oxygen levels can be generated with 
integration of an off-chip gas mixer (Fig. B.1).[378] Oxygen levels achieve equilibrium inside the 
intestinal MPS within less than an hour and can be stably and indefinitely maintained in the 
presence of constant gas flow (Fig. 4.1D). The MPS represents a small, highly sensitive, scalable 
and portable system that can accurately quantify the magnitude of hypoxia inside culture wells. 
The MPS is fabricated from relatively inexpensive commercially available materials and can be 
sterilized and reused many times. While the MPS is enclosed in a 3D-printed light-tight container 
required for phosphorescence detection during each study, the wells can be easily accessed to 
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refresh media, add compounds, and perform a variety of downstream assays including microscopy, 
transcriptomic analysis, and immunostaining.  
 
The MPS supports culture of human ISC monolayers that respond to an induced hypoxic 
environment 
We recently developed methods that support indefinite expansion of human ISCs isolated 
from intestinal organ transplant donors[60], and we integrated the ISC monolayer culture into the 
MPS. Human jejunal ISCs were cultured inside each well of the MPS, and once confluent, an iPOB 
was added to the cell surface during a media exchange, and the iPOB remained in place on the 
epithelial cell surface for the full duration of each experiment. We performed an initial 
characterization of ISCs cultured in the MPS under normoxic conditions by microscopy and 
immunofluorescence staining. ISCs were cultured to confluence using conditioned expansion 
media (EM) that supports Wnt-signaling and ISC maintenance.[379, 380] ISCs reached confluence 
within 4 days as monitored by brightfield microscopy and cells expressed the epithelial cell tight 
junction protein, occludin (Fig. 4.2A). ISC monolayers demonstrated pervasive expression of 
SOX9, which primarily marks ISCs and progenitor cells in vivo[381, 382], and a 6-hour pulse with 
S-phase marker, EdU, indicated cells in the monolayer were proliferating (Fig. 4.2A). These 
results indicate the MPS is biocompatible with primary human cell culture and supports a 
monolayer composed of cells consistent with ISCs. 
Since reliable antibodies against human ISCs are not available, we performed single-cell 
RNA-sequencing (scRNAseq) to understand the extent to which cells cultured in the MPS under 
ISC expansion conditions possessed gene expression patterns consistent with ISCs (Fig 4.2B). 
Human jejunal ISCs were cultured on expansion scaffolds in EM under normoxic conditions, 
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which represents the starting conditions for all experiments. Cells were dissociated to single cells, 
and scRNAseq libraries were generated from ~2000 cells. After computational filtering, 
dimensional reduction using UMAP was performed on the remaining 1640 cells for data 
visualization (Fig. 4.2B). Although a transcriptomic signature for freshly isolated human ISCs has 
not been described, we interrogated each cell for the expression of LGR5, OLFM4, and ASCL2, 
three biomarkers that exhibit restricted expression to the active ISC crypt-based columnar cells in 
mouse small intestine.[383-385] The data demonstrate ~68% of the cells express the general 
proliferation markers mKI67 or PCNA, and while all three mouse-associated biomarkers are 
expressed, OLFM4 was the most broadly expressed in ~67% of cells cultured in ISC expansion 
conditions. Differentiated lineage biomarkers alkaline phosphatase (ALPI; absorptive 
enterocytes), and Mucin2 (MUC2; goblet cells) were not appreciably expressed, and no expression 
for Defensin 5A (DEFA5A; Paneth cells), Chromogranin A (CHGA; enteroendocrine cells), and 
Doublecortin Like Kinase 1 (DCLK1; tuft cells) was detected (Fig. 4.2B). It is important to note 
that while scRNAseq is a powerful high-resolution technique, low expressed genes can sometimes 
be undetected in the analysis, and thus, biomarker expression at the single-cell level can be 
underrepresented. Sequencing depth per cell is on the order of 100-fold lower than that from bulk 
sequencing, which decreases the sensitivity of gene detection accordingly. However, these data, 
together with more extensive analyses (Fig. B.2), indicate that most cells in the monolayer cultures 
are proliferative cells expressing biomarkers consistent with murine ISCs and suggest the vast 
majority of cells have not engaged terminal differentiation programs (Fig. B.2).  
To better understand the extent to which human ISC expansion cultures demonstrated 
functional ISC activity, cells were dissociated to single cells and applied to conventional 3-
dimensional (3D) cultures to assess organoid forming efficiency (OFE), a proxy for in vivo ISC 
 117
activity.[386] Micro-Cell Raft Arrays (CRAs) were used as a highly accurate method to quantify 
thousands of putative ISCs that have organoid forming potential.[198, 387] Single cells plated in 
CRA micro wells were identified, quantified, and each candidate ISC was followed over a 6 day 
culture period. The data demonstrate ~4% of cells cultured in the MPS under ISC expansion 
conditions generated an organoid (Fig. 4.2C). While this is a relatively low incidence, it is 
consistent with OFE of FACS-isolated murine Lgr5-EGFP expressing single cells cultured under 
similar conditions [198, 388] and human ISCs cultured for the same period of time in synthetic 
matrices [388], suggesting the full extent of ISC activity of cells cultured in the MPS is captured 
by the 3D culture conditions. The ability to form organoids from single cells isolated from the 
normoxic MPS shows that the human ISCs maintained stem cell function, providing a platform to 
investigate stem cell potential following hypoxia.  
To determine if ISC monolayer cultures exposed to hypoxia would respond in a baseline 
predictable way, ISC monolayers were exposed to hypoxia and expression of known HIF-target 
genes was assessed. Off-chip gas mixtures were adjusted to achieve an oxygen concentration of 
<1% (below 10 µM), which is considered severely hypoxic but not anoxic.[389] Real-time oxygen 
levels at the cell-media interface were measured inside each device for the duration of the 24-hour 
experiment (Fig. 4.2D inset). The data show the MPS produced a rapid hypoxic environment of 
0.3% Oxygen (3 µM) within ~30 minutes, which was maintained during the 24-hour experiment 
(Fig. 4.2D). Interestingly, when ISC monolayers were cultured in normoxic conditions as a 
control, cellular respiration reduced oxygen levels from 18% (180 µM) to 3.5% (35 µM) in the 
MPS indicating physiologic oxygen levels for ISCs in culture is 5-fold less that atmospheric 
oxygen levels. Total mRNA was collected after 24-hours of hypoxia and expression of HIF1A and 
HIF-target genes; vascular endothelial growth factor (VEGF)[362], solute carrier family 2 member 
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1 (SLC2A1 or GLUT1)[363] and BCL2 (B-cell lymphoma 2) interacting protein 3 (BNIP3)[364] 
were quantified. As expected HIF1A demonstrated little transcriptional change since its activity is 
mediated by post-transcriptional stabilization[365, 366], however, HIF1A target genes were 
significantly upregulated compared to normoxic controls (Fig. 4.2E). Overall, our results show the 
MPS produces reproducible ISC culture replicates, generates a rapid and sustained hypoxic 
environment for prolonged periods, and demonstrates that an oxygen tension of 0.3% (3 µM) is 
sufficient to activate a canonical hypoxia response inside primary human ISCs.  
 
24hrs of hypoxia causes increased proliferation and reduced ISC activity that recovers at 48hrs 
of hypoxia 
A pressing question is whether human ISCs can tolerate hypoxic events for long periods 
of ischemia, which may be a feature of chronic inflammation in ISC microenvironments or organ 
harvest and pre-transplantation storage.[149, 204] We addressed this question by first exposing 
ISC monolayers in the MPS to 24 hours of hypoxia (<1% oxygen), and then quantified ISC 
proliferation and functional properties by single-cell organoid forming potential. Following 24 
hours of culture in either a normoxic or a hypoxic MPS, qualitatively, there was little appreciable 
difference in the number of proliferating cells in the hypoxic MPS (Fig. 4.3A), however, a more 
careful quantitative analysis by flow cytometry demonstrated a slight but significant increase in 
proliferating cells after 24-hours of hypoxia (Fig. 4.3B, C).  
To determine how longer hypoxia would impact ISC function, monolayers were exposed 
to 24-hours or 48-hours of hypoxia or normoxia as a control in the MPS; then monolayers were 
dissociated to single cells and applied to Cell Raft Arrays (CRAs) for high-throughput and accurate 
quantification of organoid forming potential (Fig. 4.3D, E). CRAs enable up to ~10,000 ISCs to 
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be plated in microwells on a small device and each ISC can be evaluated for organoid forming 
potential over time.[198] Here, we quantified the number of viable single cells and organoids 
derived from them by scanning the CRAs every 2 days for 6 days (Fig. 4.3F, G). Quantifying 
Organoid Forming Efficiency (OFE) at each timepoint demonstrated a significant decrease (~2.5-
fold) in OFE when cells were exposed to 24-hours of hypoxia (Fig. 4.3H). When we performed a 
longer 48-hour hypoxia exposure, surprisingly there was initially a significant increase in the 
number of surviving early organoids at day 2, and also unexpectedly, the OFE at later timepoints 
was indistinguishable from normoxia controls (Fig. 4.3I). These data indicate that ISC 
proliferation after 24-hours of severe hypoxia (<1% oxygen) is not substantially impaired and 
suggest there are hypoxia-regulated mechanisms that are enhancing ISC survival and preserving 
ISC function in a time-dependent manner.   
 
Hypoxia duration reveals early, mid, and late transcriptional responses  
To further explore the extent to which ISCs can tolerate severe hypoxia, we exposed ISCs 
in the MPS to short, intermediate, and long-term hypoxia and evaluated the first onset of apoptosis 
by Annexin V single cell immunocytofluorescence (Fig. 4.4A).[390] Flow cytometric 
quantification of single cells demonstrates ~90% of the cells survive through 48 hours of severe 
hypoxia without a statistical difference of normoxic controls. However, after 72 hours of severe 
hypoxia, there was a significant loss of viability, which was reduced to about half that of normoxic 
controls cultured for the same duration. These data indicate the ISC viability is highly refractory 
to severe hypoxia through 48 hours, and these results also define boundaries where ISCs in MPS 
can be investigated for transcriptomic changes in live cells during short and long-term hypoxia. 
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Organoid forming assays indicated intermediate hypoxia durations reduced ISC function 
that rebounded after 48 hours of hypoxia suggesting ISCs were engaging transcriptomic programs 
to enhance survival and preserve ISC function during a hypoxic event. Consistent with OFE 
assays, which demonstrated ISC rebound at later hypoxia time points, ISC biomarker, OLFM4, 
demonstrated a marked decrease in expression after 6-hours of hypoxia that rebounded to nearly 
normoxic control levels after 48 hours (Fig. 4.4B). In contrast, VEGFA, a hallmark target gene of 
HIF1, demonstrated an early (6-hour) increase in expression over normoxic controls followed 
by down-regulation, as compared to the 6-hour hypoxic condition, at both 24- and 48-hours of 
hypoxia. VEGFA remained significantly higher in hypoxic samples at each time point than 
normoxic samples, as expected by the known influence of hypoxia on increasing the angiogenic 
pathway. Together, with results from functional stem cell assays, these data indicate ISCs 
experience dynamic gene expression changes from the onset of hypoxia through extended hypoxic 
states and suggest hypoxia-dependent transcription factors initiate early gene expression programs 
that re-establish a functional physiologic ISC state. 
To more comprehensively investigate these time-dependent gene expression changes, we 
performed whole transcriptomic analysis on ISC cultured on the MPS under severe hypoxia for 6-
, 24-, and 48-hours. One challenging feature of microdevices is the small number of cells inherent 
to the micro-platform. To address this, we employed a new automated microfluidic platform that 
generates RNAseq libraries from as low as 1.0 ng of total RNA (Fluidigm JunoTM System). The 
data demonstrate robust depth and high reproducibility between technical replicates (n = 3) for 
each timepoint and also reveal global transcriptomic changes in ISCs between normoxic and 
hypoxic samples (Fig. 4.4C). Bulk RNA-sequencing samples were sequenced from an incredible 
range of between 39 to 93 million reads. Interestingly, gene expression analysis shows an increase 
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in the number of differentially regulated genes over time (Fig. 4.4D), and many of these genes are 
uniquely regulated during early, intermediate, and long-term hypoxia (Fig. 4.4E). Pathway 
Analysis of genes uniquely regulated at each timepoint indicates a predicted early (6-hour) 
transcriptional response to hypoxia and oxygen levels (Fig. B.3). Interestingly, mid (24-hour) and 
late (48-hour) transcriptional responses shift to pathways that regulate cell death and apoptosis 
(Fig. B.3). These data are consistent with empirical evidence demonstrating no increase in 
numbers of apoptotic cells through 48-hours of severe hypoxia and suggest global genetic 
responses are engaged to preserve viability.  
K-means clustering was then performed on the data to identify key genes activated or 
repressed by hypoxia during early, mid, and late transcriptional responses in ISCs. To minimize 
the influence of experimental noise on our interpretation, gene read counts were normalized to a 
z-score, then 20 clusters of genes were identified with different patterns. This was accomplished 
by identifying gene clusters in which expression did not change across all 3 normoxic time points, 
and by contrast, did change during different lengths of hypoxia exposure. These analyses revealed 
the identification of 4 different gene patterns that were either induced or reduced by hypoxia 
relative to normoxic conditions (Fig. 4.4F). Three of these categories are characterized by gene 
cohorts that were uniquely upregulated at different timepoints we termed Early, Mid, and Late 
responders. Early responders were significantly upregulated after 6 hours, 24 hours, and 48 hours 
of hypoxia. Late responders were upregulated only after long-term hypoxia. Interestingly, Mid 
responders showed both upregulated and downregulated expression patterns following 24- and 48-
hours of hypoxia. The downregulated gene set of Mid responders exists without subsequent 
regulation in the normoxic, time-matched controls, showing that hypoxia duration was indeed the 
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cause of significant gene downregulation. Moreover, Pathway Analysis of genes shows distinct 
downregulation of pathways that regulate DNA replication and rRNA process (Fig. B.3). 
 
Hypoxia primes transcriptional state to respond to inflammatory mediators 
Interestingly, within this subset of 4 gene expression patterns there was noticeable 
enrichment of the interleukin (IL) receptors, particularly in the gene groups that demonstrated 
hypoxia-dependent upregulation. Following early, intermediate, and long-term hypoxia, 
expression patterns of differentially expressed IL receptors were significant upregulated, as 
compared to time-matched normoxia expression (Fig. 4.4G-O). Firstly, IL17RB could be 
categorized as a hypoxia non-responder as it demonstrated control level-expression throughout all 
hypoxic durations and only increased expression at late-stage normoxia (Fig. 4.4G). Of particular 
note, IL6R, IL10RB, IL11RA and IL22RA1 demonstrated profound and consistent hypoxia-
dependent upregulation in MPS that persisted from early- to late-stage hypoxia exposure (Fig. 
4.4H-K). Other interleukin receptors demonstrated transient temporal upregulation unique to one 
of the three hypoxic durations. IL1R2 could be classified as an early-transient responder as it 
increased early during hypoxia exposure but normalized to control levels during mid- to late-
hypoxia durations (Fig. 4.4L). IL2G was a transient Mid responder, and IL17RA and IL17RC 
were unique in that they demonstrated mid-responder characteristics but exhibited over-all 
downregulation through late-term hypoxia (Fig. 4.4M-O). These results highlight key temporal 
changes in intestinal MPS during a hypoxic event, and interestingly point to the potential priming 
of ISCs to respond to interleukins secreted into the microenvironment during different times of 
hypoxia or later from blood circulation post-reperfusion, as previously reported in a human 
intestinal IR model.[53] 
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4.4. Discussion  
 For a discussion of hypoxia in the small intestine, it is important to state that physiologic 
in vivo pO2 levels inside the small intestine have been reported to be between 30 and 77 mmHg 
(3.9 to 10% O2).[204, 205, 391] There is a steep oxygen gradient inside the intestinal lumen, from 
the vascularized submucosa to the anaerobic zone.[11] Moreover, ingestion of nutrients (glucose) 
causes the intestinal submucosa to undergo absorptive hyperemia, metabolically demanding more 
than 200% of the total cardiac output to supply blood to the superior mesenteric artery for intestinal 
oxygen extraction.[314, 392] Although capillary recruitment increases as chyme passes through 
each region the intestine, absorptive hyperemia cannot prevent a drop of at least 10 mmHg (1.32% 
O2) in oxygen tension during digestion.[150] Keeping all this variation in physiologic oxygen in 
mind, a pathophysiologic intestinal oxygen (hypoxic) concentration can be defined for any 
magnitude of oxygen below 3% that activates cellular hypoxic response. For the purpose of in 
vitro human intestinal epithelial studies, we defined severe hypoxia as local oxygen tension below 
10 µM (1% O2).  
Certain durations and magnitudes of hypoxia in in vitro culture systems have been shown 
to either promote or repress pluripotency and self-renewal of other stem cell populations. 
‘Physiologic hypoxia’ is a state where cells in an anatomical niche experience lower oxygen than 
other regions but persist in a tissue. Stem cells isolated from other organs have shown distinct 
responses to different magnitudes of hypoxia. For example, human cardiac stem cells display 
increased proliferation when cultured inside specialized physiologic hypoxia (5% oxygen) 
incubators for 24 hours but increased quiescence, as evident from reduced β-galactosidase activity, 
p16 protein expression, and mitochondrial content when cultured in severe hypoxic (0.5% oxygen) 
chambers.[393] In another study of hepatic stem cells, stemness was promoted in liver physiologic 
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hypoxia (10% oxygen), as evident from increased expression of specific liver stem cell markers 
CK19, Sox9, EpCAM, and Lgr5 via immunofluorescence and Western blot analysis and single-
cell colony-forming assay, but repressed by severe hypoxia when cultured in a 1% oxygen 
environment.[394] Both studies show that physiologic hypoxia cultures, specific to each organ 
system, support stemness in stem cells.  
Most recently, colonic epithelial stem cells cultured (in an air-liquid interface) on 
Transwell membranes inside a hypoxic (2%) incubator for 21 days remained undifferentiated, with 
more CD44+ (undifferentiated) cells and less UEA1+ (goblet) cells than colonic epithelial cells 
cultured in a normobaric incubator.[374] Although it is known that a hyperoxic environment (21% 
oxygen) often disrupts stem cell culture[395, 396], the lower limit of oxygen necessary to maintain 
stemness has not been defined for human intestinal epithelial stem cells. We found that ISC 
cultured in severe hypoxia for at least 24 hours were still able to differentiate into mature 
enterocytes.  
In addition to demonstrating how physiologic hypoxia and severe hypoxic cultures impact 
ISC function, there findings are also relevant to clinical situations where low oxygen is presented 
in an intestinal injury. Specific windows of time in which ischemic tissue is under low oxygen 
tension, or more likely severely hypoxic, are necessary to determine whether or not to explant 
tissues and isolate ISCs for further expansion and later repair. Our results indicate that ISC function 
can be sustained following up to 48 hours of severe hypoxia, but 72 hours of hypoxia reduces ISC 
viability.  Jejunal segments of tissue cannot be collected during routine biopsies or elective 
surgeries due to their location in the middle region of the small intestine. Moreover, ischemic 
injury cannot be decoupled from reperfusion injury following the removal of mesenteric surgical 
clamps, as blood flow returns oxygen back to the injury site and damaging reactive oxygen species 
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initiate a cascade of inflammation.[50] Although inaccessible, the jejunum represents the segment 
of the small bowel most susceptible to vascular injuries, as it contains longer villi, where large 
networks of capillaries reside, than either the duodenum or the ileum. Using primary ISCs isolated 
from human jejunal tissue, we were able to investigate the impact of hypoxia, a consequence of 
ischemic injury, on ISC function in isolation.  
We found that human ISCs cultured under severe hypoxia upregulate downstream targets 
of HIF1A, as compared to human ISCs cultured in normoxia. This means the intestinal MPS could 
facilitate HIF1A activation in primary intestinal epithelium and provide a microenvironment to 
sustain severe hypoxia for at least 72 hours. Following 24 hours of hypoxia, the intestinal 
epithelium presented a slight but significant increase in cell proliferation. Once removed from 
MPS, dissociated to single cells, and reintroduced to normoxia in 3D Matrigel culture, ISCs 
displayed a subsequent decrease in organoid formation, as compared to normoxic ISCs. Therefore, 
reoxygenation decreased ISC survival, as compared to normoxic ISCs that had higher organoid 
formation. In contrast, after 48 hours of hypoxia, ISCs created more organoids than normoxic 
ISCs. This finding shows an extended period of hypoxia may be required for ISCs to adapt and 
perhaps better survive reoxygenation. This is supported by the bulk RNA sequencing and pathway 
analysis, which shows at 48 hours of hypoxia the top pathways are related to metabolism and 
responses to hypoxia and oxygen levels, whereas at 24 hours the top two pathways are for 
regulation of cell death and apoptosis.   
Apart from pathway analysis, bulk sequencing provided identification of specific 
upregulated genes following 3 different periods of hypoxia. Interestingly, interleukin receptors 
were among the top upregulated genes following hypoxia, as compared to normoxic time-matched 
controls. Of note, IL22RA1 was significantly upregulated at all 3 hypoxic periods, with the highest 
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fold change after the early 6-hour period. IL10RB and IL6R were among the genes significantly 
upregulated after 6-hour hypoxia and 24-hour hypoxia, respectively. IL6 has been shown to inhibit 
enterocyte cell death in vivo following ischemia reperfusion injury in the murine small 
bowel.[397] In a mouse crypt organoid model, exogenous IL6 was shown to promote crypt 
organoid proliferation and increase stem cell numbers.[398] In a more recent mouse model, 
endogenous IL6 was shown to be needed to mitigate epithelial injury following focal 
irradiation.[399] These studies suggest IL6 can rescue enterocytes following ischemic and 
irradiation injuries, but the impact of IL6 on hypoxic ISCs remains to be seen. Future studies using 
the intestinal MPS in combination with IL6 treatment and hypoxia exposure could show both ISC 
proliferation and organoid survival. 
MPS built to study cellular responses to controlled environmental factors offer many 
advantages over standard tissue culture plates and bulky incubators. Our intestinal MPS with 
integrated oxygen sensors provides real-time tracking of oxygen levels at the cell-media interface. 
As we learn more about how oxygen impacts stem cell fate, the potential to change culture 
conditions to meet the needs of a stem cell in the particular cell cycle or differentiation phase can 
be realized. Here, we provide a novel system to measure and adjust oxygen concentrations at the 
3D cell-scaffold interface. We found that primary human intestinal epithelial stem cells respond 
to low levels of oxygen by increasing proliferation and some important markers of stemness, but 
there were also signs of increased inflammatory cytokine markers which should be further 
investigated. In vitro, hypoxia initiates a cascade of interleukin receptor activation in human ISC, 
potentially influencing epithelial responses to immune cell signals during hypoxia and future 
immune responses after reperfusion. The addition of important immune cell types, such as 
leukocytes and innate lymphoid cells, into our intestinal MPS would be beneficial to discovering 
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the mechanisms underlying the cascade of inflammation following intestinal ischemia. Moreover, 
we aim to develop similar platforms to investigate other primary stem cells and optimize oxygen 
culture conditions across many organ tissues.  
 
4.5. Materials and methods  
 Primary human crypt isolation and intestinal epithelial stem cell culture. A surgical 
specimen of human small intestine (jejunum) was obtained from a donor at UNC Hospitals with 
consent of the patient (under the approved protocol UNC IRB #14- 2013). Villi and crypts were 
detached from the specimen by incubation in a chelating buffer for 75 min at 20°C followed by 
vigorous shaking in a 50 mL conical tube. The chelating buffer was composed of EDTA (2 mM), 
dithiothreitol (DTT, 0.5 mM, freshly added), Na2HPO4 (5.6 mM), KH2PO4 (8.0 mM), NaCl (96.2 
mM), KCl (1.6 mM), sucrose (43.4 mM), D-sorbitol (54.9 mM), pH 1⁄4 7.4.[400] Released crypts 
were expanded as a monolayer on a neutralized collagen hydrogel as described previously.[60] 
Briefly, crypts were placed on the top of 1.0 mg/mL collagen hydrogels (1 ml into each well of 6-
well plate (T1006; Denville, Holliston, MA)) at a density of 5,000 crypts/ well and overlaid with 
4 ml of Expansion Media (EM) containing 10 mmol/L Y-27632 (S1049; SelleckChem). EM 
contains a mixture of advanced Dulbecco’s modified Eagle medium/F12 medium (12634010; 
ThermoFisher) and Wnt-3A, R-spondin 3, noggin (WRN) conditioned medium (WRN medium 
prepared in lab from L-WRN cells (CRL- 3276; ATCC) following a published protocol[401] at a 
volumetric ratio of 1:1, and supplemented with GlutaMAX (35050061; ThermoFisher), B27 
supplement without vitamin A (12587010; ThermoFisher), 10 mM HEPES (15630-080; 
ThermoFisher), 1.25 mM N-acetyl cysteine (194603; MP Bio, Santa Ana, CA), 10 mM 
nicotinamide (N0636; Sigma-Aldrich), 50 ng/mL epidermal growth factor (315-09; Peprotech), 
 128
2.0 nM gastrin (AS-64149; Anaspec), 10 nM prostaglandin E2 (14010; Cayman Chemicals), 3.0 
µM SB202190 (S1077; Selleckchem), 100 U/mL penicillin-streptomycin (15140122; 
ThermoFisher), and 50 mg/mL primocin (ant-pm-1; InvivoGen, San Diego, CA). EM was used to 
expand the epithelial cell numbers as monolayers or organoids. Y-27632 was present only in the 
first 48 hours of cell culture and was not added to subsequent media changes. The medium was 
changed every 48 hours. When the cell coverage was greater than 80% (typically 5 to 7 days), the 
epithelium was dissociated to fragments to seed onto the intestinal MPS.  
 
Fabrication of primary human intestinal microphysiological system (MPS). The human 
intestinal MPS was fabricated from materials polymethyl methacrylate (PMMA) and 
photopolymer resin (Formlabs, Inc.). PMMA provided an optically transparent material with a low 
oxygen diffusion coefficient that could be sterilized and reused.[402] The photopolymer resin 
provided a 3D printable bottom frame to support the PMMA device and simultaneously house the 
optical reader oxygen measurements. The cell culture chamber and gas exchange channels were 
fabricated from 5.8 mm and 1.5 mm-thick polymethyl methacrylate (PMMA) sheets (44352, 
44292; US Plastics). The microfluidic culture region was composed of 5 rectangular wells, with 
dimensions of 11.6 mm by 7.0 mm each. The rectangular gas channel on top of the wells was 70 
mm by 45 mm by 1.5 mm. The bottom and top pieces of PMMA were laser cut from a 1.5 mm-
thick PMMA sheet, while the middle piece, for the cell culture wells, was laser cut from a 5.8 mm-
thick PMMA sheet. Briefly, to remove dust and burr material with minimal cracking, each PMMA 
surface was quickly wiped with 100% IPA solution and air-dried. All 3 pieces were pressed 
together between two sheets of brass using a pneumatic heat press (SwingPress 10-0403; Across 
International). Annealing was performed with the heat press set at 100°C and 300 psi for 2 hours, 
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then the bonded device was cooled for 3 hours at room temperature. A rubber gasket was laser cut 
and placed on top of the PMMA layer to seal the device, prior to bolting together. The device was 
tested for leaks using red and blue dyed water and cracks were sealed by application of 
dichloromethane to the seams. A neutralized collagen hydrogel (2.0 mg/ml) was cast into each 
well of a prefabricated PMMA device and allowed to polymerize at 37°C for 1 hour. 250 µL of 
1X DPBS was overlaid on the polymerized hydrogel and allowed to pre-swell for at least 5 hours 
at room temperature. DPBS was removed and the hydrogel was rinsed three times before 
overlaying with 250 µL of EM containing ISCs that had been mechanically dissociated by 
pipetting 10 times until cells were ~1-10 cell-clumps. Once the ISCs formed a confluent 
monolayer, an integrated phosphorescent oxygen sensor (iPOB) was added to the epithelium to 
measure oxygen. 
  
Real-time monitoring and control of oxygen concentration in 3D culture. Oxygen 
concentration in the system was continuously measured with an integrated phosphorescent oxygen 
sensor (iPOB) using Near Infrared (NIR) phosphorescence lifetime fluorimetry. The iPOB is 
composed of porous poly(2-hydroxyethyl methacrylate) (pHEMA) gel functionalized with 
palladium-benzoporphyrin derivatives (Pd-BPD) that respond to local oxygen concentrations via 
phosphorescence quenching.[332] The iPOB (Profusa, Inc., San Francisco, CA) has been 
manufactured in a variety of sizes, but for all experiments a disk-shaped, 5 mm diameter and 0.5 
mm thickness, iPOB was used. The optics front-end of the NIR phosphorescence lifetime 
fluoroscope (Profusa, Inc., San Francisco, CA) was inserted into the support frame below the MPS. 
The oxygen concentration was controlled via a PMMA gas-mixing microfluidic chip with tubing 
connecting outlets from the gas-mixing chip to the inlets of each MPS. The gas-mixing chip was 
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previously used to generate 8 concentrations of mixed gas, ranging from less than 3 µM of oxygen 
to 180 µM.(Fig. B.1)[378] Gas flow to the gas-mixing chip was regulated using an air flow control 
valve (62005K313; McMaster-Carr) and monitored with a mass flow meter with digital output 
(GFMS-010061; Aalborg GFM). Hydrated mixed gas exiting the gas-mixing chip was introduced 
into individual MPS at a rate of 5 mL/min to prevent media evaporation. Within 30 minutes, the 
gas mixture equilibrated with the local MPS environment to generate the desired oxygen 
concentration at the hydrogel surface-media interface where oxygen was measured using the iPOB 
(Fig. 1D). The intestinal epithelium inside MPS was cultured in environments made from mixed 
gases and compared to intestinal epithelium statically cultured in a normobaric incubator with an 
oxygen environment of 186 µM.  
 
Immunocytochemistry. To assess the impact of various durations and magnitudes of 
hypoxia on ISC proliferation, primary human intestinal epithelium and single cells isolated from 
each MPS chamber were stained for Ki-67. For Ki-67 staining of intestinal epithelium following 
hypoxia, the intestinal MPS was opened and media was removed from each chamber. Intestinal 
epithelium on top of the collagen hydrogels were fixed with 4% PFA for 15 minutes. After fixation, 
samples were rinsed once with 1X PBS and overlaid with PBS. Samples were permeabilized for 
15 minutes with 0.5% Triton-X 100 in 1X PBS. Samples were blocked for 30 minutes with a 3% 
BSA solution. After blocking, samples were stained for proliferation marker Ki-67 Alexa Fluor 
647 (1:250 dilution in 3% BSA, Cat. No. 652407; BioLegend) for 1 hour and nuclei counterstain 
bisbenzimide (1:1000 dilution in 1X PBS, Cat. No. 1155; Millipore Sigma) for 5 minutes at room 
temperature. To look at cell-cell contacts, tight junction protein occludin (Cat. No. 13409-1-AP; 
Proteintech) was added for 1 hour, followed by incubator with the secondary antibody Cy3 (Cat. 
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No. C2306; Sigma) for 2 hours. After staining, the gels were overlaid with 1X PBS and stored at 
4°C until imaging. All samples were imaged with an Olympus (Waltham, MA) IX81 microscope, 
using Metamorph Basic (Molecular Devices, San Jose, CA) software, and image analysis was 
performed with ImageJ.[336]  
 
Organoid forming efficiency (OFE) assay and Fluorescence-activated cell sorting 
(FACS) of live cells. Following MPS culture, human intestinal epithelium was dissociated into 
single cells, sorted using a flow cytometer, and suspended in Matrigel® on a quad Cell Raft Array 
(CRA) platform (Cell Microsystems, Durham, NC).[198] Briefly, each sample was retrieved and 
placed in a separate conical. 500 U/mL Collagenase IV (17104019; Gibco) was added to 
breakdown the scaffold and incubated for 10 minutes at 37ºC. After centrifugation, the cell pellet 
was rinsed twice in DPBS and re-suspended in 150 µL of 0.5 mmol/L EDTA in DPBS with 10 
mmol/L Y-27632 and incubated for 5 minutes at 37ºC. The fragments were further dispersed by 
triturating 30 times using a 200 µL pipet tip. After centrifugation, the cell pellet was re-suspended 
in 500 µL TrypLE Express (12605-036; Gibco) with 10 mmol/L Y-27632 and incubated for 5 
minutes at 37°C. The cell suspension was gently triturated 7 times using a 28.5-gauge insulin 
needle to further dissociate. 500 µL of EM was added to quench the reaction, and cells were 
pelleted and rinsed once in EM. After pelleting again, cells were re-suspended in 200 µL of EM 
containing 1% FBS. Immediately before FACS, APC Annexin V (1:200, 640941; Biolegend) was 
added to cells for live/dead discrimination. After staining, cells were rinsed in EM and filtered 
through 0.4 µm FACS tube top filter (352235; Corning). 5,000 Annexin V- live cells were isolated 
via FACS and re-suspended in 250 µL of Growth Factor Reduced Matrigel® (354230; Corning). 
Cell-gel suspensions were plated in each chamber of the quad CRA. To cover the CRA, each array 
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was centrifuged at 200 x g for 5 minutes. CRAs were polymerized for 20 minutes at 37°C in an 
incubator and then overlaid with EM containing 10 mmol/L Y-27632. Media was replaced every 
2 days. To determine OFE, the CRA was scanned, and the total number of organoids was counted 
on day 2, day 4, and day 6. The OFE (%) was calculated as the total number of organoids created 
in one CRA chamber, divided by 5,000 cells and multiplied by 100. FACS and flow cytometry 
were performed using a SH800Z Cell Sorter (Sony Biotechnology, San Jose, CA).  
 
Flow cytometry. Cells collected from normoxic and hypoxic MPS were dissociated 
following the protocol above up to the step of addition of TrypLE Express. Following trituration 
with the insulin needle and quenching with the EM, cells were pelleted and re-suspended in 100 
µL of 1X DPBS. Approximately 50,000 cells from each chamber were fixed by adding 400 µL of 
4% PFA solution while being constantly vortexed to prevent cell aggregation. After fixation, single 
cells were pelleted and re-suspended in 0.3% Triton-X for 15 minutes to permeabilize the cell 
membrane. Single cells were pelleted and re-suspended in a staining solution of DMEM containing 
1% FBS and anti-Ki-67 Alex Fluor 647 (1:250 dilution in 3% BSA, Cat. No. 652407; BioLegend) 
for 1 hour on ice. After staining, cells were rinsed in PBS and filtered through 0.4 µm FACS tube 
top filter (352235; Corning). Ki-67-positive single cells were quantified by flow cytometry.  
 
qRT-PCR. To assess the expression of genes that are responsive to hypoxia, human 
intestinal epithelial samples from each MPS were collected for qRT-PCR analysis. Briefly, cells 
attached to collagen hydrogels were lysed in 200 µL of RNA Lysis buffer (AM1931; 
ThermoFisher). Total RNA was extracted using RNAqueous-Micro Total RNA Isolation Kit 
(AM1931; ThermoFisher) according to manufacturer’s protocols. cDNA was generated from ~2 
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ng of total RNA from each sample using iScript Reverse Transcription Supermix for qRT-PCR 
(170-8891; BioRad) according to manufacturer’s protocols. cDNA was diluted 1:20 and 1 µL was 
used for qRT-PCR using Taqman probes (Applied Biosystems) (Table 4.1) and SsoAdvanced 
Universal Probes Supermix (1725281; BioRad) according to manufacturer’s protocols. qRT-PCR 
was carried out in a StepOnePlus Real Time PCR System (Applied Biosystems). For each sample 
and experiment, triplicates were made and normalized to 18S mRNA levels. Fold change was 
expressed relative to normoxic controls using ∆∆CT analysis.[337] All statistics for gene 
expression were generated using a Student’s t-test. In all statistical analysis, p < 0.05 was 
considered significant.   
 
RNA-sequencing. To investigate the dynamic response of ISC to hypoxia at the whole 
transcriptomic level, we performed RNA-seq on human intestinal epithelium exposed to 6 hr, 24 
hr or 48 hr of hypoxia inside intestinal MPS, along with normoxic control intestinal MPS which 
were cultured for each respective time point with no hypoxia exposure. RNA samples were 
collected from each intestinal MPS and Total RNA was extracted using RNAqueous-Micro Total 
RNA Isolation Kit (AM1931; ThermoFisher) according to manufacturer’s protocols and stored at 
−80°C. To assess RNA quality prior to submission for sequencing, an RNA integrity number (RIN) 
was measured using the Agilent 2100 Bioanalyzer. After confirmation that each sample had a RIN 
of at least 8, integrated fluidic circuits (IFCs) for gene expression and genotyping analysis were 
prepared using the Advanta™ RNA-Seq NGS Library Prep Kit for the Fluidigm Juno™ and 
sequenced with the Fluidigm Biomark™ HD system. 
Gene level expression was obtained through pseudo alignment of reads to human genome 
GRCh38 using Kallisto.[403] Principal component and sample correlation analysis were done with 
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Bioconductor packages Biobase, cluster and qvalue.[404] Expression values for plotting were 
obtained by TMM normalization across all samples using EdgeR package and differential 
expression between groups was calculated from raw pseudo counts with DESeq2.[405, 406] 
AmiGO[407] was used to initially visualize the ontologies for each time point and the Database 
for Annotation, Visualization and Integrated Discovery (DAVID)[408, 409] provided gene 
ontology enrichment analysis for bioprocess pathway analyses on the 2000 most significantly 
upregulated genes for each time point, where an adjusted P value was computed using the 
Benjamini-Hochberg method (Table 4.2).    
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Table 4.1 List of TaqMan probes for quantitative reverse-transcription polymerase chain 
reaction (qRT-PCR) 
 
Gene symbol Gene name Life Technologies assay ID 
18S Eukaryotic 18S ribosomal RNA Hs99999901_s1 
HIF1A Hypoxia inducible factor 1 alpha subunit Hs00153153_m1 
BNIP3 BCL2 interacting protein 3 Hs00969289_m1 
SLC2A1 (GLUT1) Solute carrier family 2 member 1 Hs00892681_m1 
VEGFA Vascular endothelial growth factor A Hs00900055_m1 
OLFM4 Olfactomedin 4 Hs00197437_m1 
IL6R Interleukin 6 Receptor Hs01075664_m1 
IL10RB Interleukin 10 Receptor Beta Hs00175123_m1 
IL17RB Interleukin 17 Receptor Beta Hs00218889_m1 
IL22RA1 Interleukin 22 Receptor Alpha 1 Hs00222035_m1 
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Table 4.2 List of Top Gene Ontology (GO) Upregulated Pathways  
 
Full name GO ID 
steroid metabolic process GO: 0008202 
cholesterol metabolic process GO: 0008203 
response to oxygen levels GO: 0070482 
response to hypoxia GO: 0001666 
sterol metabolic process GO: 0016125 
cholesterol biosynthetic process GO: 0006695 
lipid biosynthetic process GO: 0008610 
sterol biosynthetic process GO: 0016126 
regulation of cell death GO: 0010941 
regulation of apoptotic process GO: 0042981 
regulation of programmed cell death GO: 0043067 
regulation of cell motion GO: 0051270 
intracellular signal transduction GO: 0035556 
small GTPase mediated signal transduction GO: 0007264 
regulation of cell proliferation GO: 0042127 
negative regulation of apoptotic process GO: 0043066 
negative regulation of cell death GO: 0060548 
negative regulation of programmed cell death GO: 0043069 
regulation of phosphorylation GO: 0042325 
regulation of phosphorus metabolic process GO: 0051174 
regulation of phosphate metabolic process GO: 0019220 
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response to extracellular stimulus GO: 0009991 
regulation of organelle organization GO: 0033043 
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 Table 4.3 List of Top Gene Ontology (GO) Downregulated Pathways 
 
Full name GO ID 
rRNA processing GO: 0006364 
cell division GO: 0051301 
mitotic nuclear division GO: 0007067 
DNA replication GO: 0006260 
sister chromatid cohesion GO: 0007062 
mitochondrial translational elongation GO: 0070125 
maturation of SSU-rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
GO: 0000462 
protein localization to kinetochore GO: 0034501 
tRNA methylation GO: 0030488 
mitochondrial translational termination GO: 0070126 
DNA replication initiation GO: 0006270 
ribosomal large subunit biogenesis GO: 0042273 
mitochondrial respiratory chain complex I 
assembly 
GO: 0032981 
RNA processing GO: 0006396 
mRNA splicing, via spliceosome GO: 0000398 
cellular response to DNA damage stimulus GO: 0006974 
transcription, DNA-templated GO: 0006351 
snRNA transcription by RNA polymerase II GO: 0042795 
DNA repair GO: 0006281 
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RNA methylation GO: 0001510 
doxorubicin metabolic process GO: 0044598 
daunorubicin metabolic process GO: 0044597 
cell cycle GO: 0007049 







Figure 4.1 Development of a tunable hypoxia microphysiological system (MPS) with integrated 
oxygen sensors and primary human intestinal epithelium. (A) Schematic of exploded view of 
MPS compartments. (i) Barbed connectors screwed into the photopolymer resin (ii) top lid provide 
gas flow into and out of the device. (iii) A rubber gasket seals gas flow into and out of the 
Polymethyl methacrylate (PMMA) gas exchange channel. (iv) The gas exchange channel frame is 
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bonded to the (v) PMMA culture chamber and (vi) PMMA base support. (vii) A photopolymer 
resin bottom frame supports the entire PMMA device, and screws attach the top lid to the bottom 
frame to seal the MPS closed. (viii) The optics front-end connects via a µUSB-to-HDMI cord to a 
phosphorescence-lifetime fluorimeter detector and interrogates the middle culture well, where the 
integrated phosphorescence-based oxygen biosensor (iPOB) is located. (B) (left) Top view 
photograph of a standard microscope glass slide (75 x 25 mm) and dime, for reference, placed 
above the MPS with iPOB (black arrow) inside well 3 and red and blue dyes in wells 1 and 5 and 
2 and 4, respectively. (middle) 1 well brightfield image of confluent monolayer of cells. (right) 
Inset from 1 well brightfield image shows magnified confluent cell monolayer. (C) (top) Side view 
photograph of MPS with middle well containing the green iPOB. (bottom, left) Schematic of iPOB 
integrated into hydrogel to measure oxygen at the cell layer inside the cell culture well. The iPOB 
is composed of poly(2-hydroxyethyl methacrylate) gels functionalized with palladium-
benzoporphyrin derivatives (Pd-BPD). The photoluminescence excitation and detection 
wavelengths are 630 nm and 800 nm, respectively. (bottom, right) Schematic of porphyrin-based 
luminescence. In high oxygen, luminescence from the triplet state in porphyrin is quenched by 
energy transfer to molecular oxygen, resulting in a correlated decrease in phosphorescence 
lifetime. In the absence of oxygen, porphyrin molecules are excited by LED from the detector and 
phosphoresce with increased lifetime. (D) Plots of 8 oxygen concentration versus time (7 hours) 
measurements from the iPOB inside the MPS, with 8 different mixed gas inputs, show generation 




Figure 4.2 Proof of concept of hypoxic microphysiological system (MPS) with primary human 
intestinal epithelial stem and progenitor cells. (A) Brightfield image of human intestinal epithelial 
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stem and progenitor cells grown inside a MPS well to confluence. Red fluorescent images show 
tight junction structures between epithelial cells marked by the protein Occludin, stem cells 
marked by Sox9, and proliferative cells marked by EdU. In all fluorescent images, nuclei are 
marked by Bisbenzimide in blue. (B) (top) Single Cell RNA sequencing data of stem cell and 
proliferation markers shown as pie charts with number of LGR5, OLFM4, ASCL2, and PCNA or 
MKI67 positive cells in population of primary human epithelial cells and corresponding UMAPs. 
(bottom) Single cell RNA sequencing data of mature enterocyte markers ALPI, MUC2, DEFA5, 
and CHGA shown in pie charts and corresponding UMAPs. (C) Organoid Forming Efficiency (%) 
measured over 6 days from single cells isolated from MPS after 5 days in culture. (Insets) A single 
organoid grown inside a single well within the microarray platform and imaged on Day 2, Day 4, 
and Day 6. (D) Oxygen concentration tracked using the iPOB inside MPS containing the human 
intestinal epithelium for 24 hours with normoxic and hypoxic culture environments. (Inset) 
Schematic of human intestinal epithelium grown inside the MPS on top of the hydrogel scaffold. 
The integrated phosphorescence-based oxygen biosensor (iPOB, green) is situated within the 
human intestinal epithelium to measure oxygen at the cell-media interface. (E) RT-qPCR results 
of human intestinal epithelium for downstream HIF1A targets (BNIP3, GLUT1, VEGFA) after 24 
hours of normoxia or hypoxic environment exposure. Fold Change is calculated with ∆Ct, as 




Figure 4.3 Primary human intestinal epithelium cultured under hypoxia inside 
microphysiological system (MPS) for 24 hours shows increased proliferative capacity, while 48 
hours of hypoxia increased functional stemness. (A) Epithelium stained for Ki-67 and 
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bisbenzimide (nuclei) following 24 hours of normoxia or hypoxia culture inside separate MPS. (B) 
FACS plots from single cells dissociated from normoxic (top) and hypoxic (bottom) MPS show 
the population of mKi-67 APC+ cells versus the Forward Scatter Area (FSA). (C) Flow cytometry 
results of human intestinal epithelial single cells quantified for Ki-67 after 24 hours of culture in 
normoxia or hypoxia inside separate MPS. (D) Schematic of Functional Stemness Assay Steps: 
First, human intestinal epithelium is removed from each microphysiological system (MPS) well. 
Second, the hydrogel scaffold is digested to release epithelium and further dissociated to generate 
single cells. Third, the single live cells (Annexin V-) are isolated via Fluorescence-activated cell 
sorting (FACS) and seeded onto Micro-Cell Raft Arrays in 3D Matrigel. Lastly, intestinal 
organoids grown from single cells were imaged and quantified. (E) Image of a Micro-Cell Raft 
array well scanned to show grid of individual microwells. (Inset) Image of single microwell from 
Micro-Cell Raft array. (F) Sequential workflow for Functional Stemness Assay from each MPS 
cell isolation following either hypoxia or normoxia. (G) Brightfield images of tracked single 
intestinal organoids grown from single cells inside a microarray platform following 24 hours of 
normoxia or hypoxia inside separate MPS. (H) Results of Functional Stemness Assay plotted as 
Organoid Forming Efficiency (OFE %) for 24-hour normoxic and hypoxic samples over 6-day 
post plating time period. (I) Results of Functional Stemness Assay for 48-hour normoxic and 





Figure 4.4 Characterizing transcriptomic changes following 3 durations of hypoxia inside 
microphysiological system (MPS) using Advanta RNA-sequencing. (A) Flow cytometry results 
from single cells isolated after 6, 24, 48, and 72 hours from normoxic and hypoxic MPS and stained 
for Annexin V (-) to quantify live cells (%). (B) qRT-PCR results of human intestinal epithelium 
isolated from MPS for downstream HIF1A target (VEGFA) and active stem cell marker (OLFM4) 
after 6 hours, 24 hours, and 48 hours of normoxia or hypoxia culture inside separate MPS. (C) 
Principle component analysis of RNA-seq results showing clusters of replicate samples from each 
time point (6, 24, 48 hours) and condition (normoxia or hypoxia). Bulk RNA-sequencing samples 
were sequenced from a range of 39 to 93 million reads. (D) Volcano plots of each time point (6, 
24, 48 hours) and condition (normoxia or hypoxia). (E) Venn Diagram of genes upregulated at 
each time point (6, 24, 48 hours) after hypoxia. (F) Z-score normalized and centered expression 
values for genes with expression shifts under hypoxic conditions consistently, at the mid-point 
(top down respectively) and end of the experimental period with a single group of genes being 
downregulated at the mid-point (bottom). (G-O) Cross sample normalized gene expression is 
shown with (standard deviation) under normoxic and hypoxic conditions for interleukin receptors 




CHAPTER 5: SCOPE OF WORK, SIGNIFICANCE, AND IMPLICATIONS FOR 
FUTURE STUDIES 
 
5.1. Scope of Work 
 Biological studies of human tissues and organs can only hope to reveal accurate human-
like response in vitro if designed to use microphysiological systems that accurately recapitulate 
the tissue and provide the most realistic microenvironmental factors. One microenvironmental 
factor that is often overlooked in biological studies is oxygen. It is a vital component of all 
human tissues and is required for the regular energy metabolism of most cells within the human 
body, apart from anaerobic bacteria. As discussed in chapter 2, most biological studies ignore 
oxygen unless researchers are interested in studying oxygen-cell based phenomena, either in 
normal physiology or pathophysiology. Moreover, questions concerning the influence of oxygen 
on cellular functions can only be answered using in vitro systems, in lieu of traditional animal 
models, that provide methods and readouts to measure and regulate oxygen throughout each 
biological study. 
 Here, two particular microphysiological systems (MPS) are designed and fabricated to 
recapitulate the 3D environment of human breast epithelium and primary human intestinal 
epithelial stem cells (ISCs), respectively. Both systems are monitored in real-time using 
biocompatible oxygen sensors that are placed within the 3D culture. Using these models, we ask 
specific questions concerning oxygen regulation and tissue hypoxia on cell viability, 
proliferation, and differentiation. ISCs are also isolated from MPS and re-introduced to an 
oxygen rich 3D environment to investigate stem cell pluripotency. Using primary human ISCs 
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isolated from MPS, we performed bulk RNA sequencing to generate a data set composed of 
more than 35,000 genes from three durations of hypoxia and compared these transcriptomes to 
time-matched control ISCs.  
 
5.2. Significance of Research Findings  
 Building a microphysiological system that allowed for continuous measurement and 
control of oxygen involved designing a system with user interface in mind but required many 
iterations for optimal cell functionality. In the system described in chapter 3, human breast 
epithelial cells were first grown in tissue culture flasks, then transferred as single cells into 3D 
Matrigel with integrated phosphorescence-based photonic oxygen biosensors (iPOBs) inside the 
3D matrix. It was critical to measure oxygen at the cell layer, because concentration gradients 
naturally exist from hydrogel to media and from media to air spaces. Once oxygen monitoring 
was established, we sought to study how lowering the oxygen environment down to hypoxic 
levels influenced both healthy human breast epithelial cells as well as tumorigenic human breast 
epithelial cells. We found that nontumorigenic cells were more susceptible to cell death than 
tumorigenic cells when exposed to hypoxic culture conditions. Interestingly, genetic analysis 
revealed nontumorigenic breast epithelial cells also increased their expression of genes related to 
glycolytic metabolism in hypoxia, as compared to normoxic culture. Using this 3D breast 
epithelial cell culture, it would be possible to extend these studies to longer periods of time and 
compare the morphology and genetic functionality of organoids formed from either tumorigenic 
or healthy single cells in each oxygen condition. 
  Intestinal injuries that include oxygen deprivation are severe and can cause irreversible 
damage. Oxygen deprivation, caused by ischemia or instances of hypoxia, can itself lead to 
tissue damage and cell death. Lack of oxygen is also a trigger that can promote the production of 
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harmful substances and recruitment of damaging inflammatory and immune regulators. 
Conversely, physiological hypoxia promotes stem cell expansion and functionality in specific 
tissues and organs. We sought to better define the stem cell capabilities of primary human 
intestinal epithelial stem cells cultured under severe hypoxia, as compared to routine normobaric 
culture of ISCs. We found that ISCs culture under severe hypoxia for 24 hours showed 
increasing proliferation but decreased organoid formation. Interestingly, 48 hours of hypoxic 
culture resulted in higher initial organoid survival following the return of dissociated ISC to an 
oxygenated environment in 3D culture. Bulk RNAseq showed a similar transcriptomic response. 
By 48 hours the epithelial cells had shifted to upregulation of metabolic processes instead of the 
regulation of cell death and regulation of cell apoptosis pathways most upregulated after 24 
hours of hypoxia.  
 
5.3. Implications for Future Studies  
 Microphysiological systems (MPS) with decreased replication variability and well-
defined parameters can realistically replace standard tissue culture plates for many biological 
studies. MPS generated from patient-derived primary stem cells, as used in Chapter 4, can also 
be used to better inform patient-specific therapies and quickly rule out inactive drug candidates. 
It is important to design and build MPS for the purpose of recapitulating human physiology, 
whether to study normal cell processes or abnormal pathologies. The research presented in 
Chapter 4 focused on studying primary human intestinal epithelial stem cells in the context of 
oxygenation and stem cell function. Similar oxygen metrics could be applied to already diseased 
intestinal tissues to inform clinicians on optimal cutoffs to preserve stem cell function.  
 Beyond the intestine, oxygen control in other MPS can provide another metric to further 
investigate vascular and avascular organ systems. Many cellular pathways responsible for tissue 
 152
homeostasis and tissue development are dependent on continuous oxygen supply. When oxygen 
is no longer available, such as when primary cells are isolated from human tissues and grown in 
thick 3D scaffolds, the cells are expected to adjust or adapt to the new, potentially much lower, 
local concentrations of oxygen and continue performing cellular as in vivo. This assumption that 
no physiology is altered by the sharp decrease in available oxygen limits many findings from in 
vitro studies. By adding oxygen via gas flow or continuous perfusion of oxygenated media, a 




APPENDIX A: SUPPLEMENTARY MATERIAL FOR CHAPTER 34 
 
A.1 Detailed Materials and Methods 
 Cell Culture. Immortalized benign human breast epithelial cells (MCF-10A, CRL-10317; 
ATCC) [333] were cultured inside 75 cm2 culture flasks (10062-860; VWR) containing Mammary 
Epithelial Cell Growth Medium (EGM) supplemented with EGM SingleQuot (CC-3124; Lonza). 
Non-metastatic tumorigenic human breast epithelial cells (BT474, HTB-20; ATCC) [334] were 
cultured inside 75 cm2 culture flasks containing Dulbecco's Modified Eagle's Medium (DMEM) 
with 4.5 g/L glucose, L-glutamine and sodium pyruvate (10013CV; Corning) and supplemented 
with 10% fetal bovine serum (97068-086; VWR) and 1% penicillin streptomycin (30-002-Cl; 
Corning). MCF-10A and BT474 cells were cultured in a normobaric incubator maintaining a 
temperature of 37°C containing 5% CO2, 70.2% N2, 21% O2 and 100% humidity.  For conversion 
from 2D adherent monolayers to 3D embedded culture, cells were removed from 75 cm2 culture 
flasks using sterile 1X DPBS (MT21040CV; ThermoFisher) and Trypsin with 0.25% EDTA 
(25200072; ThermoFisher) and seeded inside 8.2 mg/mL High Concentration (HC) Matrigel 
Basement Membrane Matrix (354248; Corning). 48-well plates (100062-898; VWR) were used to 
culture cells in Matrigel® for control samples. The 200 µL of cell-laded Matrigel® was cast inside 
the cell culture chamber following established protocols for culturing breast epithelial cells in 3D 
hydrogel scaffolds.[335] 200 µL of cell-laded Matrigel® inside the 3D cell culture chamber of 
diameter 11 mm corresponds to a height of ≈ 2.11 mm. The total height of 3D tissue scaffold 
                                                 
4 Appendix A previously appeared in Biosensors and Bioelectronics. The original citation is as follows: Kristina R. 
Rivera, Patrick D. Erb, Ashlyn T. Young, Natalie A. Wisniewski, Scott T. Magness, Michael A. Daniele. Integrated 
phosphorescence-based photonic biosensor (iPOB) for monitoring oxygen levels in 3D cell culture systems. 
Biosensors and Bioelectronics, 123: 131-140, 2019. 
 154
(Matrigel® plus medium) with 200 µL of medium overlaid on top of the cell-laded Matrigel® was 
4.21 mm. 
 Computational Models. The Fluid Dynamics and Transport of Dilute Species 
Multiphysics® were coupled to establish the boundary conditions for oxygen transport within the 
device. The computational model included the diffusion coefficient of oxygen through phosphate-
buffered saline (1X PBS at 37°C, 2.46 x 10-9 m2·s-1[354]), the diffusion coefficient of oxygen in 
air (1.75 x 10-5 m2·s-1[410]), the inlet flow rate of deoxygenated air, or 100% N2, which varied 
from 1 to 7 mL·min-1, and an outlet gas pressure of 0 Pa. The simulation solved for oxygen pressure 
in units of kilopascals (kPa); therefore, O2 saturation coefficients were not required. The model 
geometry was meshed using a physics-controlled mesh and the time-dependent solver 
(PARADISO) computed solutions over a time range of 0 to 80 minutes with steps of 2 minutes. 
 Immunohistochemistry and gene expression. The breast epithelial cells encapsulated in 
Matrigel® were removed from the 3D culture-gas exchange chamber for IHC analysis. First, the 
iPOB was removed from the Matrigel® and, the remaining Matrigel® containing breast epithelial 
cells was placed into a 48-well plate, along with 4% paraformaldehyde (PFA) solution for fixation. 
After incubation at room temperature for 20 minutes, the fixative was removed from each well and 
samples were rinsed three times with 1X PBS. Cells encapsulated in Matrigel® were then 
permeabilized using a solution of 0.5% Triton-X100 in 1X PBS for 30 minutes and rinsed three 
times with 1X PBS. Samples were blocked with protein block solution (1:5 dilution in 1X PBS; 
Cat. No. X090930-2; Agilent) for 1 hour at room temperature. Briefly, after blocking, samples 
were stained with primary antibodies Laminin alpha V (rabbit, 1:100 dilution in protein block, Cat. 
No. sc-20145; Santa Cruz) and beta II Tubulin (chicken, 1:100 dilution in protein block, TUJ-S; 
Aves Labs) for 2 hours at room temperature and rinsed three times with 1X PBS. Next, samples 
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were stained with secondary antibodies, Dylight 649 (goat anti-rabbit, 1:250 dilution in protein 
block, Cat. No. 111-496-003; Jackson ImmunoResearch Laboratories, Inc.) and Dylight 488 (goat 
anti-chicken, 1:250 dilution in protein block, Cat. No. 103-485-155; Jackson) for 45 minutes at 
room temperature. Nuclei counterstain was then performed with bisbenzamide (1:1000 dilution in 
1X PBS) for 5 minutes at room temperature.  
 Briefly, cells encapsulated in Matrigel® were lysed in 200 µL of RNA Lysis buffer. Total 
RNA was extracted using RNAqueous-Micro Total RNA Isolation Kit (AM1931; ThermoFisher) 
according to manufacturer’s protocols and stored at −80°C. cDNA was generated from ~2 ng of 
total RNA from each sample using iScript Reverse Transcription Supermix for RT-qPCR (170-
8891; BioRad) according to manufacturer’s protocols. cDNA was diluted 1:20 and 1 µL was 
used for qRT-PCR using Taqman probes (Applied Biosystems) and SsoAdvanced Universal 
Probes Supermix (1725281; BioRad) according to manufacturer’s protocols. qRT-PCR was 
carried out in a StepOnePlus Real Time PCR System (Applied Biosystems).  
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APPENDIX B: SUPPLEMENTARY MATERIAL FOR CHAPTER 45 
 
B.1 Supplemental Figures 
 
Fig. B.1 Gas mixing chip integrated into microphysiological system to generate 8 different 
oxygen environments. (A) Schematic of complete microphysiological system design with mixed 
                                                 
5 Full list of contributing authors: Kristina R. Rivera, Michael J. Czerwinski, Vladimir A. Pozdin, Ming Yao, 
Michael A. Daniele, and Scott T. Magness. 
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gases in tanks leading into flow meters. Flow meters connect into humidification 15 mL conicals 
filled with sterile PBS. Humidified gases travel into each input of the gas mixer chip, and 8 
concentrations of gases exit individual outlets to connect into separate microphysiological 
systems (devices). Device oxygen concentration is monitored using detectors that send 
information to a laptop located beside the incubator. (B) Images taken of each component of the 
system. (C) COMSOL Multiphysics results for the simulated gas mixtures from each outlet of 
the gas mixing chip. (D) Image of the gas mixing chip and measured output oxygen 




Fig. B.2 UMAP plots of cell cycle scoring and marker gene expression in singe-cell RNA 
sequencing data from human intestinal epithelial culture. (A) UMAP plot of assignment of cell 
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cycle stage based on cell cycle gene scoring (left) with accompanying proliferative marker genes. 
(B) UMAP plots of gene expression for stem cell marker genes. (C) UMAP plots of gene 
expression for putative reserve stem cell marker genes. (D) UMAP plot of gene expression for 
Paneth cell maker genes. (E) UMAP plot of gene expression for Tuft cell marker genes. (F) 
UMAP plots of gene expression for absorptive enterocyte marker genes. (G) UMAP plots of 
gene expression for goblet cell marker genes. (H) UMAP plots of gene expression for 





Fig. B.3 Pathway analysis of human intestinal epithelium after 3 durations of either hypoxic 
or normoxic culture inside the microphysiological system (MPS). (A) Pathway analysis 
(DAVID) of Gene Ontology (GO) comparing the Top 1000 Upregulated Genes and 
transcriptional signatures of hypoxic versus normoxic intestinal epithelial cells after 6 hours, 24 
hours, and 48 hours. (B) Pathway analysis (DAVID) of Gene Ontology (GO) comparing the Top 
1000 Downregulated Genes and transcriptional signatures of hypoxic versus normoxic intestinal 
epithelial cells after 6 hours, 24 hours, and 48 hours. Abbreviations for GO pathways include: pr. 
(process), res. (response), reg. (regulation), met. (metabolic), mito. (mitochondrial). 
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APPENDIX C: METHODS TO ISOLATE PRIMARY HUMAN AND MURINE 
INTESTINAL MICROVASCULAR ENDOTHELIAL CELLS 
 
C.1 Overview 
 The vascular network beneath the intestinal epithelial barrier is responsible for delivering 
key signaling factors, immune cells, and, of course, oxygen in the form of bound hemoglobin, to 
the epithelium. Specifically, human intestinal microvascular endothelial cells (HIMECs), are 
chiefly responsible for creating an endothelial network that extends upward into villi at the small 
intestine. HIMECs provide a highway for circulating blood cells and for immune cells to 
extravasate when activated to target epithelial pathogens. While working in the Magness Lab 
with human intestinal tissues, I spent time developing and testing protocols to isolate primary 
HIMECs from donor small intestinal tissues, as well as primary murine intestinal microvascular 
endothelial cells (MIMECs) from mice small intestinal jejunum. After successfully isolating both 
HIMECs and MIMECs, I expanded and passaged HIMECs in standard tissue culture dishes 
coated with human fibronectin. Although I was able to passage the HIMECs once from freshly 






2.5 mg/ml Type II Collagenase Solution 
• 25 mg Type II Collagenase 
• 10 mL of Medium 199  




• 2 mL (20% Fetal Bovine Serum) 
• 100 µL of 100x penicillin/streptomycin (1X) 
• 8 mL of Medium 199 
 
Endothelial cell growth media (EGM-2) for Cell Culture* 
• 500 mL EBM-2 basal medium  
• 10 mL Fetal Bovine Serum 
• 2 mL human Fibroblast Growth Factor beta (hFGF-β) 
• 0.5 mL human Endothelial growth factor (hEGF) 
• 0.5 mL Vascular endothelial growth factor (VEGF) 
• 0.5 mL Human recombinant 3 Long arginine Insulin-like growth factor 1 (R3-IGF-1) 
• 0.5 mL Ascorbic Acid 
• 0.5 mL Heparin 
• 0.2 mL Hydrocortisone 
• 0.5 mL Gentamicin/Amphotericin B 
    * supplemented with 1:500 Primocin to prevent contamination 
 
1. Fill 5 50mL conicals with 30mL non-sterile PBS. Label 1 tube "PBS." Fill 2 of these tubes 
 with 180uL EDTA (3mM) and label "EDTA 1" and "EDTA 2". Fill 1 tube with 15 µL of 
 1M DTT to make 0.5 mmol/L dithiothreitol (DTT) solution and label "DTT". Add 30 µL 
 of Y-27632 to 2 tubes and label "Shake 1" and "Shake 2". Put all conicals on ice.  
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2. Measure intestinal segment and open longitudinally, mucosal side-up into a petri dish filled 
 with PBS  
3. Perform mucosectomy by dissecting specimen into 0.5 x 2 to 3 cm mucosal strips (see image 
 below) 
4. Rinse strips briefly in PBS labeled tube. 
5. Use 100 µm strainer to transfer mucosal strips from PBS tube to DTT tube. 
6. Shake on rocker at room temperature for 30 min at 100 rpm.  
7. Transfer strips from DTT to EDTA 1 tube. 
8. Shake on rocker at 4ºC at 85 rpm for 15 minutes - prepare collagenase solution while waiting. 
9. Transfer strips from EDTA 1 tube to EDTA 2 tube. 
10. Return to rocker for 45 minutes (60 minutes total). 
11. Pour off solution, leaving the mucosal strips in the conical. Add in Shake 1 solution. 
12. Shake at 3 cycles per second for 2 minutes. 
13. Transfer tissue to Shake 2 tube. 
14. Shake again at 3 cycles per second for 2 minutes. 
15. Use the microscope to confirm that the mucosal strips are depleted of epithelial cells. 
16. Mince mucosal strips into 2 x 2 mm fragments (see image below) inside incubator and 
 transferred fragments into Collagenase solution for 30 minutes at 37ºC to digest 
 fragments. 
17. Mechanically agitate fragments to release cells by gently shaking the tube by hand. 
18. Pass suspension through 70 µm strainer and wash strainer with Isolation media to neutralize 
 collagenase. 
19. Use the microscope to confirm there are endothelial cells in solution. 
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20. Filter half the solution through 40 µm cell strainer to generate purer preparation, label each 
 solution. 
21. Centrifuge cell suspensions at 1800g for 3 min. 
22. Resuspend each cell pellet in 2.1 mL of media, with approximately 1-5 million cells per ml. 
23. Count cells with hemocytometer. 
• take 20 µl of sample 
• add 20 µl of 0.2% trypan blue dye (1:1) to each, mixed gently 
• add 10 µl of dyed cells to hemocytometer 
• count 4 squares, then take average to multiply by 20,000. This is the cell density in 
cells /mL.  
24. Take 300 µL from each sample for single color controls. Dilute with 1200 µl of Isolation 
 media. With this 1500 µl volume cell solution, divide equally into 5 tubes (each with 250 
 µL) labeled as: 
• CD326 only 
• CD45 only 
• CD31 only 
• Annexin V and 7-AAD together  
• unstained control 
25. Stain 1.8 mL of cell sample with antibodies for CD45 (1:250, 7.2 µl), CD326, CD31 (both 
 1:100, 18 µl each) and make single color controls (1:100, 2.5 µl each, except CD45 
 1:250, 1 µl). 
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26. Incubate stained cells on ice for 45 minutes. - prepare human fibronectin coated plates while 
 waiting, using cell count to determine # wells (assuming 5% CD31+ cells in FACS 
 isolation) 
• Create 10 µg/ml fibronectin solution by adding 10 µl of human fibronectin (1mg/ml) to 
990 µl of cold DPBS to each well of 48 well plate, incubate 30 minutes at room 
temperature 
• Aspirate solution, then allow each plate to dry with lid off inside tissue culture hood 
for 30 minutes 
27. Centrifuge samples at 1800 g for 5 minutes on clinical centrifuge at 4ºC. 
28. Rinse each sample 1 time with ice cold isolation media and resuspend in isolation media. 
29. Add vital dyes (Annexin V 1:1000, 7-AAD 1:1000) to labeled control tube and cell sample 
 tube right before walking over to FACS machine. Dilute stock dyes 1:10 then add 1 µL to 
 color controls. Use 1.9 µL for cell sample.  
30. Before sorting put cells stained with dead antibodies in 37ºC bath to warm for 30 seconds. 
31. Sort color controls to set FACS gates, then cell sample, isolate CD31+ cells only and 
 immediately plate on collagen coated plate at ~25,000 cells each 48 well plate well. 
32. Change media in 24 hours to remove dead cells, then change media every 48 hours until 





Figure C.1 Intestinal Mucosectomy (Left) Segment of human jejunum while mucosectomy is 
being been performed, with mucosal strips in PBS solution surrounding the segment of tissue. 
(Right) Mucosal strips minced into fragments to collect HIMECs after depleting the tissue of 
epithelial cells. 
 
C.3 Preliminary Results 
 I performed this protocol one time using human intestinal tissue and three times using 
murine intestinal tissues. For the MIMEC FACS experiments, I replaced the human FACS 
antibodies for the same fluorophore conjugated FACS antibodies (CD326, CD45, and CD31) 
specific for murine epithelial, immune, and endothelial cells, respectively. The data showing the 
portion of CD31+ cells isolated from each intestinal segment, as compared to the total parent 
population (excluding doublets and dead cells) of live single cells and the total population of 




Figure C.2 Fluorescence activated cell sorting (FACS) results (Left) FACS of CD31+ cells 
from one HIMEC isolation using my protocol, compared to one HIMEC isolation following the 
protocol for isolating myofibroblasts (Magness Lab Protocol). (Right) Three separate MIMEC 
isolations from either a single mouse or 2 pooled mice samples.  
 
 The human FACS results show a population of approximately 3.1% HIMECs can be 
isolated from an intestinal segment using CD31 as the positive marker for endothelial cells, 
sorting out CD45+ (leukocytes) and CD326+ (epithelial cells) and Annexin V+/7-AAD+ (dead 
cells). We also found that the population of CD31+ cells isolated from the tissue using the 
protocol for myofibroblast preparation was much lower (1.4%) than the protocol established 
above.  
 I was able to culture the isolated HIMECs for 7 days (Brightfield images below) on a 
well plate coated with human fibronectin. After 7 days in culture, the HIMECs achieved more 
than 90% confluence. HIMECs were then passaged and expanded for 2 days, and then HIMECs 
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were fixed and stained using the marker for endothelial cells CD31 (red) used during FACS and 
the nuclei marker DAPI (blue). 
 
 
Figure C.3 Human Intestinal Microvascular Endothelial Cell (HIMEC) Expansion (Left & 
Middle) Day 7 brightfield images of Passage 0 sorted HIMECs. (Right) Fluorescent image of 
Day 2 Passage 1 HIMECs stained for endothelial cell marker CD31 (red) and nuclei DAPI 
(blue).  
 
 The initial results of the human isolation show that HIMECs can be isolated from 
intestinal tissues using a mucosectomy and FACS. Fluorescently tagged and sorted HIMECs can 
then be grown and expanded on fibronectin-coated well plate to confluence. The first passage 
also shows that HIMECs can be passaged and retain the endothelial cell marker CD31, 
suggesting they are true endothelial cells and not transforming into fibroblasts. There is the 
potential to further expand HIMECs for long-term cultures and transplant expanded HIMECs 
into intestinal microphysiological systems to better recapitulate the human small intestine. An 
ideal human intestinal microphysiological system would also include immune components and 
extracellular matrix supporting cells, such as fibroblasts and smooth muscle cells, derived from 
the same donor tissue.  
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APPENDIX D: REPRINTING PERMISSIONS 
 
D.1 Reprinting Permissions 
1. Chapter 2 previously appeared in Analyst. Original citation: Kristina R. Rivera, Murat A. 
Yokus, Patrick D. Erb, Vladimir A. Pozdin, Michael A. Daniele. Measuring and 
regulating oxygen levels in microphysiological systems: Design, material, and sensor 
considerations. Analyst 144(10), 3190-3215. (2019). - Reproduced by permission of The 
Royal Society of Chemistry. 
2. Chapter 3 and Appendix A previously appeared in Biosensors and Bioelectronics. 
Original citation: Kristina R. Rivera, Patrick D. Erb, Ashlyn T. Young, Natalie A. 
Wisniewski, Scott T. Magness, Michael A. Daniele. Integrated phosphorescence-based 
photonic biosensor (iPOB) for monitoring oxygen levels in 3D cell culture systems. 
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